Rockefeller University

Digital Commons @ RU
Student Theses and Dissertations

2014

Functional and Structural Studies of the Human
Voltage-Gated Proton Channel
James Anthony Letts

Follow this and additional works at: http://digitalcommons.rockefeller.edu/
student_theses_and_dissertations
Part of the Life Sciences Commons
Recommended Citation
Letts, James Anthony, "Functional and Structural Studies of the Human Voltage-Gated Proton Channel" (2014). Student Theses and
Dissertations. Paper 177.

This Thesis is brought to you for free and open access by Digital Commons @ RU. It has been accepted for inclusion in Student Theses and
Dissertations by an authorized administrator of Digital Commons @ RU. For more information, please contact mcsweej@mail.rockefeller.edu.

FUNCTIONAL AND STRUCTURAL STUDIES OF THE HUMAN VOLTAGEGATED PROTON CHANNEL

A Thesis Presented to the Faculty of
The Rockefeller University
in Partial Fulfillment of the Requirements for
the degree of Doctor of Philosophy

by
James Anthony Letts
June 2014

© Copyright by James Anthony Letts 2014

FUNCTIONAL AND STRUCTURAL STUDIES OF THE HUMAN VOLTAGEGATED PROTON CHANNEL

James Anthony Letts, Ph.D.
The Rockefeller University 2014

The activity of voltage-gated cation channels underlies the action potentials that allow for
neuronal signaling and muscle contraction. The canonical family of voltage-gated K+,
Na+ and Ca2+ channels has been the subject of extensive electrophysiological,
biophysical, genetic, biochemical and structural characterization since the 1950s. These
channels all share a conserved six-transmembrane helix topology (S1-S6) in which the
first four transmembrane helices (S1-S4) form the regulatory voltage-sensor domain and
the last two transmembrane helices (S5 and S6) comprise the ion-conducting pore
domain. It was thought that all voltage-gated cation channels shared this conserved
domain architecture. However, this scheme was challenged by the discovery of the gene
for the voltage-gated H+ channel. This voltage-gated cation channel has a four
transmembrane helix topology that is homologous to the voltage-sensor domain of the
canonical voltage-gated cation channels alone, without a separate pore domain.
In this thesis, I present my work, which constitutes the first ever biochemical
characterization of the human voltage-gated H+ channel (hHV1). First, I demonstrate by
site-specific cross-linking that hHV1 is a dimer in the membrane and define the
oligomerization interface. Then, by developing methods for the heterologous expression,
purification and reconstitution of hHV1, I establish that the four transmembrane helix

voltage-sensor-domain-like putative channel protein is in fact responsible for H+
conduction. Next, I present my work on the structural characterization of hHV1 by X-ray
crystallography. I solved a low-resolution structure of a chimeric voltage-gated proton
channel but then demonstrated that although this channel is functional in a membrane, the
conformation seen in the crystal is non-native. Finally, I present my work on the analysis
of hHV1 by solution state NMR in detergent micelles. This technique allowed us to define
the secondary structure of the channel for the first time but full three-dimensional
structural characterization was determined to be unfeasible. From these studies, I
conclude that the HV channel structure is dependent on the constraints imposed by the
lipid bilayer and is destabilized upon detergent solubilization. Future structural studies of
HV channels will have to focus on channels imbedded within a membrane-like
environment.
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CHAPTER 1: INTRODUCTION

In order to support the highly complex processes required for life, cells must be able to
isolate desired components such as ions, small-molecule nutrients and biological
macromolecules and precisely control their concentrations such that the chemistry of life,
which derives from their interactions, can occur. This problem was solved in part by the
evolution of the cellular membrane; an oily barrier composed of a bilayer of amphipathic
phospholipids, which envelopes and defines the cell. Unlike the aqueous medium inside
and surrounding cells, which allows for the free diffusion and interaction of biological
molecules and ions, the membrane interior excludes water and hence creates an energetic
barrier for passage of hydrophilic components. In this way, the membrane solves the
problem of keeping the cells’ contents from diffusing away, allowing for the chemistry of
life to occur.
However, the existence of the membrane creates a new problem: it blocks the
release of waste products from inside the cell and the uptake of nutrients from outside.
The evolution of “membrane proteins” that express hydrophobic exteriors and therefore
are able to insert and reside within the cellular membrane, allowed cells to fully exploit
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the membrane’s properties. Indeed, some membrane proteins have evolved to catalyze
the specific conduction or transport of hydrophilic ions and molecules across the
membrane, thus helping the cell gain precise control over its contents.
Another property of the cellular membrane that cells have evolved to utilize is its
ability to separate electrical charge, i.e. its capacitance. Cells can store energy across the
membrane by controlling the relative concentrations of ions inside and outside the cell.
This energy manifests itself as an electrical potential across the membrane, which the cell
can then use to do work. In most cells, this work is performed locally on a specific class
of voltage-sensitive ion channels or enzymes, allowing for the fast transmission of signals
along the cell membrane. Moreover, in certain organisms, specialized electrogenic organs
have evolved that use biologically generated electric fields from an organized array of
cells to detect the electric fields of other organisms, a process known as electroreception.
In extreme cases, such as the electric knifefish (a.k.a. electric eel) and the electric rays,
biological electricity is used in hunting to stun or even kill prey.
In this chapter, I will discuss how cells generate and control electrical potentials
across the membrane using ion channels and transporters. I will introduce the canonical
voltage-gated ion channels and how cells can use them to directly tie the membrane
potential to membrane permeability. Then, I will introduce the biophysics of the voltagegated proton channel and discuss its diverse physiological roles. Finally, I will discuss the
motivation and aims for my research on the human voltage-gated proton channel.
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1.1 GENERATION AND CONTROL OF CELLULAR ELECTRICITY
1.1.1 Channeling Ions – the charge carriers of bioelectricity
The inorganic ions Na+, K+, Ca2+ and Cl- are the major charge carriers used to generate
electrical potentials across the membranes of cells (Hille 2001). The relative abundance
of these ions on either side of the membrane is regulated by the activity of two classes of
membrane proteins: ion channels and ion transporters (a.k.a. ion pumps).
Ion channels allow only for the passive diffusion of ions down their
electrochemical gradient and are defined (and named) by two major properties:
selectivity and gating. Selectivity refers to the fact that different channels show a
preference for the conduction of specific ionic species. For example, a K+ channel allows
for the easy passage of K+ ions across the membrane but not the easy passage of Na+ ions.
Gating refers to the ability of the channels to open and close, that is, to transition between
conductive and non-conductive states. The stimulus that causes a channel to gate varies
widely between channels. Some channels are gated by the binding of ligands (for
example the ATP-gated K+ channel, KATP), others are gated by the transmembrane
potential (for example the voltage-gated K+ channel, KV), others, by the mechanical state
of the membrane itself (e.g. tension) and others, by environmental cues such as
temperature and light (Hille 2001). Many channels are gated to varying degrees by the
combination of different stimuli, for example the Slo1 K+ channel is gated both by
transmembrane voltage and by binding of intracellular Ca2+ ions (Barrett et al. 1982).
Ion pumps use cellular energy (usually in the form of ATP) to pump ions against
their concentration gradient (Albers 1967). For example, the Na+ K+ ATPase pumps three
3

Na+ ions out of the cell while at the same time pumping two K+ ions into the cell and
hydrolyzing an ATP molecule to form ADP and inorganic phosphate (Post et al. 1972).
Since the number of ions pumped in each direction is uneven and the charge on each ion
is the same, this pumping cycle is electrogenic. Thus, the Na+ K+ ATPase separates
charge across the membrane, thereby charging the membrane capacitor and contributing
to the membrane potential (Albers 1967). In the next section, I will describe how the
activity of ion channels and pumps working in concert can be used to control the
electrical potential of the cell.

1.1.2 Electro-diffusion – how the membrane voltage is set
Ion pumps consume cellular energy to pump ions against their concentration gradients
and thereby establish an uneven distribution of ions across the membrane (Albers 1967).
For example, in mammalian skeletal muscle the distribution of ions is such that [Na+] is
high outside relative to inside, [K+] is low outside relative to inside, [Ca2+] is high outside
relative to inside and [Cl-] is high outside relative to inside (Table 1.1; Hille 2001).
Because each ion carries a charge, the free diffusion of the ions across the semipermeable membrane does not depend solely on the concentration difference and does
not go to equilibrium when the concentration of the specific ionic species reaches the
same value on either side of the membrane (Nernst 1888; Nernst 1889; Hille 2001). For
example, diffusion of a single K+ ion down its concentration gradient removes a positive
charge from the inside of the cell and adds a positive charge to the outside. Therefore,
diffusion of ions across the membrane creates an electrical potential resulting in a force
opposing the further diffusion of similarly charged ions. Equilibrium is reached when the
4

strength of the electrical potential results in balanced diffusion, such that there is no net
flux of ions across the membrane. The electrical potential at which this balance is reached
is known as the Nernst equilibrium potential (ES) and is calculated for each ionic species
(S) using the Nernst equation (equation 1.1), where R is the gas constant, T is the
temperature, zS is the charge on the ionic species, F is Faraday’s constant, [S]o is the
external concentration of the ion and [S]i is the internal concentration (Nernst 1888). The
Nernst equilibrium potentials for each of the four major biologically important inorganic
ionic species in muscle cells at 37°C are shown in Table 1.1 (Hille 2001).

ES =

RT [S] o
ln
zSF [S] i

{1.1}

€
Table 1.1 Free
ion concentrations and equilibrium potentials for mammalian
skeletal muscle (adapted from Hille 2001)

a

Concentration (mM)

[S]o
[S]i

Potentiala (mV)

145

12

12

+67

K+

4

155

0.026

-98

Ca2+

1.5

100 nM

15,000

+129

Cl-

123

4.2b

29b

-90b

H+ c

4 × 10-5

1 × 10-3

0.04

-86

Extracellular

Intracellular

Ion

Concentration (mM)

Na+

Calculated from equation 1.1 at 37°C

b

Calculated assuming a -90 mV resting potential for the muscle membrane and that Cl- is

at equilibrium at rest.
c

€

Equilibrium

Values from Carter et al. 1967
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Because the cell membrane separates many different ionic species, the reversal
potential (Erev) at which there is no net ion flux across the membrane is not found at the
Nernst equilibrium potential of a single ion, but at a weighted mean of all the Nernst
potentials (Goldman 1943; Hodgkin & Katz 1949). The different Nernst potentials are
weighted by the relative permeability of the different ions according to the GoldmanHodgekin-Katz voltage equation, which if K+, Na+ and Cl- are the permeant ions gives
equation 1.2, where PS is the permeability of the membrane to the specific ionic species
(S = K+, Na+, Cl-) and all other terms are defined as in equation 1.1 (Goldman 1943;
Hodgkin & Katz 1949; Hille 2001).

E rev

+
+
−
RT PK + [K ] o + PNa + [Na ] o + PCl − [Cl ] i
=
ln
F
PK + [K + ] i + PNa + [Na + ] i + PCl − [Cl− ] o

{1.2}

€ 1.2 holds only in the simplified case in which there are no active
Equation
electrogenic pumps in the cell and all of the permeant ions carry the same absolute value
of charge (the equation takes an alternate form when divalent cations such as Ca2+ are
taken into account; Hille 2001). Although PS is defined as the rate of flux of ion S across
the membrane (in units of cm/s), it is proportional (though non-linearly) to the
conductance of ion S across the membrane (gS, with units of Siemens [kg-1·m-2·s3·A2]),
which is a function of the number of open ion channels that can conduct ion S and the
driving force for the conduction of that ion (Hodgkin & Huxley 1952c; Hille 2001). If the
membrane is only permeable to a single ionic species, equation 1.2 simplifies to the
Nernst equilibrium potential for that ion (equation 1.1).

6

In the average resting cell, the presence of inward rectifying K+ channels makes
the membrane far more permeable to K+ than to any other ionic species; therefore, Erev is
close to EK (approximately -60 to -90 mV, see Table 1.1; Hille 2001). Through changes
in the permeability of the membrane to the different ionic species (i.e. opening and
closing of K+ and Na+ ion channels), the cell can control its Erev, allowing it to set the
membrane potential to any value between EK ≈ -98 mV and ENa ≈ +67 mV (Table 2;
Goldman 1943; Hodgkin & Katz 1949; Hille 2001). Voltage-gated cation channels,
whose open probability is a function of the membrane potential, directly tie the
permeability of the membrane to K+, Na+ and Ca2+ to the membrane potential, which
allows for the rapid propagation of electrical signals across the membrane known as
action potentials (Hodgkin & Huxley 1952a).

1.2 VOLTAGE-GATED ION CHANNELS AND THE VOLTAGE SENSOR DOMAIN
1.2.1 Discovery and common features of voltage-gated cation channels
Hodgkin and Huxley first described voltage-gated cation currents in their classical studies
on the action potentials of the giant squid axon in the 1950s (Hodgkin & Huxley 1952c;
Hodgkin & Huxley 1952b; Hodgkin & Huxley 1952d; Hodgkin & Huxley 1952a). As
their name suggests, the opening and closing (i.e. gating) of the voltage-gated cation
channels is strongly dependent on the transmembrane potential. It wasn’t until the 1980s
that the first genes of a voltage-gated Na+ (NaV) channel and a voltage-gated K+ (KV)
channel were identified and cloned (Noda et al. 1984; Tempel et al. 1987). These
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sequences were then followed by the sequences of many more voltage-gated Na+, K+ and
Ca2+ channels from many different species (for a review see Yu & Catterall 2004).
Analysis of these sequences identified a simple pattern: KV channels were made
up from a short polypeptide subunit, whereas, NaV and CaV channels were made up of a
longer polypeptide containing four “KV-channel like” domains (Rehm & Tempel 1991;
Guy & Durell 1994). Each one of the subunits or domains shared a conserved sixtransmembrane-helix (6-TM) architecture (S1-S6) with a conserved series of positively
charged arginine or lysine amino acid residues along the fourth transmembrane helix
(S4), as well as conserved negatively charged residues on (S1 and S2; Fig 1.1; Rehm &
Tempel 1991; Guy & Durell 1994; Yu & Catterall 2004; Bezanilla 2000). For the KV
channels, it was shown that the last two transmembrane helices (S5 and S6) comprise the
pore of the channel (Fig. 1.1; Mackinnon & Miller 1989; Mackinnon et al. 1990;
Mackinnon & Yellen 1990; Yellen et al. 1991). The discrepancy between the length of
the KV channel and NaV/CaV channel genes was resolved when it was found that four
identical KV channel subunits come together in the membrane to form a four-fold
symmetric tetramer (Mackinnon 1991). Based on sequence analysis, the first four
transmembrane helices (S1-S4) were proposed to fold into a separate domain that was
thought to be responsible for voltage sensing, and hence was coined the voltage-sensor
domain (VSD; Fig. 1.1; Greenblatt et al. 1985; Nelson et al. 1999).

8

Fig. 1.1 Topology of voltage-gated channels
(A) Schematic representation of the six-transmembrane helix topology of KV channels
which become concatenated to form the topology of the NaV or CaV channels (B). The
helices that comprise the voltage-sensor domain (S1-S4) in each domain are shown in
orange while the helices that comprise the pore (S5 and S6) are shown in brown. The
conserved gating-charge residues on S4 are indicated by “+” signs. Horizontal black lines
denote the membrane boundaries (cytoplasm side down).
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One of the most well characterized families of voltage-gated cation channels is
the voltage-gated K+ channel family KV1.1 (for a review see Fedida & Hesketh 2001).
This channel is closed at hyperpolarized membrane potentials (negative inside relative to
outside) and opens upon depolarization (Fig. 1.2). By measuring the instantaneous
current-voltage relation from the tail currents and plotting the normalized current (I/Imax)
as a function of transmembrane potential (V), it is possible to get an estimate of the open
probability of the channel at the different values of V (Fig. 1.2; Hodgkin & Huxley
1952c; Hille 2001). This normalized current-voltage (IV) curve can be modeled by the
two-state Boltzmann function shown in equation 1.3, where z is the effective gating
charge on the channel (see below), Vmid is the voltage at which half the channels are open
and F, R and T are defined as in equation 1.1.

I
I max

=

1
# zF
&
1+ exp% −
V − Vmid )(
(
$ RT
'

{1.3}

€ equation shows, at V greater than Vmid the exponential term approaches
As this
zero and the ratio I/Imax goes to one, at V less than Vmid the exponential term approaches
infinity and I/Imax goes to zero, at V equals Vmid the exponential term equals one and I/Imax
equals 0.5.
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Fig. 1.2 KV1.1 channel activity
(A) Whole-cell current elicited from CHO cells expressing rat KV1.1 according to the
voltage-step protocol depicted in the schmatic. (B) Current-Voltage plot (IV curve) of tail
currents elicited by stepping back to the resting potential of (-80 mV) after each voltage
step corrected for leak and fitted to the two-state Boltzmann (equation 1.3). Data
provided by Josefina del Mármol.

In order to sense and undergo conformational changes in response to changes in
the transmembrane voltage, the channels must contain “gating charges” within the
membrane interior, which move in response to changes in the transmembrane potential,
resulting in channel gating (Hodgkin & Huxley 1952a). Gating charges have been
directly observed during the gating of voltage-gated channels (Armstrong & Bezanilla
1973; Taglialatela & Stefani 1993; Perozo et al. 1992; Perozo et al. 1993). As equation
1.3 shows, this gating charge (z) is a scalar multiplier of the voltage difference (V-Vmid).
Therefore, the gating charge modifies the steepness at which changes in voltage near Vmid
alter the I/Imax ratio: the larger the gating charge, the smaller the voltage difference (VVmid) is required to bring I/Imax to one or zero. These gating charges were measured to be
12 to 14 elementary charges per channel (3.0 to 3.5 per subunit) and identified to be the
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conserved positively charged amino acid residues on the S4 helix with contributions from
a conserved negatively charged residue on S2 (Seoh et al. 1996; Aggarwal & Mackinnon
1996).
Although these charges are required for the proper functioning of voltage-gated
cation channels, due to the low electrical permittivity of the membrane interior, charges
are unstable within its depths (Yaroshchuk 2000). How voltage-gated channels
circumvent this energetic barrier and stabilize the gating-charge arginines in the
membrane was not fully understood until the elucidation of the eukaryotic KV channel
structures (Long et al. 2005; Long et al. 2007).

1.2.2 Structure of the KV channel – the VSD revealed
The first structures of the prokaryotic KV channel KVAP established the domain
arrangement of the channel’s fold (Jiang et al. 2003a). As was previously demonstrated,
the KV channel was seen to be a four-fold symmetric tetramer with the tetramerization
interface completely comprised of the last two transmembrane helices (S5 and S6)
(Mackinnon 1991; Jiang et al. 2003a). The S5 and S6 helices from each subunit come
together to form a central pore, with the ion conduction pathway down the central fourfold symmetry axis (Fig. 1.3A) (Jiang et al. 2003a). This pore structure was nearly
identical to the structures of the non-voltage-gated K+ channels that had previously been
solved (Doyle et al. 1998; Zhou et al. 2001; Jiang et al. 2002).
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Fig. 1.3 KV channel Structure
(A) The pore domain of the KV1.2 channel shown in stick representation surrounded by
translucent atom space filling spheres with carbon grey, nitrogen blue, oxygen red and
sulfur yellow. VSDs have been removed for clarity (Long et al. 2007). The surface of the
pore is shown in blue drawn with the program HOLLOW (Ho & Gruswitz 2008). (B) The
KV channel tetramer looking down from the extracellular medium showing the peripheral
arrangement of VSDs around the central pore domain, each subunit is colored differently
with each α-helix represented as a cylinder (Long et al. 2007).

13

The first four transmembrane helices (S1-S4) arrange themselves around the
periphery of the pore and form the VSD, which is responsible for voltage dependent
conformational changes (Fig. 1.3B) (Greenblatt et al. 1985; Caprini et al. 2001).
Although it was demonstrated that the conformation of the VSD seen in the full-length
KVAP structure was in a non-native conformation (Jiang et al. 2003a; Lee et al. 2005;
Long et al. 2005; Long et al. 2007), the structure did allow for the identification of the
functionally important S3-S4 helix-turn-helix motif coined the “voltage-sensor paddle”
(Jiang et al. 2003a). It has subsequently been shown that this motif is found in all VSD
containing proteins and that it can be swapped between different VSDs and still result in
functional voltage-gated channels (Alabi et al. 2007). Structures of the isolated VSD
from KVAP and, later, the structure of eukaryotic KV channels revealed the native fourhelix bundle fold of the VSD (Fig. 1.4; Jiang et al. 2003a; Long et al. 2005; Long et al.
2007). These structures allowed the first understanding of how the gating-charge
arginines are stabilized within the membrane and were later followed by the structures of
prokaryotic NaV channels (Payandeh et al. 2011; Zhang et al. 2012; Payandeh et al.
2012).
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Fig. 1.4 The VSD structure from the KV1.2-2.1 Paddle Chimera
Structure of the VSD is shown in ribbon representation with the side chains of charged
amino acid residues within the transmembrane region shown as sticks with carbon grey,
nitrogen blue and oxygen red (Long et al. 2007). The side chain of F233 is shown in blue.
The S4 gating-charge residues are numbered according to the equivalent positions along
the S4 of Shaker (Tempel et al. 1987). Horizontal black lines denote the approximate
membrane boundaries (cytoplasm side down). The sites of charge compensation within
the membrane are highlighted by pink circles.
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Because of the large energy cost of burying a charge in the low permittivity
medium of the membrane interior, membrane proteins have evolved to minimize the
number of charged amino acid side chains within their transmembrane segments
(Eisenberg et al. 1984). However, if —such as in the case of a VSD— the presence of a
charged residue in the membrane is mechanistically required, then compensation for the
charge must be provided by the protein structure. In many cases, this compensation is
provided by the presence of oppositely charged residues protruding from other parts of
the protein. Charge compensation of this type can readily be seen in the structures of
VSDs. As shown in Fig. 1.4, all of the positively charged S4 gating charges that are
buried within the hydrophobic membrane are paired with a conserved negatively charged
residue from one of the other transmembrane helices (Glu183 on S1, Glu226 and Glu236
on S2 and Asp259 on S3a). This pairing stabilizes the charges in the membrane, hence
stabilizing the structure of the VSD itself.

1.2.3 Mechanism of voltage sensing – the charge transfer center
The internal charge-compensation site occupied by K5 in Fig. 1.4 is known as the charge
transfer center (Tao et al. 2010). This site differs from the external charge-compensation
sites by the presence of two negatively charged side chains and the proximity to the
“phenylalanine gap” (represented by the blue side chain of F233 in Fig. 1.4). This
phenylalanine gap forms a hydrophobic barrier that separates the external and internal
charge compensation clusters and is considered the most constrictive point within the
VSD structure (Fig. 1.3; Tao et al. 2010; Starace & Bezanilla 2004).
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The structure shown in Fig. 1.4 is the depolarized conformation of the Kv1.2-2.1
paddle chimera VSD (Long et al. 2007). It is thought that, during gating, the S4 gating
charge residues that occupy each of the charge compensation sites changes. For example,
in the hyperpolarized state immediately preceding the depolarized state, R2 would be in
the external charge compensation site occupied by R3 in Fig. 1.4, R3 would be in the site
occupied by R4 and R4 will be in the internal charge transfer center occupied by K5. This
coordinated movement between the sites would allow for sustained charge compensation
throughout the gating conformational changes of the VSD. In more hyperpolarized
conformations, it is thought that R2 or even R1 would occupy the charge transfer center
(Tao et al. 2010). This model of gating charge motion provides a structural and
mechanistic understanding for the existence of multiple closed states of the VSD, the
existence of which was first proposed by Cole and Moore in 1960 to explain the observed
delay in channel activation after prolonged strong hyperpolarizations (Cole & Moore
1960). The clear mechanistic importance of the pattern of charged residues within the
transmembrane region of the VSD is demonstrated by the conservation of this pattern of
charges throughout evolution (Yu & Catterall 2004; Bezanilla 2000).

The HV channel constitutes a unique member of the voltage-gated cation channel
family. The remainder of this chapter will introduce the properties of this channel, its
many important physiological roles and the scientific questions it poses.
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1.3 VOLTAGE-GATED H+ CHANNELS
1.3.1 Discovery of HV channels
Voltage-gated H+ channels were first proposed to exist by Fogel and Hastings in 1972 for
their model of bioluminescence in the single cellular eukaryotic algae Noctiluca miliaris
(Fogel & Hastings 1972). However, the first biophysical characterization of voltage-gated
H+ currents was not until ten years later when Thomas and Meech published their
voltage-clamp studies on snail neurons (Thomas & Meech 1982). Thomas and Meech
found that, upon depolarization, the membranes of these cells greatly increase their
permeability to H+, which led them to propose that “H+ channels may be more
widespread than hitherto suspected” (Thomas & Meech 1982). This proposal was
confirmed by the subsequent discovery of HV channels in many different cell types from
a diverse set of organisms (Barish & Baud 1984; DeCoursey 1991; DeCoursey & Cherny
1993; Kapus et al. 1993; Demaurex et al. 1993; Taylor et al. 2011; Smith et al. 2011).
The Clapham and Okamura groups published the first genes for HV channels in
2006. As explained in the previous section, the pattern of evolutionarily conserved
charges within the VSD makes up a signature sequence. By using the sequences of
known VSDs, Ramsey et al. and Sasaki et al. searched the human and mouse genomes
with the aim of identifying any previously unknown VSD containing proteins (Ramsey et
al. 2006; Sasaki et al. 2006). In 2006, both groups published the discovery of the
previously unknown gene of the voltage-gated H+ (HV) channel (Ramsey et al. 2006;
Sasaki et al. 2006).
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1.3.2 Domain overview of HV channels—not your canonical voltage-gated channel
The sequence of hHV1 is shown in Fig.1.5A and is very different from all previously
described voltage-gated cation channels in that it does not have a 6-TM topology (see Fig
1.1). HV channels contain the first four transmembrane helices (S1-S4) of the VSD but
lack the last two transmembrane helices that comprise the pore domain in the canonical
6TM channels (KV, NaV and CaV channels, Fig. 1.1). Nonetheless, when these genes are
expressed in HEK cells, robust depolarization-dependent, Zn2+-sensitive, H+ currents can
be measured (Ramsey et al. 2006; Sasaki et al. 2006).
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Fig. 1.5 Primary structure and transmembrane topology of hHV1
(A) Amino acid sequence of hHV1. The predicted unstructured N-terminus is underlined
in red, the predicted transmembrane helices are highlighted in grey and labeled S1-S4,
the predicted C-terminal coiled-coil (Lupas et al. 1991) is underlined in black, the
putative short helices within the N-terminus are boxed by blue dashed lines, the two
known phosphorylation sites are boxed in green (Musset et al. 2010a) and the two
histidines that are known to bind Zn2+ are boxed in orange (Ramsey et al. 2006). Critical
residue D112 in S1 is boxed in blue. (B) Transmembrane topology of the hHV1 channel.
Horizontal black lines denote the approximate membrane boundaries (cytoplasm side
down). The S4 gating charge residues are represented as “+” signs.
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Human HV1 (hHV1) is comprised of 273 amino acid residues with both the N- and
C-termini residing in the cytoplasm (Fig. 1.5B). Secondary structure prediction identifies
the four transmembrane helices of the VSD fold (highlighted in grey in Fig. 1.5A and
labeled S1 through S4). Although it is very clear that these four transmembrane helices
are present in the structure of the channel, the exact boundaries (i.e. the amino acid
positions at which the helices start and terminate) are unknown. The first ~90 amino acid
residues of hHV1 are predicted to be mostly disordered (Fig. 1.5A). The high proportion
of negatively charged glutamate (E) and aspartate (D) residues, as well as the many
proline (P) residues in the N-terminus, suggest an unstructured random coil. However,
secondary structure prediction algorithms indicate that two short helices may be present
in the N-terminus: one spanning residues A18-H27 (distant from the transmembrane
helices in primary sequence) and the other spanning residues D87-S97, directly preceding
S1 (Cole et al. 2008). Short amphipathic helices preceding the S1 have been observed in
the structures of other voltage-sensor domains (VSDs) and have been termed S0 (Long et
al. 2007; Butterwick & Mackinnon 2010). Therefore, it is possible that hHV1 also
contains a S0 helix preceding S1. It is also interesting to note that a phosphorylation site
that affects channel gating has been identified at T29, adjacent to the short predicted Nterminal helix. This suggests that this region of the protein may interact closely with the
transmembrane domain (Musset et al. 2010a). The C-terminal end of human HV1 is
predicted to comprise one half of a coiled-coil structure; a number of structural and
biochemical studies examining this isolated sequence demonstrate that it forms a
homodimer coiled-coil structure (Li et al. 2010; Fujiwara et al. 2012; Fujiwara et al.
2013a).
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1.3.3 Biophysical features of HV channels
In addition to exhibiting near perfect selectivity for H+ (DeCoursey 2003b), the voltagegated H+ currents measured in a variety of organisms share specific biophysical features,
as described below.

ΔpH dependence of gating
Very early on, it was found that the gating of the depolarization activated H+ current was
not solely dependent on the transmembrane potential, but that it also strongly depended
upon the pH difference across the membrane (ΔpH, defined as external pH [pHo] minus
internal pH [pHi]; Byerly et al. 1984). An example of currents elicited from whole-cell
patch clamp recordings of HEK cells expressing hHV1 is shown in Fig. 1.6 at three
different values of pHo (Fig. 1.6A pHo = 7.0, Fig. 1.6B pHo = 6.5 and Fig. 1.6C pHo =
6.0). It is clear from the current recordings that the different pHo has an effect on the rate
of channel opening and closing (Fig. 1.6A-C). By plotting an IV curve from the
normalized tail currents, it becomes clear that the different pHos also have a strong effect
on the voltage dependence of the gating (Fig. 1.6D). Reducing pHo (increasing the
external concentration of H+) results in a significant shift of the threshold voltage (Vthr,
defined as the voltage at which you begin to see H+ current) to more depolarized
potentials (rightward shift on the IV plot; Fig. 1.6D). This ΔpH dependence is also seen
upon changes of pHi and results in the channels only ever opening at membrane
potentials more positive than the Nernst equilibrium potential for H+ (EH; Fig. 1.6D;
Cherny et al. 1995; DeCoursey 2003b).
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Fig. 1.6 Whole cell patch clamp recording of HEK cells expressing hHV1 channels
Current recordings from the same HEK cell expressing hHV1 channels at different pHo
(A) pHo = 7.0, (B) pHo = 6.5 and (C) pHo = 6.0; pHi = 6.5 for each recording. Voltage
step protocols are represented schematically above each recording. (D) Normalized IV
curves plotted from tail-currents. The arrows at the bottom indicate the different values of
EH for each ΔpH shown (calculated by equation 1.1).
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Through their dependence on ΔpH, these channels become outward rectifiers:
they only ever open in resting mammalian cells such that the electrochemical potential
for H+ conduction is outward. In other words, HV channels are acid extruders, only
opening to allow H+ to leave the cytoplasm. This property defines the many physiological
roles played by the HV channels (discussed in the next section). Although models have
been proposed for how this gating behavior could be achieved (Cherny et al. 1995;
DeCoursey 2003b), the mechanism remains unknown and the amino acid residues
involved in pH sensing on both sides of the membrane remain to be identified.

Inhibition by Zn2+
To varying degrees, all HV channels thus far characterized are inhibited by polyvalent
metal cations, with Zn2+ in general being the most potent inhibitor (Byerly et al. 1984;
Mahaut-Smith 1989; DeCoursey 2003b). It is thought that the major mechanism of
inhibition is through the direct binding of Zn2+ to an extracellular receptor site on the
channel, which stabilizes the hyperpolarized (closed) conformation and thereby shifts the
voltage-dependence of gating to more depolarized potentials (Cherny & DeCoursey
1999; DeCoursey 2003b). The binding of Zn2+ was found to be highly sensitive to pHo
and detailed competition studies indicated that H+ and Zn2+ compete for binding to the
same site composed of multiple groups (Cherny & DeCoursey 1999). Furthermore, since
both external H+ or Zn2+ binding stabilize the closed conformation, it was proposed that
the groups responsible for Zn2+ binding may also be responsible in part for the ΔpH
dependence of gating (Cherny & DeCoursey 1999).
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After the discovery of the HV gene, Ramsey et al. identified the Zn2+ binding site
in hHV1 (Ramsey et al. 2006). The binding site bridges two histidine residues, one at
position 140 (near the extracellular end of S2) and the other at position 193 (within the
voltage-sensor paddle motif; see Fig. 1.5A). When either or both of these two histidines
are mutated to alanine, Zn2+ inhibition is alleviated (Ramsey et al. 2006). However, a
systematic study of the role of these histidine residues on the ΔpH dependence of gating
has yet to be published. It is also interesting to note that the HV channel found in
calcifying coccolithophores (see below) does not have histidine residues at these
positions and yet remains inhibited by extracellular Zn2+ ions, indicating that an
alternative receptor exists for Zn2+ in these channels (Taylor et al. 2011).

Conduction via protein mediated hydrogen-bonded chain
The conduction of H+ both in water and through proteins is dissimilar to that of other ions
in that it does not occur via simple diffusion but via the formation of transient covalent
bonds (de Grotthuss 1806; Cukierman 2006; DeCoursey 2003b). Channel-mediated
conduction of H+ across the membrane has commonly been found to occur by two
distinct mechanisms: as H3O+, via a continuous water wire as in the gramicidin channel
(Cukierman 2000), or as H+ via a hydrogen-bonded chain (the transfer of the H+ to a
titratable amino acid side chain in the channel which then passes it to water on the other
side of the membrane) as in the influenza M2 channel (Pinto et al. 1992; DeCoursey
2003b).
Which mechanism do HV channels utilize for H+ conduction? By measuring the
effect of buffer concentration, temperature and the deuterium (2H) isotope on proton
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conduction, DeCoursey and Cherny established that the rate of H+ conduction through HV
channels is not diffusion-limited (DeCoursey & Cherny 1996; DeCoursey & Cherny
1998; DeCoursey & Cherny 1997). This indicates that there is a rate-limiting step for H+
conduction as it permeates the channel. When comparing the temperature and deuterium
isotope effects to other channels with established conduction mechanisms, such as the
gramicidin and influenza M2 channels, the values found for hHV1 are more consistent
with a hydrogen-bonded chain mechanism, as opposed to a continuous water-wire
mechanism (DeCoursey 2003b). This titratable residue was later identified in hHV1 to be
D112 on the S1 helix (Fig. 1.5A; Hille 2001; Musset et al. 2011). Mutation of this residue
to valine results in a defective H+ channel unable to conduct H+; mutation to other amino
acid residues results in Cl- leakage through the channel (see Chapter 3 for a more
complete discussion; Musset et al. 2011).

1.3.4 HV channels diverse physiological roles
Although the first description of HV channel currents was from snail neurons, the role that
the channels play in neuronal physiology remains poorly understood. In humans, HV
channels are mainly found in cells of the immune system and in sperm cells (Barrett et al.
1982; DeCoursey 2010; Capasso et al. 2010; Lishko et al. 2010). In addition, a
potentially significant role of HV channel activity is being uncovered in cancer cells
(Wang et al. 2012; Wang et al. 2013a). In this section I will briefly discuss a selection of
the physiological roles that HV channels play in humans, as well as some of the important
roles they play in single-celled eukaryotes.
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Phagocytes
HV channels have been best characterized physiologically for the role they play in
stabilizing the activity of the NADPH oxidase during oxidative bursts in phagocytes’
phagosomes (DeCoursey 2010). Upon encountering a bacterium, a phagocyte engulfs it
into a specialized vacuole known as the phagosome. Through the activity of the NADPH
oxidase (which transfers electrons from NADPH to molecular oxygen, generating
NADP+ and H+ in the cytoplasm and the superoxide ion [O2-] in the phagosome), the
macrophage attacks the bacterium with reactive oxygen species (ROS; DeCoursey 2010).
In this way, the activity of the NADPH oxidase results in the depolarization of the
phagosome membrane (inside negative with respect to the cytoplasm) and the
acidification of the cytoplasm. Because of the voltage-dependence of NADPH oxidase
activity, this activity would be self-inhibitory in the absence of any compensatory
mechanism (DeCoursey et al. 2003). HV channels in the phagosome membrane provide
the required compensatory mechanism: they open in response to the NADPH-oxidaseinduced membrane depolarization and conduct H+ into the phagosome, simultaneously
repolarizing the membrane and deacidifying the cytoplasm (DeCoursey et al. 2003;
DeCoursey 2003a).

Human sperm cells
The HV channel is integral for regulation of the internal pH of the sperm cell (Lishko et
al. 2010; Lishko & Kirichok 2010). The pH of the sperm cytoplasm is a major regulator
of sperm cell motility, capacitation, hyperactivation and the acrosome reaction, all
essential processes for the fertilization of the egg (Lishko et al. 2012). For example, the
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capacitation process (by which sperm cells go from a quiescent state to an actively
swimming state) was known to involve the extrusion of protons out of the sperm
cytoplasm (Giroux-Widemann & Jouannet 1991; Hamamah & Gatti 1998). In 2010,
Lishko et al. showed this proton efflux in human sperm cells is facilitated by HV channels
(Lishko et al. 2010).
Upon the identification of role played by HV chanels in sperm cell physiology, a
potential mechanism for the role of Zn2+ in sperm cell activation was proposed (Lishko et
al. 2010). Since the very early characterization of HV current, it was shown that Zn2+ is a
potent inhibitor of the channel (see above; Mahaut-Smith 1989). It is telling that the
highest concentration of Zn2+ in the human body is found in the seminal fluid (Saaranen
et al. 1987; Lishko et al. 2012). Through inhibition of HV channels, a high concentration
of Zn2+ would prevent premature sperm capacitation; conversely, removal of Zn2+ would
promote proton efflux from the sperm cytoplasm. It has been demonstrated in rats that,
upon entering the female reproductive tract, the Zn2+ from the seminal fluid is rapidly
diluted (Gunn & Gould 1958). There is also evidence that the lipid-derived hormone
anandamide present in the human reproductive system (Schuel & Burkman 2005) may
have a direct activating influence on HV channels (Lishko et al. 2010).

Cancer
The metabolism of cancer cells is markedly different than that of normal cells (for a
review see Griffin & Shockcor 2004). Cancerous cells require a large amount of energy
to fuel their expansive growth. Therefore, many cancers are characterized by increased
levels of metabolism, specifically increased activity of the glycolytic pathway (Gatenby
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& Gillies 2007). Furthermore, because of the high cell density of tumors, cancer cells
tend to be hypoxic (Knowles & Harris 2001). Therefore, due to their high metabolism
and their hypoxic environment, cancer cells start to accumulate high levels of H+ (a
byproduct of anaerobic glycolysis) in their cytoplasm (Gatenby & Gillies 2007). Without
a mechanism for extruding protons out of the cytoplasm, these cells would not be able to
continue proliferating or to metastasize.
The discovery of the expression of hHV1 in highly metastatic breast and colorectal
cancer cells, both from human cancer biopsies and established cancer cell lines, has led to
the hypothesis that these channels are responsible for the regulation of cytoplasmic pH
that allows the high proliferation of these cells (Wang et al. 2011; Wang et al. 2012;
Wang et al. 2013a). Additionally, it has been demonstrated that HV channels are
overexpressed in the highly metastatic glioma cell SHG-44 and that inhibition of HV
channel activity by Zn2+ when these tumors are implanted into nude mice results in
significantly smaller tumor size (Wang et al. 2013b). These findings indicate that HV
channels might be effective targets for anticancer drugs.

Calcification in Coccolithophores
Coccolithophores comprise a large group of phytoplankton that is found in all oceans
around the globe (Winter & Siesser 1994). These unicellular algae generate elaborate
calcium carbonate scales (coccoliths) of unknown physiological function (Marsh 1999).
Nonetheless, because of the tendency of coccolithophores to grow into immense blooms,
they are the most numerous calcifying organisms in the ocean. Coccolithophores
significantly impact marine biogeochemical cycling and atmospheric chemistry by
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incorporating inorganic carbon into their coccoliths and carrying it to the bottom of the
ocean when they die (Rost & Riebesell 2004).
The process of coccolith formation occurs within an intracellular compartment
and involves the combination of Ca2+ and bicarbonate (HCO3-) to produce calcite
(CaCO3), releasing one mole of H+ for every mole of CaCO3 produced (Marsh 1999;
Brownlee & Taylor 2004; Paasche 2001). Without a mechanism for H+ removal from the
cytoplasm, it is predicted that coccolith production would acidify the cell at a rate of ~0.3
pH min-1 (Taylor et al. 2011). The mechanism of H+ dumping from the coccolithophores
was not understood until the discovery that these cells express HV channels (Taylor et al.
2011). The activity of these HV channels allows for the maintenance of calcification by
regulating cytoplasmic pH homeostasis, thereby influencing the composition of the
atmosphere on a global scale.

Bioluminescence in dinoflagellates
In 1972, Fogel and Hastings first proposed the existence of voltage-gated proton channels
as a component of their theoretical model describing the process of bioluminescence in
dinoflagellates (Fogel & Hastings 1972). It was not until 2011 that the existence of HV
channels in dinoflagellates was experimentally confirmed (Smith et al. 2011). The HV
channels found in these single cellular algae are unique in that they activate at membrane
potentials negative to the Nernst equilibrium potential for H+, thus allowing for inward H+
current (Smith et al. 2011). This feature is necessary for this HV channel to fulfill its
proposed role in the triggering of bioluminescence by rapid H+ influx into the specialized
small organelles known as scintillons (Fogel & Hastings 1972). Additionally, this
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distinctive gating behavior allows these HV channels to participate in the production of
action potentials that carry the H+ signals along the algal membranes to the scintillon
organelles (Smith et al. 2011).

1.4 MOTIVATION AND AIMS OF THESIS RESEARCH
1.4.1 Many fundamental questions to tackle
Hv’s significant deviations from the canonical voltage-gated domain structure, namely,
its lack of separate voltage-sensing and pore domains, raised a number of fundamental
questions as to its mechanism of gating, conduction and regulation. How does the
channel conduct H+ without a pore domain? Is the gene identified actually the H+ channel,
or does the protein associate with some unknown factor in the HEK cell membrane to
mediate H+ conduction? Given that the pore helices create the multimerization interface
in the KV channels, what is the multimeric state of the HV channel?
I joined the MacKinnon laboratory in 2008, less than two years after the first
discovery of the HV genes by Ramsey and Sasaki (Ramsey et al. 2006; Sasaki et al.
2006). At the time, all that was known about the HV channel protein was its sequence and
the histidine residues that were responsible for Zn2+ binding (Ramsey et al. 2006); many
of the biophysical and physiological studies mentioned in the previous sections had yet to
be performed. In this thesis, I describe my efforts on the investigation of the molecular
mechanisms of HV channel gating and conduction through attempts at functional and
structural characterization.

31

In Chapter 2, I describe my work on the multimeric state of the hHV1 channel in
membranes. Together with the postdoctoral fellow Dr Seok-Young Lee, I demonstrated
that HV channels form dimers in the membrane and we identified the dimerization
interface to be along the S1 helix in the membrane and along the coiled-coil in the
cytoplasm (Lee et al. 2008).
In Chapter 3, I describe our approach of studying the purified HV channels in
detergent and reconstituted into vesicles. Whereas all other research on HV channels has
been performed in cells, we decided to biochemically characterize the purified channel,
taking advantage of the expertise in membrane protein expression and purification in the
MacKinnon laboratory. By studying the purified protein reconstituted in lipid vesicles,
we demonstrated for the first time that the hHV1 gene alone is able to conduct H+ (Lee et
al. 2009b). Furthermore, to identify amino acid residues that play an important role in H+
conduction, we purified and reconstituted mutated hHV1 channels and subjected them to
functional analysis. We identified D112 as a candidate residue involved in H+ conduction
and showed that the mutation of an equivalent position to aspartate in the isolated VSD of
the prokaryotic KV channel KVAP increases the rate at which this protein conducts H+.
In Chapters 4 and 5, I describe my efforts towards the structural characterization
of HV channels. Determining the atomic resolution structure of a protein and using it to
generate experimentally testable hypotheses is one of the most powerful ways to produce
mechanistic understanding. Needless to say, this would be particularly useful for many of
the poorly understood HV-channel biophysical properties. Encouraged by our
development of expression and purification methods for hHV1 as well as by our
colleague’s determination of the KVAP isolated VSD structure (Jiang et al. 2003a), we
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decided to pursue the structure of hHV1 by x-ray crystallography. Our efforts to this end
are discussed in detail in Chapter 4.
In addition to the crystallographic approach, together with postdoctoral fellow Dr
Joel Butterwick, I also examined HV channels in detergent by solution state NMR.
Because of its sensitivity to the protonation state of amino acid residue side chains, NMR
constitutes an ideal methodology for probing the conduction mechanism of HV channels.
Additionally, NMR can be used to calculate protein structures and since Dr Butterwick
had solved the structure of KVAP isolated VSD by this method (Butterwick & Mackinnon
2010), we thought this would be a complementary approach to solving the hHV1
structure. Our efforts on the NMR of HV channels are discussed in detail in Chapter 5.
Although the attempts at complete structural characterization of HV both by
crystallography and NMR have thus far been unsuccessful, we were able to define the
secondary structure of the channel for the first time and determine that the channel
requires a lipid bilayer for the stabilization of its three-dimensional fold. Ongoing and
future research into HV channel structure must focus on membrane like environments. For
crystallography this includes detergent-lipid mixtures, bicelles and lipidic cubic phase
crystallography. For NMR solution state studies can be performed on the channel in lipid
nanodisks or solid state NMR can be attempted on pellets of reconstituted channels.
Significant progress has been achieved in the last 7 years since the HV genes were
identified. However, many fundamental questions still remain. Complete mechanistic
understanding of HV conductance and gating will ultimately require the atomic
description of the protein in multiple states. As such, structural characterization of HV
remains a pressing goal for the voltage-gated ion-channel field. Understanding of this
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unique voltage-gated channel will contribute to our understanding of the diverse
mechanisms that have evolved which allow voltage-gated cation channels to fulfill their
diverse and important physiological roles.
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CHAPTER 2: HV IS A DIMER IN THE MEMBRANE

Voltage-gated six-transmembrane (6-TM) cation channels (Na+, K+, and Ca2+) contain
voltage-sensor and pore domains (Hille 2001). In the case of voltage-gated K+ (KV)
channels, four 6-TM subunits come together in the membrane to form a four-fold
symmetric tetramer (Mackinnon 1991; Long et al. 2007). The last two transmembrane
helices (S5 and S6) from each subunit come together to form the pore domain, with the
ion conduction pathway through the central four-fold access of symmetry (Yellen et al.
1991; Doyle et al. 1998). The first four transmembrane helices (S1-S4) form the voltagesensor domain (VSD); the four VSDs of the tetramer arrange themselves around the
periphery of the pore (see Fig. 1.3B on page 15; Long et al. 2007). The multimeric
interface of the KV channel is completely composed of the pore domain (S5 and S6)
without any contribution from the VSDs (Long et al. 2007).
Until the cloning of voltage-gated proton (HV) channels, it was thought that all
voltage-gated cation channels had a 6-TM architecture, containing distinct VSDs and
pore domain (Yu & Catterall 2004). However, the work of Ramsey et al. and Sasaki et al.
revealed that the voltage-sensor domain can also exist independently, as the cloned
sequences showed that HV channels contain only a voltage-sensor domain in the
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membrane without a separate pore domain (Ramsey et al. 2006; Sasaki et al. 2006).
Because the pore domain of other voltage-gated cation channels is instrumental in
generating higher-order structure in the membrane (e.g. the tetramerization of the KV
channels), the oligomeric state of the HV channel was unknown. This fundamental
property of the channel can have significant repercussions for our mechanistic
understanding of the channel’s gating and conduction. It has been shown that in order for
VSDs to function properly in KV channels two interfaces are necessary between the VSD
and the pore (Lee et al. 2009a). Do HV channels require support from other protomers in
the membrane in order to properly function? The conduction pathway for other voltagegated cation channels is found at an assembly interface (Yellen et al. 1991; Long et al.
2007). Where is the conduction pathway of HV channels? Does it form at an oligomeric
interface or do H+ conduct through the VSD itself?
In this chapter I will discuss my work carried out together with Dr Seok-Yong
Lee, which addressed these questions through evaluation of the subunit stoichiometry of
the human HV1 (hHV1) channel. By site-specific cross-linking in cell membranes we were
able to demonstrate that hHV1 is a dimer in the membrane and we were able to define the
dimeric interface (Lee et al. 2008).
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2.1 HUMAN HV1 IS A DIMER IN THE MEMBRANE
2.1.1 Non-specific cross-linking in HEK cells
To probe the oligomeric state of hHV1, cell membranes isolated from HEK cells
transfected with hHV1 cDNAs were subjected to the amino-group specific bifunctional
cross-linker disuccinimidyl suberate (DSS) and visualized by western blot analysis using
antibodies directed against the hHV1 channel coiled-coil. Amino-group specific crosslinkers have been successful in defining the oligomeric status of several membrane
proteins (Albright et al. 2007; Aller et al. 2004). Recombinant HV1 makes functional
channels in HEK cells (Ramsey et al. 2006; Sasaki et al. 2006; Musset et al. 2008). hHV1
migrated at approximately 35 kDa in SDS-PAGE under reducing conditions, which is
consistent with the molecular weight of a monomer (32 kDa; Fig. 2.1A). As the
concentration of the cross-linker (DSS) was increased, a band migrating near 73 kDa
appeared with a concomitant decrease in the monomer band. Further increase of crosslinker concentration yielded a series of weak bands corresponding to higher oligomers in
addition to the strong dimer band. These were probably due to non-specific cross-linking
with other membrane proteins or cross-linking between the hHV1 dimers. However, the
appearance of strong dimer bands at low concentrations of DSS suggested that hHV1
forms a homo-dimer in the membrane. Dimerization in hHV1 is not a consequence of
disulfide bond formation because mutants lacking cysteines showed the same DSSmediated cross-linking pattern as wild type (Fig. 2.1B).
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Fig. 2.1 hHV1 is a dimer
Western blots of membranes from tsA201 cells transfected with (A) wild type and (B)
cysless hHV1 cDNAs and exposed to increasing concentrations of the amino-group
specific cross-linker DSS (from left to right: No DSS, 25 µM, 75 µM, 250 µM, 2.5 mM).
Membrane samples were run on SDS-PAGE under reducing conditions as per methods.
All the gels that were used are 12 %. Molecular weight markers are shown on the left
side of each blot.

2.2 PROBING THE DIMERIC INTERFACE
2.2.1 Design of site-specific cross-links
The finding of a dimeric subunit stoichiometry for hHV1 leads to the question of how two
voltage sensors arrange relative to each other in the membrane. If the hHV1 homo-dimer
contains a two-fold rotation axis normal to the membrane, a single cysteine mutation
close to the dyad axis should form a cross-linked dimer under oxidizing conditions, or in
the presence of a bifunctional cross-linker. By sequence analysis, hHV1 can be dissected
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into three subdomains: an N-terminal acid- and proline-rich region, a transmembrane
voltage-sensor domain, and a C-terminal coiled coil domain (see Fig. 1.5 on page 22 and
Fig. 2.2). Using the voltage sensor of the KV1.2-KV2.1 paddle chimera structure as a
reference (Long et al. 2007), we examined both the two naturally existing cysteine
residues and a series of substituted cysteines on a natural-cysteine-free background (Fig.
2.2). Positions that were mutated to cysteine included: R100 (preceding S1), C107 and
L120 (S1), I127 and N132 (S1-S2 loop), T145 and I155 (S2), E164 (S2-S3 turn), L173
and V187 (S3), Q194 (S3-S4 turn), L203 and I212 (S4), T222 (after S4), and C249
(putative coiled coil; Fig. 2.2). Limited proteolysis and preliminary biochemical data
suggested that the N-terminal region is largely unstructured and does not affect the
oligomeric state of the protein. Therefore, although the full-length hHV1 was used, the Nterminal region was not investigated in this cross-linking study.
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Fig. 2.2 Introduction of cysteine mutations into hHV1
(A) The positions that were mutated to cysteine are indicated by filled circles on the
voltage-sensor structure of the KV1.2-2.1 paddle chimera (PDB ID: 2R9R). The S1-S2
loop from the paddle chimera was drawn as a shorter loop to match the length of hHV1.
(B) The amino acid sequence of hHV1. Predicted transmembrane regions, based on the
structure of the paddle chimera and hydropathy, are highlighted gray. Residues mutated
to cysteine are colored red.

C107 and C249 are natural cysteines. The region

corresponding to the coiled coil was calculated by the program COIL (Lupas et al. 1991).
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2.2.2 Dimer interface of HV channels
Each of the 14 cysteine-mutant cDNAs was transfected into tsA201 cells and membranes
isolated from these cells were subjected to cross-linking reactions. The oligomeric state
of each mutant was assessed by western blot analysis. Among the 15 mutants that we
tested for cross-linking, only R100C failed to be expressed, by western blot analysis. As
shown in Fig. 2.3A, all mutants migrated as a monomer under reducing conditions on
SDS-PAGE. However, several mutants migrated as a dimer under non-reducing
conditions (Fig. 2.3B). I127C, which is located in the loop between S1 and S2, formed an
almost complete spontaneous disulfide bond, whereas C249—a natural cysteine located
in the predicted coiled-coil domain—formed a significant quantity of spontaneous
disulfide bond. N132C and T222C also showed some degree of disulfide bond formation.
This pattern of disulfide bond formation suggests that S1 and the adjacent loop form a
dimer interface on the extracellular side of the cell membrane and that the C-terminus,
through a coiled-coil, forms a dimer interface on the intracellular side of the membrane.
Oligomer formation was also studied under conditions that ‘force’ cross-linking,
either by the addition of the oxidant CuSO4 and o-phenanthroline (CuP) or by the
addition of the bifunctional cross-linker 1,3-propanediyl bismethanethiosulfonate (M3M),
which has a 13 Å spacer separating the two cysteine-reactive methanethiosulfonate
functional groups (Fig. 2.3C and D). Both reagents drove cross-links at I127C and at
C249 nearer to completion. They also produced cross-linked cysteines to a lesser extent
at positions near I127 (position 120 within S1 and position 132 in the S1-S2 loop) and
near 249 (position 222 within the C-terminus).
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Fig. 2.3 Dimer interface of hHV1
Western blots of membranes from tsA201 cells transfected with 14 individual hHV1
cysteine-containing mutant cDNAs that were subjected to (A) reducing reagent (5 %
(v/v) b-mercaptoethanol), (B) air oxidation, (C) CuP-induced cross-linking, or (D) M3Mmediated cross-linking as per methods. Cross-linked dimers migrate at approximately 73
kDa while monomers migrate at approximately 35 kDa. Other weak bands probably
correspond to proteolytic fragments of hHV1. A mutant hHV1 in which the native
cysteines were removed was included as a control (cysless). The number represents the
amino acid position of the cysteine residue.
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Forcing conditions also resulted in weak cross-links in two new regions: the S2S3 turn—also known as the membrane interface anchor (positions 164 and 173) (Lee et
al. 2005)—and the tip of the voltage sensor paddle (positions 187 and 194; Fig. 2.3C and
D; Jiang et al. 2003a; Jiang et al. 2003b).
By covalently trapping rare conformations or molecular arrangements, forcing
conditions can sometimes result in cross-link formation between residues that are only
rarely in close proximity to each other. An example of this would be intermolecular
cross-links (in this case inter-dimer cross-bridge formation between pairs of dimers). The
blot in Figure 2.4A provides evidence for such dimer pairing by cross-linking of
cysteines at position 173. When combined with a cysteine at 127 (which by itself formed
a cross-linked dimer to near completion; Fig. 2.3B), cysteine at 173 resulted in the
appearance of bands near the size of a tetramer (Fig. 2.4A). This observation is explicable
if cross-links between position 173 cysteines formed between S2-S3 loops from separate
dimers, because cross-links within a dimer would not produce a tetramer. A similar
analysis of cysteine at position 194 in the background of a cysteine at 127 produced a
different, yet equally interesting result. Cysteine at 194 did not produce tetramers in this
setting, but reduced the degree to which cysteine at 127 formed a cross-linked dimer
(compare Fig. 2.3C and D with Fig. 2.4A). The location of position 194 at the tip of the
voltage sensor paddle, which is adjacent to the S1-S2 loop within a single voltage sensor
of the dimer (see Fig. 2.2A), offers a possible explanation for this cross-linking outcome.
By forming an intramolecular cross-link with cysteine 127 within the same subunit,
cysteine at 194 would compete with cysteine 127-mediated dimer cross-linking. These
more subtle aspects of the blots suggest that the S2-S3 turn and the voltage sensor paddle
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are not actually part of the tight dimer interface, but that less specific cross-links are
formed under forcing conditions.
A more extensive inspection of covalent dimer formation via cysteine residues
within the S1 and S1-S2 loop showed differential propensities to react (Fig. 2.4B and C).
Even among amino acids that we expect to reside outside the membrane (positions 124128), positions 126 and 127 reacted to a greater extent, as if they were most optimally
positioned to form a disulfide bridge relative to their molecular symmetry equivalents.
Position 120, which we expect is buried in the membrane, formed a disulfide partially in
the presence of CuP. Disulfide formation in a low dielectric environment suggests that
position 120 is probably very near its molecular symmetry partner (Schwem &
Fillingame 2006; Yu & Oprian 1999).
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Fig. 2.4 Further study of the dimer interface.
(A) Distinguishing intra- from inter-dimer cross-linking. Numbers at the bottom of each
gel indicate the cysteine position. (B) Specificity of cross-linking in the S1-S1 dimer
interface. Transmembrane region of S1 (117 to 120) and the adjacent loop (124 to 128)
were subjected to (B) air oxidation and (C) CuP - mediated oxidation.

46

2.3 DISCUSSION OF RESULTS AND SUBSEQUENT LITERATURE
2.3.1 Schematic representation of the hHV1 dimer
These cross-linking data support the conclusion that HV1 exists in the cell membrane as a
dimer of identical voltage sensor protomers. Two regions of contact between the voltage
sensors correspond to the extracellular C-terminal side of S1 and the adjoining S1-S2
loop and intracellular C-terminus, which may form a coiled coil structure. The native
cysteine at position 249 may help to stabilize the dimer at the coiled coil but a disulfide
bridge at this position is not essential for holding the dimer together. We conclude that
two voltage sensor protomers of a dimer come into direct contact at both the extracellular
and intracellular side of the membrane. A schematic representation of the HV1 dimer,
based on the known crystal structures of KV channel voltage sensors and the contact
surfaces identified in this study, is shown in Fig. 2.5 (Jiang et al. 2003a; Long et al. 2005;
Long et al. 2007).
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Fig. 2.5 A model of the hHV1 dimer
(A) Topology diagram showing the dimer arrangement of hHV1 transmembrane regions
based on the cross-linking data, viewed from the extra-cellular side. An ellipsoid denotes
the 2-fold rotation axis normal to the membrane. (B) A cartoon representation of the
hHV1 dimer. Transmembrane helices are labeled. The helical representation of the
putative interfacial region (after S4) and the predicted coiled coil region are also
included.
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Contemporary publications from two groups corroborated and complemented our
discovery that HV channels are dimers in the membrane (Koch et al. 2008; Tombola et al.
2008). By expressing two differentially tagged mouse HV channels subunits in HEK cell
and performing pull-down experiments, Koch et al. showed complex formation between
the two HV constructs (Koch et al. 2008). Furthermore, they demonstrated that the
amount of detectable complex is significantly reduced by deletion of the C-terminal
coiled coil, providing further evidence for the importance of the coiled-coil in stabilizing
the dimer interface (Koch et al. 2008). Using single molecule photobleaching on GFPtagged hHV1, Tombola et al. also demonstrated that HV channels are dimers in Xenopus
oocyte membranes (Tombola et al. 2008). Our work, together with the work from these
other two groups, established that HV channels are dimers in the membrane.

2.3.2 Each subunit has a separate H+ conduction pathway
Many membrane proteins exist as oligomers of identical or similar subunits. In many
cases, the need for an oligomeric structure is clear: potassium channels, for example,
require four subunits to form a single ion conduction pathway in between the subunits
(Doyle et al. 1998). In other membrane proteins, the reason for an oligomeric structure is
less clear: in aquaporin channels (Murata et al. 2000) and in ClC Cl- channels (Dutzler et
al. 2002), the water and ion conduction pathways are formed entirely by atoms of a single
protomer and yet these transport proteins are tetramers and dimers of identical protomers,
respectively.
Into which category does the HV channel fall? Based on electrophysiological
studies showing that mutant KV channel voltage sensors can themselves conduct ions
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(Tombola et al. 2005) or H+ (Starace & Bezanilla 2004) across the membrane, and based
on atomic structural studies showing that KV channel voltage sensors contain protonatable
chemical groups extending most of the way across the membrane (Long et al. 2007), it is
not difficult to imagine that H+ flows through individual voltage sensors in HV channels.
In other words, each sensor might contain its own H+ conduction pathway.
The contemporary work by Tombola et al. provided evidence for this claim
(Tombola et al. 2008). By generating tandem hHV1 dimers (i.e., both subunits expressed
on a single polypeptide) with specific cysteine mutations in each subunit and reacting
them with a cysteine-specific reagent that disrupted H+ conduction, they demonstrated
that each subunit contributed approximately 50% of the total H+ current (Tombola et al.
2008). Moreover, by making a chimeric HV channel in which the N- and C-termini were
replaced by those of the voltage-sensor phosphatase from Ciona intestinalis (Ci-VSP),
Tombola et al. were able to monomerize the channel and demonstrate that the
monomerized channel was still able to conduct H+ (Tombola et al. 2008).
More recently mutagenesis studies on hHV1 by Musset et al. found that a single
point mutation, D112V, is able to completely abolish H+ conduction (Musset et al. 2011).
Further mutagenesis data on hHV1 suggest that D112 interacts with the S4 gating-charge
arginines, indicating that this side chain is directed into the central cavity of the VSD
itself and not located at the dimeric interface (Berger & Isacoff 2011). This finding
further supports the notion that each subunit contains a separate conduction pathway.
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2.3.3 HV channel dimer and cooperativity
Sometimes, multiple subunits allow active sites to function in a non-independent manner.
Hemoglobin is a well known example in which an oligomeric structure underlies
cooperativity (Perutz 1989), allowing a steep relationship between oxygen saturation and
oxygen partial pressure. In ClC Cl- channels, one form of gating might arise from its
dimeric architecture (Bykova et al. 2006). Thus, oligomeric architectures in both soluble
and membrane proteins can allow for much more than the multiplicity of active sites.
Electrophysiological studies have demonstrated strong cooperativity between the
two subunits of the HV channel dimer (González et al. 2010; Tombola et al. 2010; Musset
et al. 2010b). Using voltage-clamp fluorometry and specifically labeling Ciona
intestinalis HV channels on S4 with a fluorescent probe, Qui et al. demonstrated that each
subunit undergoes independent conformational changes prior to a concerted opening of
the H+ conduction pathway (Qiu et al. 2013). It has also been noted that truncation of the
channel on the N- and C-terminus (or the C-terminus alone) removes the cooperativity of
HV channel gating, which has been argued to be due to monomerization of the channel
(González et al. 2010; Tombola et al. 2010; Musset et al. 2010b).
Although it is clear from Koch et al.’s pull down experiments that truncating the
termini of HV channels reduce the proportion of dimer observed, there is still some dimer
present, indicating that the truncated channel subunits may still be associated in the
membrane and may only come apart during the many washes of the pull-down protocol
(Koch et al. 2008). Furthermore, Fujiwara et al. demonstrated that mutation of three
amino acid residues in the C-terminal coiled coil is sufficient for disruption of the
cooperative gating without disruption of the dimer (Fujiwara et al. 2012). Therefore, the
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cooperativity of gating can be modulated independently of channels’ multimeric state in
the membrane. Hence, simply because deletion of the C-terminus removes cooperative
gating does not necessarily mean the channel has become monomeric. In fact, evidence is
mounting that, by affecting the oxidation state of a native cysteine residue in the coiled
coil, C249 in hHV1 (shown in Fig. 2.3B to be able to spontaneously form a inter-subunit
disulfide bond), the cell is able to tune the cooperativity of the channel, thereby
physiologically linking channel activity to the redox state of the cell (Fujiwara et al.
2012; Fujiwara et al. 2013b).

2.3.4 Mechanistic Implications of the dimer
In HV1 channels, a dimeric architecture might be related to the mechanics of channel
gating. It is interesting to note that the location of the extracellular dimer interface in the
HV1 channel corresponds well to the region of contact between voltage sensor and pore in
KV channels (Long et al. 2007). In KV channels, the contact between S1 and the pore at
the extracellular surface is proposed to serve as a mechanical fixed point so that motions
of the voltage sensor paddle (S3 and S4) are efficiently transmitted to the pore’s gate
(Long et al. 2007; Lee et al. 2009a). By analogy, contacts between S1 helices in the HV1
dimer might serve a similar function by fixing S1 and S2, thus permitting the voltage
sensor to move and open a conduction pathway within each voltage sensor.
However, the work of Tombola et al. on the monomerized HV-channel chimera, in
which both N- and C-termini are replaced by sequences from Ci-VSP, indicates that HV
channels are able to function in the absence of the dimer (Tombola et al. 2008).
Additionally, the voltage-sensor phosphatase (VSP) functions as a monomer in the
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membrane, indicating that not all VSDs require a fixed support at the extracellular side of
S1 to function (Kohout et al. 2008). If they are able to function as monomers, what
makes the mechanism of HV channels and VSP different from the 6-TM voltage-gated
cation channels, which have been shown to require a fixed support at the extracellular
side of S1 in order to function (Lee et al. 2009a)?
All VSDs are able to change conformation in response to changes in the
transmembrane voltage. However, the VSDs of the 6-TM voltage-gated cation channels
are electromechanical force transducers: the conformational changes need to be
transmitted to the pore helix, via the S4-S5 linker and the S6 helix bundle, in order to
open and close the ion conduction pathway (Long et al. 2007; Lee et al. 2009a). In order
to efficiently transmit force to the pore domain, a fixed anchor in the membrane is
required (Lee et al. 2009a). Are the VSDs of HV channels and VSPs electromechanical
force transducers? The conformational changes of these VSDs are not coupled to opening
or closing of a separate pore as in the case of the canonical 6-TM voltage-gated cation
channels. If the role of these non-canonical VSDs were simply to undergo conformational
changes and not to transmit force, they would not require a fixed anchor in the
membrane. Since the conduction pathway for H+ in HV channels is located within the
VSD itself, conformational changes of the VSD without force transduction should be
sufficient to open the channel. Therefore, the purpose of the HV dimer would not be to
provide a fixed anchor to allow force transduction but to allow for modulation of gating
through the regulation of cooperativity discussed in the previous section, and hence the
channels would still be functional as monomers.
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2.3.5 Implications of the dimer on future structural studies
In order to fully understand the mechanism and regulation of cooperativity in HV
channels structures of both the reduced and oxidized dimers would be required (Fujiwara
et al. 2013b). However, Tombola et al. show that a monomerized HV-VSP chimera is
functional as a monomer (Tombola et al. 2008). Therefore, it should be possible to gain
insight concerning the gating and conduction of HV channels from the structure of a
monomerized channel. In order to confirm that the monomeric channel is functional,
constructs that disrupt dimerization should be built in the absence of chimerization and
functionally characterized. These channels will have to be shown to be monomeric in
membranes by their inability to form site-specific cross-links along S1. The C-terminally
truncated channels (discussed above) that lack cooperativity during gating have not been
experimentally shown to be monomeric and therefore may still exist as dimers in the
membrane. If the truncated channels are found to still be dimeric in the membrane it may
be possible to disrupt the dimer by introduction of tryptophan amino acid residues along
the S1 dimer interface. Due to its large bulky side chain tryptophan has been used
successfully in other studies to disrupt membrane protein structure (Sharp et al. 1995).
Alternatively, it has been suggested that due to its lack of a C-terminal coiled-coil the HV
channel found in the dinoflagellates Karlodinium veneficum may exist as a monomer
(Smith et al. 2011). However, this has yet to be experimentally verified. As discussed
above, a definitive demonstration that monomeric HV channels are functional would
significantly contribute to our understanding of the mechanism of gating and greatly
improve our confidence in interpretations of structural studies on monomerized channel
in detergent (see Chapters 4 and 5).
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CHAPTER 3: FUNCTIONAL RECONSTITUTION OF HUMAN HV1
Due to the complexity of the proteic component of a cell’s cytoplasm and membrane, it
can be very difficult to determine the function of each of the individual proteins. When
Sasaki et al. and Ramsey et al. expressed the putative HV channel proteins in HEK cells,
they observed the robust generation of voltage-gated H+ currents (Ramsey et al. 2006;
Sasaki et al. 2006). However, whether this H+ conduction occurred through the putative
HV gene product was unclear. Given that the HV protein has homology to the regulatory
voltage sensor domain (VSD) of canonical voltage-gated cation channels, but lacks the
pore domain responsible for ion conduction, it remained possible that HV was not an ion
channel at all, but, instead, an accessory subunit for the modulation of a separate,
unknown endogenous HEK cell membrane protein. In order to determine whether or not
the putative HV channel is in fact responsible for H+ conduction a reductionist approach
was necessary; the activity of the putative channel had to be assessed in isolation from all
other cellular proteins.
In this chapter, I will discuss my work in collaboration with Dr Seok-Yong Lee
addressing this issue (Lee et al. 2009b). Working with the eukaryotic expression vector
Pichia pastoris, we were able to develop a protocol for the purification and reconstitution
of human HV1 (hHV1) into lipid vesicles. By assaying the activity of the purified
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reconstituted channel using a fluorescence-based concentrative uptake assay, we were the
first to demonstrate that the putative HV channel gene product alone is in fact responsible
for H+ conduction. By reconstituting the protein at different protein-to-lipid ratios, we
were able to demonstrate that the majority of the hHV1 channels that we purified were
functional, validating our purification protocol for use in more detailed biochemical and
structural studies. As controls, we reconstituted several other voltage-gated channels to
prove that the H+ flux observed was specific to HV channels and not due to non-specific
leaks caused by the presence of protein in the membranes. Extensive mutagenesis studies
of purified and reconstituted hHV1 identified D112 on S1 as an important amino acid
residue for H+ conduction. Furthermore, mutation of the equivalent position to aspartate
on the KVAP isolated VSD increased the rate of H+ flux through this protein, indicating
that this residue is sufficient to promote H+ conduction through VSDs. A model of H+
uptake qualitatively recapitulated our experimental results. These findings will be
discussed in the context of the more recent HV channel electrophysiological literature.
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3.1 THE PUTATIVE HV CHANNEL MEDIATES H+ FLUX IN VESICLES
3.1.1 Expression, Purification and Reconstitution of Human HV1
Heterologous expression of hHV1 channels was attempted in both prokaryotic
(Escherichia coli) and eukaryotic vectors (Pichia pastoris yeast, Sf9/baculovirus insect
cells and HEK mammalian cells). Although expression of extractable channel was low in
each system, it was determined that Pichia pastoris provided sufficient protein for the
reconstitution experiments. Due to the poor expression, the high affinity C-terminal 1D4tag was needed to isolate the low-abundance channel protein from high-abundance
endogenous contaminants. The channels were extracted from the yeast membranes using
dodecylmaltoside (DDM) detergent and purified by affinity chromatography on an anti1D4 antibody resin, followed by size exclusion chromatography (see Materials and
Methods for details). Purified protein appeared as a single band corresponding to the
expected size of a monomer on gel electrophoresis under denaturing and reducing
conditions (Fig. 3.1A). Reconstitution of HV protein into lipid vesicles was carried out by
detergent removal from channel-detergent-lipid mixtures via dialysis, using different
protein to lipid ratios. As a control for tight lipid bilayer formation, reconstitution of
empty vesicles was carried out in parallel in the absence of protein, allowing us to
measure any non-specific membrane leakage.
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Fig. 3.1 H+ flux into vesicles containing recombinant Hv channels
(A) SDS-PAGE gel showing purified HV channels. Lane 1: molecular weight marker, 2:
final wash, and 3: hHV-1D4 eluted with 0.4 mg/ml 1D4 peptide. (B) Fluorescence-based
H+ flux assay. Vesicles (cyan) loaded with high concentration of K+ are diluted into low
concentration K+ buffer containing the fluorescence dye ACMA (9-amino-6-chloromethoxyacridine). Addition of valinomycin (red), a K+ selective ionophore, results in K+
efflux, which generates a driving force for H+ influx. If there is a H+ channel (blue) in the
vesicle membrane, pH inside the vesicle will decrease. This pH decrease is monitored by
ACMA because the protonated form, which becomes trapped inside vesicles, loses
fluorescence whereas unprotonated ACMA diffuses freely across the membrane (Zhang
& Forgac 1994). (C) Fluorescence-based H+ flux assay for vesicles with and without
hHV1 colored blue and red, respectively (n = 5). Error bars indicate standard error of the
mean. Valinomycin and CCCP are added at the indicated time points.
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3.1.2 Monitoring HV channel conduction by fluorescence
To study H+ flux into lipid vesicles containing human HV channels, we used the
fluorescence-based concentrative uptake H+ flux assay depicted in Fig. 3.1B. This assay
was originally developed to study H+ flux through V-ATPase (Zhang & Forgac 1994).
Vesicles were reconstituted in the presence of 150 mM K+ and diluted 20-fold into buffer
containing 7.5 mM K+ generating a 10-fold K+ gradient across the membranes. Upon
addition of the K+ selective ionophore valinomycin, the K+ diffuses out of the vesicles,
generating an electric potential across the vesicular membrane of approximately -60 mV
(negative inside relative to outside, calculated by equation 1.1). If a H+ conduction
pathway is present in the membrane, the negative electrical potential inside the vesicles
will cause H+ to enter, lowering the internal pH. We monitored the changes in pH by a
H+-induced quenching of the fluorophore 9-amino-6-chloro-2-methoxyacridine (ACMA).
Fig. 3.1C shows the fluorescence change caused by the addition of valinomycin to
a sample of empty vesicles and to a sample of hHV1 reconstituted vesicles at a protein to
lipid ratio of 1:100 (wt:wt). The empty vesicles exhibited a very gradual fluorescence
change, consistent with there being a very slow non-specific leak for H+ entry until the
proton ionophore carbonyl cyanide m-chlorophenyl hydrazone (CCCP) is added. Vesicles
containing HV channels showed a robust change in fluorescence upon addition of
valinomycin, consistent with the HV channel providing a specific pathway for H+ entry.
The further reduction in fluorescence brought about by the addition of CCCP reflects a
small fraction of empty vesicles. The ~15% of empty vesicles seen even at high proteinto-lipid ratios stems from a population of vesicles that appear incapable of incorporating
functional HV channels (see below). Similar fractions of reconstitution deficient vesicles
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have been described previously in studies of other channels and transport proteins (Eytan
1982; Goldberg & Miller 1991; Heginbotham et al. 1998).

3.1.3 The Majority of Reconstituted HV Channels are Functional
In order to further investigate the functioning of HV channels, we performed the
reconstitution at various protein-to-lipid ratios (Fig. 3.2A). The fluorescence-based assay,
which indirectly measures H+ flux through an unknown relationship between H+
concentration and fluorescence, precludes quantitative determination of H+ conduction
rates (Fiolet et al. 1974). The assay does, however, allow us to estimate the fraction of
total channels in the reconstitution that are functional, as explained below.
The fluorescence decay brought about by the addition of valinomycin (FHv) is
proportional to the number of vesicles that contain at least one functional HV channel.
The fluorescence decay brought about by valinomycin plus CCCP (Ftotal) is proportional
to the total number of vesicles. Given that we know the mass protein to mass lipid ratio in
the reconstitution, and that the reconstitution occurs efficiently (Fig. 3.2B), with a few
assumptions we can calculate the mean number of channels per vesicle µ from equation
3.1, where gHv and gL are the grams of Hv channel and lipid added, r is the estimated
average radius of a vesicle, ML is the molecular weight of the average lipid molecule (754
Da), σ is the estimated area per lipid molecule and MHv is the molecular mass of the Hv
channel dimer (70,000 Da).

µ=

€
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Fig. 3.2 H+ flux into vesicles containing HV channels at various protein-to-lipid ratios
(A) Fluorescence-based H+ flux assay for vesicles containing a decreasing number of HV
channels. Protein-to-lipid ratios of 1:100 (dark blue, n = 5), 1:500 (pink, n = 2), 1:1000
(orange, n = 3), 1:5000 (yellow, n = 3), 1:10,000 (cyan, n = 4), 1:20,000 (light green, n =
3), 1:40,000 (green, n =4), 1:60,000 (violet, n = 3) and empty vesicles (red squares, n = 4)
are plotted (error bars represent the standard error of the mean, range of mean for 1:500).
(B) Sucrose cushion of vesicles containing HV channels. Numbers denote the fractions
collected from top to bottom. (C) Determination of the fraction of functional HV
channels. Plot of µ versus the ratio of fluorescence decay contributed by HV containing
vesicles over the total fluorescence decay by addition of CCCP where µ is the ratio of the
number of channels over number of vesicles calculated with equation 3.1. The two curves
are derived from equation 3.2 with φ (fraction of functional HV) = 1.0, θ (fraction of
reconstitution deficient vesicles) = 0.15 (red) and φ = 0.5, θ = 0.15 (green).
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The main assumptions are that the lipid head group area is 63 Å2 (DeCoursey
2003b; Rand & Parsegian 1989) and that the vesicles are uniform in size with a radius of
100 nm (Moffat et al. 2008). If incorporation of HV channels into vesicles is random, then
we expect equation 3.2 to be true, where θ is the fraction of reconstitution deficient
vesicles (~15%, measured directly from the data) and φ is the fraction of channels that are
functional (Heginbotham et al. 1998).

+
% −φµ ( .
FHv /Ftotal = (1 − θ ) -1 − exp'
*0
& (1 − θ ) ) /
,

{3.2}

The €
red curve in Fig. 3.2C corresponds to the curve generated from equation 3.2
with φ = 1.0. To ensure that this conclusion is not mistakenly based on an incorrect
assumption of the vesicle radius (which we have not measured but estimate from values
in the literature), we fit the data using alternative values. At 70 nm, vesicles would be too
numerous given the number of channels: φ would have to be greater than 1.0, which is
physically impossible. At 130 nm, the best fit still corresponds to a φ value of
approximately 0.75. Therefore, even given the degree of uncertainty introduced by our
assumptions of vesicle radius, uniformity, and lipid molecule surface area, the data
support the conclusion that the majority of HV channels in the reconstitution are
functional.
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3.1.4 H+ Flux is Specific to HV Channels
The small conductance inferred from this study (see the section on modeling the flux
below), raises the concern that the H+ flux into the vesicles may be due to a non-specific
leak resulting from the presence of protein in the membranes. To examine this possibility,
we expressed, purified and reconstituted three additional proteins at equivalent protein to
lipid ratios (to match the number of VSDs per vesicle): full-length KVAP (KVAP), KVAP
isolated VSD (KVAP VSD), and KV1.2-2.1 paddle chimera (paddle chimera). The
fluorescence-based H+ flux analysis of these proteins showed that vesicles containing
either KVAP or paddle chimera generated very little fluorescence decay (Fig. 3.3).
Because both KVAP and paddle chimera contain K+ pores, the K+-driven membrane
potential may be established before valinomycin addition. Initial fluorescence values with
vesicles containing these channels were very similar to other vesicle preparations (HV or
empty), suggesting that no H+ influx occurred before the first point of data collection.
Interestingly, vesicles containing KVAP VSD exhibited fluorescence decay but at a
significantly slower rate than vesicles containing HV channels (Fig. 3.3). Sucrose
cushions of these vesicles confirmed efficient reconstitution of all proteins. These data
suggest that the H+ flux through HV is not simply a manifestation of membrane protein
reconstitution into the vesicles: rapid H+ flux is specific to HV. The slower H+ flux
observed for KVAP VSD might reflect an intrinsic H+ conduction potential of the VSD,
which is suppressed by its association with the K+ channel pore.
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Fig. 3.3 Specific H+ permeation through hHV1
Fluorescence-based H+ flux assay for vesicles containing hHV1 (dark blue, n=5), KVAP
VSD (green, n=4), KVAP (dark green, n=4), paddle chimera (cyan). Empty vesicles are
shown in red. Error bars indicate standard error of the mean. Valinomycin and CCCP are
added at the indicated time points. KVAP, KVAP VSD, and paddle chimera channels were
expressed and purified according to published procedures (Jiang et al. 2003a; Long et al.
2007). Reconstitutions were carried out as described in materials and methods with the
following protein to lipid ratios (wt:wt) 1:200 (KvAP VSD), 1:100 (KvAP), and 1:50
(paddle chimera).
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3.2 MUTAGENESIS OF THE HV CHANNEL TRANSMEMBRANE DOMAIN
3.2.1 H+ flux through mutant hHV1 channels
In order to find the amino acid residues responsible for H+ conduction through the
transmembrane domain of HV channels, we conducted extensive mutagenesis studies.
Because hydrophilic residues are required for specific interaction with ions in the
hydrophobic interior of the membrane, we focused our mutagenesis on polar and charged
amino acids within the transmembrane domain. Fig. 3.4 shows the transmembrane
sequence of hHV1 aligned to the equivalent sequence of the KV1.1 channel Shaker,
highlighting the 14 positions that were individually mutated to alanine or leucine. Each of
the mutant channels was expressed, purified and reconstituted into lipid vesicles at a
protein to lipid ration of 1:100 (wt:wt). To ensure that the mutations did not significantly
affect the reconstitution efficiency of the channel, we ran sucrose cushion flotation assays
on each of the reconstituted mutant channels.
The activity of each mutant was tested by the fluorescence-based concentrative
uptake flux assay described in Fig. 3.1B and compared to that of reconstituted wild type
hHV1 and empty vesicles. Mutation of a residue that is required for H+ conduction should
result in the absence of fluorescence quenching. The data from the reconstituted mutant
channels presented in Fig. 3.5A-D are organized by the transmembrane helix (S1-S4) on
which the mutated residue resides. However, the mutants can also be organized by their
effect on H+-mediated fluorescence quenching and it is in this context that I will discuss
them below.
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S1
Shaker
hHV1

PESSQAARVVAIISVFVILLSIVIFCLETLPEFK
LRKLFSSHRFQVIIICLVVLDALLVLAELILDLK
100
110
120

S2

Shaker
hHV1

HYKVF-/-----PFFLIETLCIIWFTFELTVRFLA
IIQPDKNNYAAMVFHYMSITILVFFMMEIIFKLFV
130
140
150
160

S3
Shaker
hHV1

CPNKLNFCRDVMNVID-IIAIIPYFITLATVVAE
F--RLEFFHHKFEILDAVVVVVSFILDIVLLFQE
170
180
190

S4

Shaker
hHV1

EEAMSLAILRVIRLVRVFRIFKLSRHSKGLQI
HQFEALGLLILLRLWRVARIINGIIISVKTRS
200
210
220

Fig. 3.4 hHV1 transmembrane residues targeted for mutagenesis
The transmembrane sequence of hHV1 is shown aligned to the equivalent sequence of the
KV1.1 channel Shaker. Numbering at the bottom corresponds to the hHV1 amino acid
position. The putative transmembrane helices are highlighted in grey and labeled S1-S4.
The sites of the mutations are highlighted in red with the exception of position D112 that
is highlighted in green. The phenylalanine that corresponds to the phenyalanine gap in S2
is highlighted in cyan (see Fig. 1.4).
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Fig. 3.5 H+ flux into vesicles containing mutant hHV1 channels
Fluorescence-based H+ flux assay for vesicles containing mutant hHV1 channels
compared to vesicles containing wild type channels and empty vesicles. (A) Mutations
along S1. (B) Mutations along S2. (C) Mutations along S3. (D) Mutations along S4. In
each case valinomycin was added after 150 s and CCCP was added after 450s except in
the case of D112L were CCCP was added after 900s. For empty vesicles CCCP was
added at 1350 s (A) and 780 s (B C and D). All channels were reconstituted at a proteinto-lipid ratio of 1:100 (wt:wt). Each curve corresponds to the average of 3-4 repetitions
with the error bars indicating the standard error of the mean.
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3.2.2 Mutations with small or no effect on H+ conduction
Many of the mutations investigated had little or no effect on the H+ conduction when
compared to the wild type channel (Fig. 3.5A-D). These included E119L on S1 (Fig.
3.5A), all residues tested on S2, H140A, S143A, E153A and K157A (Fig. 3.5B), D185A
and H193A on S3 (Fig. 3.5C), as well as N214A on S4 (Fig. 3.5D). Although many of
these mutants showed some effect on either the initial rate of H+ conduction (e.g. D185A
on S3; Fig. 3.5C) or on the fraction of empty vesicles measured (e.g. H140A on S2; Fig.
3.5B), none of these mutants completely abolished H+ conduction. Differences in the
fraction of empty vesicles indicated a higher proportion of non-functional channels in the
vesicles. However, in each case, a significant proportion of the channels remained
functioning and we are able to clearly observe H+ conduction. Small effects of the
mutations on the initial rate of fluorescence quenching may indicate a role for those
amino acids in H+ conduction; however, those roles are not critical, given that conduction
is only slightly affected.
One HV channel mutation that was reported to disrupt H+ conduction in oocyte
membranes expressing hHV1 channels is N214R (Tombola et al. 2008). However, when
we expressed purified and reconstituted this mutant at different protein-to-lipid ratios and
tested it in our flux assay, we did not observe any significant difference in H+ conduction
compared to wild type hHV1 channels (Fig. 3.6A). Another mutagenesis study on the
mouse HV (mVSOP) channel expressed in HEK cells and characterized by whole-cell
patch clamp electrophysiology also found that the equivalent mutation N210R results in
functional channels (Sakata et al. 2010).
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Fig. 3.6 H+ flux into vesicles containing additional mutants of the hHV1 channel
Fluorescence-based H+ flux assay for vesicles containing mutant hHV1 channels
compared to vesicles containing wild type channels and empty vesicles. (A) Dilution
series of the N214R mutation on S4. (B) Mutations at position D112 on S1; all channels
were reconstituted at a protein-to-lipid ratio of 1:100 (wt:wt). In each case valinomycin
was added at 150 s and CCCP was added where indicated. Each curve corresponds to the
average of 3-4 repetitions with the error bars indicating the standard error of the mean.
(C) Sucrose cushion of vesicles containing D112L hHV1 channels demonstrating efficient
reconstitution. Numbers denote the fractions collected from top to bottom.
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3.2.2 Mutations that generate leaky vesicles
Another class of mutations, e.g. E171A and D147A on S3 (Fig. 3.6C); and R205A,
R208A and R211A on S4 (Fig. 3.6D), showed an initial decrease in fluorescence that was
followed by a slow recovery. This may be explained by the mutations causing a
membrane leak that allowed the passage of Na+ or Cl-, both of which are present in high
concentrations in these experiments. After addition of valinomycin, the membrane
potential was clamped at the equilibrium potential for K+ (approximately -60 mV,
negative inside relative to outside, calculated with equation 1.1). This negative potential
creates a driving force for the entrance of H+ into the vesicles. However, the negative
electrical potential also creates a driving force for Cl- to exit the vesicles (the
concentrations of Cl- is nearly symmetric across the vesicular membrane) and an even
stronger driving force for Na+ entry (there is a large Na+ gradient across the membrane:
150 mM Na+ outside vs. ~0 mM Na+ inside). Therefore, if the mutation resulted in the
generation of a leak for either of these ions, they would cross the membrane and dissipate
the driving force for H+ uptake into the vesicles.
Depending on the rate of the leak, it might still be possible to see the fast influx of
H+ followed by a slower dissipation of the H+ driving force caused by the leak, after
valinomycin addition. This would result in the slow efflux of H+ from the vesicles and a
slow recovery of the fluorescence signal (see below for a comparison between
experiment and theory for leaky vesicles). To varying degrees, this is exactly what was
observed for these mutant HV channels (e.g. R205A in Fig. 3.5D), indicating that the
mutation resulted in a Cl- or Na+ leak through the VSD. If the leaky VSD were permeable
to K+ in addition to Na+ or Cl-, a collapse of the K+ gradient would begin prior to addition
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of valinomycin, resulting in a lower overall fluorescence signal upon addition of
valinomycin. This is what was observed for the R208A and R211A mutants (Fig. 3.6D).
In fact, more recent electrophysiological experiments on R211 in hHV1 indicate that
mutation to Ser or Cys results in the leak of the organic guanidinium cation through the
channel (Berger & Isacoff 2011).
Mutations of VSDs that result in a leak current through the VSD itself (the socalled “omega current”) are relatively common and have been characterized in both KV
and NaV channels (Tombola et al. 2006; Sokolov et al. 2005). Given the delicate
structural balance that the VSD must fulfill— compensating the charges of the gating
residues within the low electrical permittivity of the membrane— it is not surprising that
mutation of charged residues within the transmembrane domain leads to disruption of the
structure, producing a leak pathway for the conduction of ions. It is interesting to note
that all of the mutations that caused significant leak resulted from the removal of a
charged amino acid side chain (Fig. 3.5C and D).

3.2.3 D112 an interesting position
A single mutation significantly slowed the H+ flux into the vesicles: D112L on S1 (Fig.
3.5A). Interestingly, an aspartate at this position on S1 is highly conserved in HV
channels, but the equivalent position in the VSDs of other voltage-gated cation channels
is a serine (Fig. 3.5; Musset et al. 2011). If this mutation only affected the rate of H+
conduction, we would expect that, given enough time to equilibrate, the same HV
dependent fluorescence quenching (FHv) would be observed when compared to wild type.
However, even if the experiment is run over long time courses, the fluorescence
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quenching seen in the D112L mutation never reached the same levels as wild type (Fig.
3.6B). Since the D112L reconstitution occurs efficiently (Fig. 3.6C), this indicates either
that there are a larger proportion of non-functional channels in the vesicles, or that there
is a leak current that results in partial dissipation of the electrical driving force, resulting
in a stable steady state level of H+ uptake and fluorescence-quenching (see below for a
theoretical analysis incorporating Cl- leak).
To further investigate the potential role of D112 in the mechanism of H+
conduction, two additional mutations were made: D112S and D112A, both of which also
displayed a significant decrease in H+ flux (Fig 3.6B). More recent electrophysiological
experiments have demonstrated that mutation of D112 can make the channel leak Cl- ions
(Musset et al. 2011). In that study, both the D112S and D112A mutations were shown to
have a strong Cl--dependent shift in the reversal potential of the measured current,
indicating Cl- conduction through the HV channels (Musset et al. 2011). The D112L
mutation was not investigated in that study; however, Musset et al. did generate D112N
and D112F, both of which also showed Cl- conduction (Musset et al. 2011). Therefore, it
is likely that the D112L mutation also results in Cl- leak, which would account for our
observations in the flux assay that this mutant doesn’t show the same steady state level of
HV dependent fluorescence quenching (FHv) as wild type channels (Fig. 3.5A and 3.6B).
Because the D112L mutation alters H+ conduction through the channel in the flux
assay (Fig. 3.5A and 3.6B) and the D112V mutation, examined by Musset et al.,
completely abolished conduction though the channel (Musset et al. 2011), it has been
postulated that D112 is critical to both the conduction and selectivity of HV channels.
However, whether the aspartate is sufficient remained unknown. To determine if an
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aspartate at the equivalent position as D112 in S1 is sufficient to induce H+ flux through
VSDs, we generated the S38D mutation in the isolated-VSD of KVAP (Fig. 3.7). As
shown in Fig. 3.3, removal of the KVAP VSD from the pore domain revealed a possible
intrinsic potential for H+ conduction: a slow H+ conduction was observed in the
reconstituted isolated VSD. However, when we made the mutation S38D, we saw a
significant increase in the rate of H+ conduction through the isolated VSD (Fig. 3.7). This
indicates that an aspartate at this position on S1 is sufficient to promote H+ conduction
through the VSD.
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Fig. 3.7 D112 in S1 is sufficient for H+ conduction
Fluorescence-based H+ flux assay for vesicles containing the wild type (blue) and S38D
mutant (brown) KVAP isolated VSD compared to vesicles containing full-length KVAP
(green) channels, hHV1 channels (cyan) and empty vesicles (orange). Each curve
corresponds to the average of 3-4 repetitions with the error bars indicating the standard
error of the mean. Valinomycin and CCCP are added at the indicated time points. KVAP
channels, KVAP VSD, and KVAP VSD S38D were expressed and purified according to
published procedures (Jiang et al. 2003a). Reconstitutions were carried out as described
in materials and methods with the following protein to lipid ratios (wt:wt) 1:100 (KvAP),
1:200 (KvAP VSD), and 1:200 (KvAP VSD S38D).
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3.3 MODELING H+ CONDUCTION THROUGH RECONSTITUTED HV CHANNELS
3.3.1 Understanding the time course of fluorescence decay
Although we are unable to determine the H+ conduction rate we can ask to what degree
the time course of fluorescence decay is at least qualitatively consistent with our
expectation based on theory. We simulated H+ flux into a population of vesicles with a
mean number of µ channels per vesicle assuming that a vesicle will have n channels with
subset m facing outside-in with a frequency:

n

# 1 & µn −µ
n!
f (n,m) =
e
% (
m!(n − m)! $ 2 ' n!

{3.3}

Upon
€ addition of valinomycin, the membrane potential is driven to very near the
Nernst equilibrium potential for K+ (about -60 mV inside calculated from equation 1.1)
because the K+ permeability exceeds H+ conductance under all conditions in the
simulation (see equation 1.2). We modeled HV voltage-dependent gating with a two-state
Boltzmann function with midpoint activation voltage Vmid = 40 mV and valence 3
(Ramsey et al. 2006; DeCoursey 2008).
The change in internal H+ concentration was calculated using the algorithm
described in Moffat et al. with slight modifications (Moffat et al. 2008). To account for
the voltage-dependent gating property of the HV channels, the proton flux (JH) was
calculated by equation 3.4, where GH is proton conductance, V is the membrane potential,
EH is the equilibrium potential for H+, F is Faraday’s constant, z is the effective gating
charge (a value of 3.0 e0 was used; (DeCoursey 2008; Qiu et al. 2013; González et al.
76

2013), Vmid is the midpoint voltage of activation for HV (a value of 40 mV was used;
Ramsey et al. 2006), R is the ideal gas constant and T is the absolute temperature in
Kelvin (298 K).
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{3.4}

The €
algorithm was run successively for a unit volume of one vesicle of radius 100
nm with n channels (where n = 1, 2, 3,...,30), either facing outside-in or outside-out
(expressed as a multiplier of either 1 or -1 on the V in the two-state Boltzmann). This
basic set of 60 time courses representing the internal pH change of the vesicle was
combined to generate the expected flux of a population of vesicles each containing n
channels according to equation 3.5, where n signifies the total number of channels and m
the number of channels facing outside-in.

# 1 &n
n!
f (n,m) =
% (
m!(n − m)! $ 2 '

{3.5}

Since
€ the flux from channels facing outside-in is much greater than the flux due to
channels facing outside-out (by more than 3 orders of magnitude), we applied the
simplifying assumption that flux into any vesicle containing channels in both orientations
was equal to the flux generated by only the channels facing outside-in. This operation
results in a new basis set of 30 time courses that correspond to the H+ flux into
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populations of vesicles with total of n channels in either orientation (where n = 1, 2,
3,…,30). This new basis set was then applied to the distribution of vesicles with n
channels at the various protein-to-lipid ratios used according to equation 3.6, where ƒ(n)
is the fraction of vesicles with n channels, φ is the fraction of functional HV channels (a
value of 1.0 was used), θ is the fraction of reconstitution deficient vesicles (a value of
0.15 was used) and µ is the ratio of number of channels to number of vesicles (see
equation 3.1).
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All €
simulations were performed using MATLAB and the code can be found in
Appendix I.

3.3.2 Comparing Experimental Results and Simulations
Fig. 3.8A graphs the simulation results for populations of vesicles with channels
distributed according to equation 3.3. If one focuses on a single vesicle, a value 1.0 on the
y-axis corresponds to a free (unbound) internal H+ concentration of 10-7 M and a value 0
corresponds to a free internal H+ concentration of 10-6 M. During the simulation, the free
internal H+ concentration in the given vesicle changes from 10-7 to 10-6 (approximately),
following a time course that depends on the number of channels and their orientation in
the vesicle. The graph shows the weighted sum of time courses for all vesicles (including
empty) in the population for a 200 s interval. The curves show a fast decay followed by a
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slower one at smaller values of µ: the slower component is attributable mainly to a
fraction of vesicles with only outside-out channels, which have a very low open
probability. The curves also show a negative second derivative (curvature) at early time
points, due to H+ buffering inside the vesicles. These same qualitative features are
observed in fluorescence decay data (Fig. 3.8B).

Fig. 3.8 Comparison of dilution series data with theory
(A) Theoretical curves for the decrease of internal pH over time at the equivalent protein
to lipid ratios as in Fig 3.2A, scaled with the theoretical fraction of empty vesicles.
Curves are colored to match the equivalent experimental traces in Fig 3.8B; a theoretical
curve corresponding to empty vesicles is not shown. Simulations were all performed
using MATLAB. (B) Experimental fluorescence traces from Fig. 3.2A highlighting the
first 200 seconds after the addition of valinomycin.
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The theoretical and experimental curves are different in two obvious respects. As
a function of µ, the curves do not exhibit the same spacing between them. We think this
most likely reflects the nonlinear (and unknown) relationship between free internal H+
concentration and fluorescence (Fiolet et al. 1974). We emphasize that this unknown
relationship prevents us from determining H+ flux rates, but it does not prevent us from
determining the fraction of vesicles with no channels versus vesicles with at least one
channel (Fig. 3.2A and equation 3.2). The second difference between theory and
experiment is a more prominent slow component of fluorescence change in the data,
which is consistent with channel-independent H+ leak in the vesicles (which we have not
included in the model).
In the simulation, the curves correspond to an open channel conductance of 0.1
fS. This value should not be taken as an accurate determination of HV channel
conductance for the reasons discussed above. However, this value is smaller than the
reported conductance measured electrophysiologically – 10-100 fS (Cherny et al. 2003;
DeCoursey 2008) – by a factor too large to be accounted for by the unknown relationship
between H+ concentration and fluorescence. One possibility is that the values used for
Vmid in our two-state Boltzmann distribution (equation 3.4) result in an overestimation of
the open probability of the channel. Although these values were taken from the literature
(Ramsey et al. 2006; DeCoursey 2008), it is well established that, due to H+ depletion
effects and the strong dependence of HV channel gating on the transmembrane pH
gradient, it is difficult to get an accurate measure of Vmid (DeCoursey 2008). Also, there
is debate as to what the exact value of the valence of HV channels gating (z) is, with
experimental values ranging 2-3 (Fujiwara et al. 2012; González et al. 2013). The
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ambiguity in these values would only have a minor effect on the results from our model;
however, they are sources of uncertainty that could contribute to underestimation of the
unitary conductance. Additionally, our model treats each subunit of the dimeric HV
channels as independently gating, whereas more recent data in the literature has
established that the subunits behave cooperatively (González et al. 2010; Tombola et al.
2010; Musset et al. 2010b). Cooperativity would also affect the open probability of the
channels in our simulation.

3.3.3 Simulating the effect of Na+ and Cl- leak on H+ uptake
Because some of the mutations we have investigated with the flux assay have been shown
to cause leak through the hHV1 channel (Berger & Isacoff 2011; Musset et al. 2011), we
can ask how much does the time course of fluorescence signal observed for these mutants
agree with theory incorporating a Na+ or Cl- leak in the membrane? Na+ and Cl- leak can
be easily incorporated into equivalent circuit flux algorithm described in section 3.3.1
(and by (Moffat et al. 2008) by the addition of flux terms for the permeant ions. These
flux terms are defined in equation 3.7 for Na+ flux (JNa) and equation 3.8 for Cl- flux (JCl),
where GNa is the conductance of Na+, ENa is the Nernst equilibrium potential for Na+, GCl
is the conductance of Cl-, ECl is the Nernst equilibrium potential for Cl- and all other
terms are defined as in equation 3.4.

J Na =

G Na
(V − E Na )
F
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{3.7}

J Cl = −

G Cl
(V − E Cl )
F

{3.8}

For €
simplicity the added Na+ and Cl- leak conductances were modeled as
independent of HV channel gating. Versions of the algorithm that incorporated HV
channel state dependence into the leak currents did not alter the shapes of the curves
calculated but only slightly altered the kinetics and final steady state positions for the
theoretical pHi. This modified algorithm can be found in Appendix I.
Fig. 3.9A shows theoretical curves calculated from the algorithm used for
simulation of the H+ flux into the vesicles with the addition of Na+ leak. These curves
recapitulate the main features of the data for the leaky mutants E171A, D147A, R205A
and R208A (compare Fig. 3.5C and D to Fig. 3.9A). Additionally, by increasing gNa in
the simulation, theoretical curves similar to the data for R211A can also be produced. Fig
3.9B shows the theoretical curve for the simulation of H+ flux into the vesicles with the
addition of Cl- leak. The theoretical curve in Fig. 3.9B (bottom) differs from the data in
that the H+ flux reaches a steady state more quickly than what is seen in the D112L
mutant fluorescence data. This discrepancy can be understood if the D112L mutation also
decreased the H+ conductance. In order to reduce bias, the H+ conductance was kept the
same as for the simulations in Fig 3.8 during the leak simulations (Fig. 3.8).
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Fig. 3.9 Comparison of mutant data to theory incorporating leak conductances
(A) Comparison of R205A mutant channel flux data (top) to theoretical curves for the
decrease followed by slow recovery of internal pH over time incorporating a Na+
conductance (GNa) in the membrane of 0.05 fS scaled with the theoretical fraction of
empty vesicles (0.15, bottom). Simulations were all preformed using MATLAB. (B)
Comparison of D112L mutant channel flux data (top) to theoretical curves for the
decrease of internal pH over time incorporating a Cl- conductance (GCl) in the membrane
of 10 fS scaled with the theoretical fraction of empty vesicles (0.15, bottom). Simulations
were all preformed using MATLAB according to the protocol described in section 3.2
with protein-to-lipid ratios of 1:100 (wt:wt).
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3.4 DISCUSSION AND FUTURE DIRECTIONS
The data presented in this chapter clearly establish the ability of the putative hHV1
channel to conduct H+ (Lee et al. 2009b). Furthermore, through mutagenesis studies on
the transmembrane domain, we identified an interesting amino acid residue position—
D112 on S1— which, when mutated, impairs the channel’s ability to conduct H+. This
finding has since been confirmed electrophysiologically by Musset et al., who
demonstrated that mutation of this position can lead to Cl- leak through hHV1 and that the
D112V mutant is incapable of conducting ions (Musset et al. 2011). By mutating the
equivalent position on S1 of the KVAP isolated VSD to aspartate (S38D), we
demonstrated that an aspartate at this position is sufficient to promote H+ conduction
through VSDs.
Going forward, it would be interesting to generate, purify and reconstitute the
D112V mutant and to test it for H+ flux in our assay. Given that Musset et al. failed to see
any conduction through the D112V mutant channel even though it was efficiently
expressed to the cell membrane (Musset et al. 2011), we would expect that this mutant
would completely abolish H+ flux in our assay. In order to fully understand the role of
D112 in conduction, it would be ideal to solve the structure of the channel in both the
conductive and non-conductive states. Because of the delicate charge balance that is
found in VSDs, one may expect that mutations of D112 to an uncharged residue may
disrupt the protein’s stability. However, given that the D112L mutant channel displayed
greater stability in detergent than wild type hHV1 in our expression and purification
experiments, we believe that the D112L mutant may constitute a good structural target.
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Many of the mutants we characterized in our flux assay show behavior consistent
with the generation of a leak conductance through the membranes (Fig. 3.9). However, in
order to confirm whether these mutations cause the production of leaky VSDs these
mutants

will

have

to

be

expressed

in

cell

membranes

and

characterized

electrophysiologically. The cases in which the indicated mutants or similar mutants have
been characterized electrophysiologically have demonstrated that leak currents exist
through the channel (Berger & Isacoff 2011; Musset et al. 2011).
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CHAPTER 4: CRYSTALLOGRAPHY
One major goal of my doctoral work was to obtain the structure of the human voltagegated H+ channel (hHV1), in order to shed light on the unique properties of HV channels.
Although structures may not provide direct mechanistic insight, they do provide a model
for hypothesis generation, which can then be followed up by functional studies. Before I
joined the lab, Dr Seok-Yong Lee had done initial construct design and crystallization
screening on hHV1. My work described here follows from Dr Lee’s initial work, and we
worked as a team for the first three years.
In our efforts to crystallize the hHV1 channel, Dr Lee and I generated many
different constructs (discussed below), which were tested for expression and biochemical
stability. Biochemical stability here is defined as monodispersity on a size exclusion
chromatography (SEC) column after remaining in solution undisturbed at high
concentrations for 5-7 days, as monodispersity on SEC has been shown to correlate well
with crystallizability (Kawate & Gouaux 2006). Only biochemically stable constructs
were pursued in crystallization trials.
In addition to hHV1, 21 other putative HV channel genes were synthesized and
screened for biochemical stability. Appendix II contains the sequences of all genes
synthesized and shows a multiple sequence alignment between all of the putative HV
channel genes as well as the voltage sensor domain of rat KV1.2. Dr Scott Hansen a
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postdoctoral fellow in the lab joined Dr Lee and I in this effort, which unfortunately
failed to identify any other promising functional targets. The putative HV channel from
the plant genus medicago was biochemically well behaved but when reconstituted into
lipid vesicles did not result in any H+ conduction and was therefore set aside.

4.1 NATIVE AND FUSION PROTEIN CRYSTALLOGRAPHIC ATTEMPTS
4.1.1 Crystallography of wild type truncated channels
Despite many attempts, crystals of the full-length hHV1 never grew. This is not
surprising, given that the acid-and-proline-rich N-terminus of hHV1 is predicted to be
disordered. To increase crystallizability by removal of the unstructured regions, Dr Lee
worked with Dr Qingjun Wang (Laboratory of Mass Spectrometry and Gaseous Ion
Chemistry at the Rockefeller University) to define the structural core of the hHV1 channel
by limited proteolysis and by mass spectroscopy. Upon the identification of two trypsinsensitive sites (at amino acid R83 in the N-terminus, preceding the transmembrane
domain, and at K221, between the transmembrane domain and the coiled coil), Dr Lee
designed two truncated constructs: one with the C-terminal coiled coil removed (hHVΔC)
and one with both N- and C-termini removed (hHVΔNΔC).
Expressing these constructs in Pichia pastoris and using the high affinity 1D4-tag
for purification, Dr Lee was able to purify both constructs and grow small crystals of the
hHVΔNΔC construct (Fig. 4.1A). These truncated channels crystallized under many
conditions; however, none diffracted better than ~10 Å (Fig. 4.1B). Nevertheless, this
was encouraging, since similar diffraction had been previously observed for the isolated
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voltage-sensor domain (VSD) of the voltage-gated K+ channel KVAP. When an antigenbinding fragment (Fab) of an antibody raised against the isolated VSD of KVAP was used
as a crystallization chaperone, Jiang et al. were able to solve the structure of isolated
VSD to 1.9 Å resolution (Jiang et al. 2003a). Therefore, by analogy, we reasoned that, if
we could obtain a Fab against the hHV1 channel and use it in crystallization, we should be
able to obtain crystals with improved diffraction.

Fig. 4.1 Best diffracting crystals of hHVΔNΔC
(A) Representative crystals of hHVΔNΔC grown in DM/HEGA9 detergent at 30%
PEG400, 50 mM NaAcetate pH 4.5. (B) Best diffraction from crystals shown in (A),
resolution extends to 9.6 Å, apparent space group is F23 a=b=c=169.7 Å. Weak
diffraction is also seen for a unit cell with an alternate orientation indicating possible
twinning. These crystals were grown and their diffraction tested by Dr Seok-Yong Lee.
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4.1.2 Raising antibodies against hHV1
We attempted raising antibodies against both the wild type and truncated (hHVΔNΔC)
hHV1 channels by mouse injection. The only anti-hHV1 antibodies that were isolated were
against an intracellular C-terminal coiled-coil epitope, which, according to the limited
proteolysis studies, is connected to the transmembrane domain by a flexible linker.
Although these antibodies worked well in Western blots and were used for the
stoichiometry studies discussed in Chapter 2, no crystals of hHV1-Fab complex grew in
our crystallization trials. Given that Fabs that were successful for the crystallization of the
KVAP isolated VSD were targeted towards an extracellular loop of the transmembrane
domain (the S3-S4 helix-turn-helix motif known as the voltage-sensor paddle), an antihHV1 antibody that targeted the voltage-sensor paddle of hHV1 was desirable. An
additional round of mouse injections was performed with the hHVΔNΔC doubly truncated
construct, with injections of the channel reconstituted in lipid vesicles, followed by
boosters of detergent-solubilized channels. As in the wild type case, we were unable to
isolate any anti-hHV1 antibodies.
Because mouse injection has been very successfully applied in the MacKinnon
laboratory for raising antibodies against membrane proteins (Zhou et al. 2001; Dutzler et
al. 2003; Jiang et al. 2003a; Brohawn et al. 2013), a purely technical reason for our
failure was unlikely. A possible explanation is that, given the human and mouse HV
channel sequence-similarity (78% identical over the entire sequence and 84% identical
within the transmembrane domain alone), the hHV1 channel may not be sufficiently
immunogenic in mice to produce a strong antibody response.
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In order to address this possible issue, we attempted another round of mouse
injections using chimeric channels that contained the voltage-sensor paddle of hHV1
spliced into the KVAP isolated VSD, reasoning that the HV sequence presented in this
context should increase the immunogenicity. We built and characterized six chimeras
based on three possible KVAP/hHV1 alignments (Fig. 4.2A and B). Although the chimeric
channels expressed well and were biochemically well behaved (Fig. 4.2C), they were not
sufficiently immunogenic for us to be able to isolate any anti-hHV1 Fabs.
More recent work in the literature has demonstrated that hHV1 channels play a
physiological role in B-cell receptor signaling: hHV1 knockdown in B-cells results in
impaired antibody production (Capasso et al. 2010). Thus, it is likely that there is a
negative selection against B-cells that produce high-affinity anti-HV1 antibodies that are
able to bind to extracellular epitopes. Such negative selection is a possible explanation as
to why we were unable to raise any antibodies by mouse injection.
Despite these setbacks, we still reasoned that it should still be possible to improve
the diffraction of hHV1 crystals with a crystallization chaperone. Two additional
strategies were attempted to this end: fusion proteins and epitope-swapped chimera. The
fusion protein strategy was ineffective and I will only discuss it briefly below. The
epitope-swapped chimera will be more fully discussed in the following section.
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Fig. 4.2 Sequences and biochemical stability of KVAP VSD-hHV1 paddle chimeras
(A) Three possible registers for sequence alignments between the S3-S4 paddle motif of
KVAP (in black) and hHV1 (in blue). The numbers above the KVAP sequence denote the
positions of the gating-charge arginines (highlighted red in all sequences) for the first
alignment. The alignments are named based on the relative position of the first hHV1
gating-charge arginine with respect to the KVAP gating-charge arginines. For example
alignment 1-1 aligns the first arginine of hHV1 with the first arginine of KVAP, alignment
1-2 aligns the first arginine of hHV1 with the second arginine of KVAP etc. (B) Paddle
sequences of the six chimeric (APHV) constructs built, organized by the alignment that
was used for their construction. (C) SEC profiles of each chimeric construct organized by
alignment. Each chromatogram contains the KVAP VSD curve (blue) to allow for
comparison of expression levels. From these data it is clear that, although all constructs
are monodisperse, we are able to purify larger quantities of APHV3 and APHV4 from the
1-2 alignment.
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4.1.3 Lysozyme Fusion Proteins
The fusion of the highly crystallizable enzyme lysozyme into the transmembrane domain
loops of membrane proteins has been used as a chaperone strategy to crystallize difficult
membrane protein targets. For instance, this strategy was used to determine the structure
of the first G-protein coupled receptor (GPCR; Rosenbaum et al. 2007). We attempted
this strategy by splicing lysozyme into both extracellular loops of the hHVΔNΔC
construct (the S1-S2 and S3-S4 loops). At low concentrations, the lysozyme fusions
looked promising; however, they readily aggregated at high concentration. Optimization
of linker length between the hHV1 and lysozyme sequences was carried out, but no
construct was sufficiently well behaved for large-scale crystallization attempts. Because
of this tendency for aggregation, the lysozyme fusion strategy was abandoned.

4.1.4 Dimerization Fusion Proteins
Since we knew from our cross-linking studies that hHV1 is a dimer in the membrane, we
reasoned that by fusing readily crystallizable dimeric protein onto hHV1 we might be able
to promote crystallization. A major criterion for the fusion partner would be for it to have
its N- or C-terminus arranged in the dimer such that it would be positioned to align with
our experimental model of the hHV1 dimer (see Fig. 2.5 on page 48). Four top candidates
were identified from the protein data bank: secretion chaperone CsaA (accession code
2NZH; Shapova & Paetzel 2007), F420H2:NADP+ oxidoreductase (FnO; accession code
1JAX; Warkentin et al. 2001), the bleomycin resistance determinant (Bleo; accession
code 1ECS; Maruyama 2000) and 4-diphosphocytidyl-2-C-methylerythritol synthetase
(CDP; accession code 1INJ; Richard et al. 2001). Two of these proteins were selected for
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N-terminal fusion (FnO and CDP) and two for C-terminal fusion (Bleo and CsaA) to the
hHVΔNΔC construct. For each fusion, four or five different constructs were built to
optimize linker length. After much effort, however, and although some of the constructs
generated well-behaved dimeric chimera, no fusions gave crystals. Therefore, this
approach was also abandoned.

4.2 HV1-KVAP EPITOPE-SWAPPED CHIMERA
4.2.1 Design and selection of hHV1-KVAP paddle chimera
As discussed in the previous section, by analogy to the KVAP isolated VSD, we reasoned
that Fab-mediated crystallization would facilitate structure determination of hHVΔNΔC.
Since we were unable to raise antibodies against wild type hHV1 channels by mouse
injection or to obtain crystals by the fusion protein strategy, we needed to innovate. It
occurred to us that it should be possible to make a hHV1-KVAP (HAP) chimera in which
the paddle epitope that is responsible for binding anti-KVAP Fabs is spliced into the hHV1
sequence. It has been previously demonstrated that the paddle motif can be swapped
between different VSD of voltage-gated cation channels and still produce functional
voltage-gated cation channels (Alabi et al. 2007). In this way, we could generate
functional chimeric HV channels that would bind to the anti-KVAP Fabs, allowing us to
use the anti-KVAP Fabs as crystallization chaperones.
Due to the ambiguity in the sequence alignment between hHV1 and KVAP
along the S4 helix, many different constructs needed to be built and characterized before
crystallization trials could proceed. Based on three different possible hHV1 and KVAP S4
93

alignments, 17 chimeras were constructed (Fig. 4.3) and each was expressed in both full
length and C-terminally truncated forms (ΔC). Small-scale purification and biochemical
characterization using size exclusion chromatography (SEC) was carried out to gauge the
stability of each chimeric channel. Two chimeras each with different alignment—
HAP5ΔC and nHAP3ΔC—were chosen as the best candidates for structure
determination, based on their biochemical stability and Fab-binding. When probed for
binding with the anti-KVAP antibodies 33H1 and 6E9, both chimeras were ELISA- and
Western-blot-positive, indicating that the antibodies were able to recognize the paddle
epitope of the chimeric constructs (Fig. 4.4).
The HAP5ΔC chimera was highly stable, giving a stable monodisperse peak on
the SEC column after several days at high concentrations at room temperature in DM
(Fig. 4.5A-C). However, when mixed with anti-KVAP Fabs and run over the SEC
column, only a small complex peak was formed, with most of the protein eluting at
positions characteristic of the channel and Fab alone (Fig 4.5D and E). This is in contrast
to what is observed with wild type KVAP channel or isolated VSD, which elute
completely as VSD-Fab complex. This indicated that, although HAP5 is ELISA-positive
for binding to 33H1 and 6E9 Fabs (Fig. 4.4), the interaction is much weaker than the
binding of the Fabs to the wild type KVAP VSD.
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Fig. 4.3 HAP chimera construct sequences
(Top) Three possible registers for sequence alignments between the S3-S4 paddle motif
of KVAP (in black) and hHV1 (in blue). The numbers above the KVAP sequence denote
the positions of the gating-charge arginines (highlighted red in all sequences) for the first
alignment. The alignments are named as in Fig. 4.2. The first 16 HAP chimeras were
generated and characterized by Dr Seok-Yong Lee and were all based on the 1-3
alignment. The “New Chimera” designated with an “n” were constructed based on the 12 and 1-1 alingments.
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Fig. 4.4 ELISAs and western blots of chimeras using αKVAP paddle antibodies
(A) Bar graphs of ELISA signal intensity as a function of Ab dilution (indicated on right)
for KVAP VSD (cyan), nHAP2ΔC (red), nHAP3ΔC (yellow), HAP5ΔC (green) and hHV1
(purple) using the αKVAP monoclonal antibodies 6E1 (left) and 33H1 (right). The low
signal seen for the KVAP VSD is due to poor binding of this protein to the plates. (B)
SDS-PAGE gels and corresponding western blots against the indicated chimera using the
αKVAP monoclonal antibodies 6E1 (left and center) and 33H1 (right).
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Fig. 4.5 Biochemical stability of HAP5ΔC and binding of αKVAP paddle antibodies
(A) SEC chromatogram of rerun single concentrated fraction after initial SEC
purification. (B) SEC chromatogram of pooled fractions from initial SEC run
concentrated and left overnight (O/N) at room temperature (RT). (C) SEC chromatogram
of pooled fractions from initial SEC run concentrated and left for 4 days at RT. (D) SEC
chromatogram of HAP5ΔC with 6E1 Fab indicating some weak complex formation in
DM. (E) SEC chromatogram of HAP5ΔC with 33H1 Fab indicating no significant
complex formation. All SEC runs were done in DM.
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The nHAP3ΔC chimera was less stable than the HAP5ΔC construct; nHAP3ΔC
readily aggregated at high concentrations in DM (Fig 4.6A and B). However, in the more
dispersive detergent LDAO nHAP3ΔC was more stable (Fig4.6C-E) and it eluted
completely as complex with the anti-KVAP 6E1 Fab on the SEC column (Fig. 4.6F),
similar to the wild type KVAP VSD. Because of the differences in the biochemical
behavior of these two chimeras, it was decided that both would be pursued for structure
determination.
In order to explore possible crystallization conditions, the detergent-stability
profiles of the two chimeras was examined. After purification of the constructs in
decylmaltoside (DM), small volumes of the protein were injected onto a SEC column
equilibrated in the detergent of interest. Stability in the new detergent was judged based
on the monodispersity of the protein peak eluting from the SEC column. In this way, 19
detergents were examined (Table 4.1). Consistent with the differential stability of the
chimeras in DM (see Fig. 4.5A-C vs. 4.6A and B), the HAP5ΔC chimera was stable in a
diverse array of detergents, whereas the nHAP3ΔC chimera was only highly stable in
dispersive and lipid-like detergents (Table 4.1).
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Fig. 4.6 Biochemical stability of nHAP3ΔC and binding of αKVAP paddle antibodies
(A) SEC chromatogram of rerun single concentrated fraction after initial SEC
purification in DM. (B) SEC chromatogram of pooled fractions from initial SEC run
concentrated and left O/N at RT in DM. (C) SEC chromatogram of detergent exchange
from DM to LDAO. (D) SEC chromatogram of pooled fractions from (C) concentrated
and left O/N at RT in LDAO. (E) SEC chromatogram of pooled fractions from (C)
concentrated and left for 5 days at RT in LDAO. (F) Reducing SDS-PAGE gel (left) of
SEC chromatogram (right) fractions for nHAP3ΔC with 6E1 Fab indicating complex
formation in LDAO (right)
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Table 4.1 Detergent stability profiles of HAP5ΔC and nHAP3ΔC chimeras
Detergent stability is graded qualitatively from A to F based on peak monodispersity
during detergent exchange experiments on SEC. A dash (-) indicates that the experiment
was not done. Inset shows an example A grade (left) vs. an example F grade (right).

Given the diversity of detergent conditions in which the chimeras were stable,
many conditions needed to be explored for crystallization. Initial crystallization trials of
HAP5ΔC and nHAP3ΔC with the 6E1 anti-KVAP Fab gave small crystals in the case of
the HAP5ΔC construct in DM (Fig. 4.7), but did not give any crystals in the case of the
nHAP3ΔC in DM, LDAO or DHPC. However, crystalline precipitate was seen in many
drops of the nHAP3ΔC/6E1 crystallization screens, indicating that it might be possible to
further optimize the conditions to produce crystals. For HAP5ΔC, I was unable to

100

successfully refine the initial hits from 6E1 crystal screens, suggesting that alterations to
the construct might be required to facilitate efficient crystallization.
Although the C-terminally truncated wild type hHV1 (hHVΔC) construct gave
some crystals, truncation of both the N- and C-termini improved crystallizability (Fig.
4.1). Therefore, we reasoned that removal of the N-terminus might also be required to
improve crystal formation of the chimeric constructs, as described below.

Fig. 4.7 Initial crystal hits for HAP5ΔC in complex with 6E1 Fab
Bright field (left) and UV emission (right) images of small crystals that grew in drops
containing HAP5ΔC/6E1 in DM with 10-30% PEG400, 200 mM CaCl2, 50 mM
NaAcetate, pH 4.5. The fluorescent signal see in the UV emission image indicates that
the crystals are protenacious.
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4.2.2 Construct optimization and improvement of the initial crystals
In order to optimize the chimeric constructs in an unbiased manner, we performed limited
proteolysis on both HAP5ΔC and nHAP3ΔC. In this way, any differences in the proteaseresistant regions of the constructs could be examined and compared to wild type hHV1
channels. By defining the protease resistant core of the chimeras, we would be able to
redesign the constructs to remove any flexible or unstructured regions that might be
interfering with crystallization.
Limited proteolysis was carried out for each chimera using four proteases: trypsin,
chymotrypsin, elastase and subtilisin (Fig. 4.8). For both chimera, one hour of
trypsinization resulted in the smallest stable fragment. These fragments were then
analyzed by both N-terminal sequencing and mass spectrometry, which revealed that the
trypsin cleavage site was located between amino acids R83 and A84. This is the same
position at which limited proteolysis removes the N-terminus of the wild type hHV1
channel, indicating that the beginning of the structured transmembrane domain is
unaltered in the chimeric constructs.
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Fig. 4.8 Example limited proteolysis experiments for nHAP3ΔC in DM
(A) nHAP3ΔC was mixed with the indicated proteases at ratios ranging from 0.0001 mg
protease/mg channel to 0.1 mg protease/mg channel for 1 hour at room temperature.
Digestions were stopped by addition of 5 mM PMSF. (B) Western blot analysis of the
proteolysis fragments generated at the highest protease concentrations in (A). SDS-PAGE
gel (left) indicating the presence of each of the fragments as well as wild type hHV1 and
KVAP VSD controls. Western blot (middle) using the αKVAP-paddle mAb 6E1 as
primary Ab indicating that each proteolysis fragment contains the paddle epitope
indicating that the transmembrane region is resistant to proteolysis. The contents of each
well are indicated in the legend (right). Trypsin fragment was further characterized by Nterminal sequencing and mass spectrometry.
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After initial proteolysis experiments, a trypsinization time-course was carried out
to compare the relative stabilities of HAP5ΔC and nHAP3ΔC (Fig. 4.9). These
experiments indicated that the trypsin-digested HAP5ΔC was highly stable: no further
proteolysis was observed after the initial cleavage even at very high trypsin
concentrations (Fig. 4.9B). In contrast, the nHAP3ΔC continued to degrade over time,
indicating instability (Fig. 4.9A). However, by stopping the trypsin digestion of
nHAP3ΔC at an early time point by addition of phenylmethanesulfonylfluoride (PMSF),
it was possible to isolate the transmembrane fragment before it was further digested (Fig.
4.9A).
Since it was possible to isolate a stable transmembrane fragment of both chimeric
constructs, preparative trypsinization was attempted as a possible method for protein
production for crystallization. Using this methodology, the protein was digested by
addition of trypsin during the purification, the digestion was stopped by addition of
PMSF, the transmembrane fragment was isolated by SEC, mixed with the anti-KVAP
Fabs (6E1 or 33H1) and then set up in crystallization screens. This process resulted in the
growth of crystals of trypsinized-HAP5ΔC (tHAP5ΔC) in complex with 6E1. No crystals
were observed for the nHAP3ΔC construct with either 6E1 or 33H1 Fabs.
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Fig. 4.9 Trypsinization time-course to compare stability of chimeric constructs
(A) nHAP3ΔC in LDAO and (B) HAP5ΔC in DM were subjected to trypsinization at the
indicated trypsin-to-channel ratios (bottom of gels). At the indicated time points an
aliquot was taken and quenched with PMSF then run on the SDS-PAGE gel. LDAO was
used for nHAP3ΔC since the channel is more stable in this detergent than in DM (see
Table 4.1).
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Refinement of the tHAP5ΔC/6E1 crystallization conditions resulted in the growth
of large (~0.4 x 0.2 x 0.1 mm) crystals (Fig. 4.10A). In order to confirm that these
crystals contained both channel and Fab, crystals were harvested, washed and run on an
SDS-PAGE gel, which was developed using silver staining (Fig. 4.10B). This gel
indicated that the crystals contained both Fab and tHAP5ΔC (Fig. 4.10B), demonstrating
that, even though the interaction between this construct and the Fabs are too weak to
purify complex on the SEC column, complex does form under crystallization conditions.
The X-ray diffraction properties of these tHAP5ΔC/6E1 crystals were examined
at the synchrotron. The crystals diffracted anisotropically to ~3.5 Å in the good direction
and ~9 Å in the other two directions (Fig. 4.10C). Although I was unable to index this
data set, it was encouraging to see diffraction from these crystals. We decided it would be
best to focus efforts on improving this crystal form and to forego working on the
nHAP3ΔC chimera, which had yet to produce any crystals.
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Fig. 4.10 Crystals of trypsinized HAP5ΔC in complex with 6E1
(A) Crystals of trypsinized-HAP5ΔC (tHAP5ΔC) in complex with 6E1 Fab grown in
30% PEG400, 50 mM potassium phosphate pH 7.0. (B) Silver stained SDS-PAGE gel of
crystals from these conditions indicating that the crystals contain both 6E1 Fab and
tHAP5ΔC. (C) Best diffraction pattern generated by crystals from these conditions.
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To improve the diffraction, I needed to eliminate any source of heterogeneity
originating from the protein preparation. To generate channel protein for these crystals,
the construct was expressed as a C-terminal GFP-1D4 fusion, with the channel and GFP1D4 tag separated by a PreScission protease cleavage site. The channel was purified by
1D4-affinity chromatography followed by PreScission protease digestion to remove the
GFP-1D4 tag, followed by an additional round of 1D4-affinity chromatography to
separate the cleaved GFP-1D4 from the channel, trypsinization to remove the N-terminus
and then SEC to isolate the transmembrane fragment. PreScission protease is a highly
specific protease isolated from human rhinovirus that cleaves the sequence LEVLFQ/GP
where the “/” indicates the site of cleavage (Cordingley et al. 1990). Because of the eight
amino acid residue long recognition site and an additional three amino acid residues
introduced for cloning purposes, removal of the C-terminal GFP-1D4 tag by PreScission
protease resulted in the presence of nine non-HV derived amino acid residues
(SNSLEVLFQ) following the final native lysine residue (K221 in wild type channels) on
the C-terminus of the HAP5ΔC construct. Mass spectrometry of the trypsinized channel
indicated that not only did the trypsin cut at position R83 on the N-terminus, but it also
cut much more slowly at the final native lysine residue, producing a mixture of C-termini
(Fig 4.11). We reasoned that removal of this source of heterogeneity by redesign of the
expression construct should improve crystal growth.
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Fig. 4.11 Mass Spectrometry of HAP5ΔC trypsinization time course
(A) Mass spectrum of undigested HAP5ΔC generated using the ultrathin-layer method
(Cadene & Chait 2000). The experimental mass agrees well with the theoretical mass for
the full-length construct with the N-terminal methionine removed. The additional ~42 Da
mass difference between the theoretical and experimental masses indicates that the
protein contains a post-translational modification, most likely N-terminal acetylation. (B)
Mass spectrum of HAP5ΔC after 3 hours of trypsin digestion indicating that the Nterminus has been completely removed by trypsin digestion at R83. Two distinct peaks
corresponding to the transmembrane (TM) fragment are visible. The masses of the two
fragments TM1 and TM2 correspond to within 1 Da of the theoretical masses of the
HAP5ΔC TM fragment plus/minus the nine non-native amino acid residues left over from
the PreScission protease site on the C-terminus. (C) Mass spectrum of HAP5ΔC after
overnight trypsin digestion at 0.1 mg trypsin/mg channel indicating that given enough
time the nine non-native amino acid residues are completely removed.
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To bypass preparative trypsinization, the GFP tag was moved to the N-terminus,
making the PreScission site N-terminal to the transmembrane domain. Since the Nterminal site of trypsinization was located between R83 and A84, through overlapping of
the PreScission cleavage site with this trypsin site, it was possible to generate a final
PreScission-digested N- and C-terminally truncated chimera that only differed from the
wild type HVΔNΔC by having a glycine instead of an alanine at position 84 and by
terminating at the lysine position 221 (and, of course, by having the KvAP paddle swap).
However, because the 1D4 affinity tag is C-terminal, moving the tag to the N-terminus
required using a different affinity purification protocol. At first, an N-terminal FLAG tag
was used, which also allows antibody affinity for the purification of low-yield proteins.
However, after initial expression and purification trials, it was found that moving the
GFP tag to the N-terminus greatly improved the protein expression and more than
doubled the yield. Therefore I was able to switch the affinity tag from a FLAG tag to a
Deca-His tag and thus use immobilized metal-affinity chromatography (IMAC) in the
purification.
By making the above modifications to the expression construct, I was able to
simplify the purification protocol by removing the need for preparative trypsinization.
With this construct, the purification protocol after protein extraction consisted of IMAC
using Co2+ resin, PreScission digestion to cleave off the His-GFP tag, another round of
IMAC to separate the cleaved tag and the HAP5ΔNΔC construct, followed by a final
SEC purification. Mass spectrometry confirmed that this new construct and purification
protocol resulted in the production of a homogenous protein sample without any
additional proteolysis or post-translational modifications.
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Setting up crystallization screens with this construct in the presence of the 33H1
Fab in DM resulted in two new crystal forms both of which contained Fab and
HAP5ΔNΔC (Fig 4.12). After refinement of the crystal growth conditions and initial
diffraction analysis, it was determined that the crystal form shown in Fig. 4.12A did not
diffract better than ~9 Å resolution, whereas the other crystal form, shown in Fig. 4.12B,
displayed greater variability with some crystals diffracting better than 4 Å. Screening of
many different crystals from these conditions resulted in collection of a complete, though
anisotropic, data set to 3.9 x 5.1 x 3.8 Å resolution (Fig. 4.13, Table 4.2).
Before discussing the structure of HAP5ΔNΔC that I obtained from this data set, I
will use the following section to describe the functional work that was performed in
conjunction with the biochemistry described in the previous sections. Throughout the
design and modification of the chimeras, great care was taken to insure that each new
construct was a functional voltage-gated proton channel. The functional data presented in
the next section are essential for interpretation of the structural work.
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Fig. 4.12 Crystals grown from HAP5ΔNΔC construct in complex with 33H1 Fab
(A) Crystals grown in 30% PEG400, 50 mM MES pH6.5, 100 mM NaLiSO4. (B)
Crystals grown in 30% PEG400. The silver stained gels of the crystals (right) indicate
that the crystals contain both 33H1 Fab and HAP5ΔNΔC.
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Fig. 4.13 Diffraction from crystals of HAP5ΔNΔC/33H1 complex crystals
Two diffraction images from the same crystal grown in 30% PEG400 taken at ~90°
separation clearly showing anisotropy. The concentric circles indicate resolution shells,
going from the center outwards 20 Å, 8 Å and 4 Å are shown.

Table 4.2 Summary of data collection for HAP5ΔNΔC/33H1 complex
Data Set

HAP5ΔNΔC/33H1

Resolution (Å)

3.9, 5.1, 3.8

Space Group

P1

Source

BNL X29

Cell Dimensions: a, b, c (Å) 99.8, 136.1, 148.1
α, β, γ (°)

82.2, 89.4, 76.6

Unique reflections

53,138

I/σI

7.33 (2.47)

Ellipsoid truncation and anisotropic scaling was performed on the data set using the
UCLA MBI diffraction anisotropy server (Strong et al. 2006).
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4.2.3 The best candidates for structure determination are functional
By reconstituting the chimeric channels into lipid vesicles and using the fluorescencebased concentrative uptake flux assay described in Chapter 3, I determined that HAP5ΔC,
nHAP3ΔC and the trypsinized HAP5ΔC were able to conduct H+ (Fig. 4.14A and B). In
each case, the H+ conduction observed from these constructs was qualitatively similar to
that of the reconstituted wild type hHV1 channel (Fig. 4.14A and B). The fact that the
fluorescence quenching time courses went to completion without any slow recovery or
intermediate level of quenching indicated that the chimeric constructs also maintained H+
selectivity (see Chapter 3 for a more in depth discussion on implications concerning
selectivity from this assay). These functional data from the flux assay were sufficient for
me to pursue these chimeric constructs as possible structural targets; however, once a
complete data set was obtained for the HAP5ΔNΔC, a more rigorous electrophysiological
characterization was desired.
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Fig. 4.14 H+ uptake into vesicles containing the chimeric constructs
(A) Fluorescence-based H+ flux assay for vesicles containing HAP5ΔC (green),
nHAP3ΔC (red) compared to empty vesicles (orange) and wild type hHV1 containing
vesicles (cyan). (B) Fluorescence-based H+ flux assay for vesicles containing HAP5ΔC
(green) and trypsinized-HAP5ΔC (tHAP5ΔC, brown). In each case valinomycin was
added after 150s, CCCP was added at 450s and the fluorescence measurements were
repeated 3-4 times (error bars represent the standard error of the mean). The significant
fluorescence quenching seen for the empty vesicles in (B) indicate that this batch of
vesicles was more leaky than usual.
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To test the voltage-gating properties of the HAP5 chimera, the full-length
sequence was cloned into a HEK-cell expression vector and the activity of the channel
was compared to wild type hHV1 in HEK cells by the whole-cell patch clamp method.
Although both channels generated robust voltage-gated currents, the gating properties of
the HAP5 chimera are significantly different from that of hHV1 channels (Fig. 4.15A and
B). Both the rate of opening and closing were significantly faster in the HAP chimeric
channel (Fig. 4.15B). The rate of closing of the HAP5 chimera was so fast that, when
using a similar voltage step protocol as for hHV1, tail current was not observable (Fig.
4.15B). Due to the speed of channel closing when the voltage was stepped to negative
potentials, the reversal potential of the currents elicited by opening of the HAP5 channel
could not be accurately measured. This precluded definitive determination of the ion
selectivity for this channel; however, as mentioned above, the stability of fluorescence
quenching seen in the flux assay suggests that the HAP5 channel maintained its H+
selectivity.
Further characterization of the chimeric channel under different external and
internal pH and ionic conditions may have allowed for accurate measurement of reversal
potentials; however, further structural and biochemical analysis described in the
following sections precluded the need for further functional characterization of this
channel. Although the functional changes elicited by the paddle swap are interesting unto
themselves (the channel gating actually more resembles that of KVAP than hHV1), my
major focus was to solve the structure of a HV channel and, thus, only confirmation that
the HAP5 chimera was a functional voltage-gated H+ channel was needed. The data
presented in Fig. 4.14 and 4.15 demonstrate that the HAP5 chimera is functional.
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Fig. 4.15 HAP5 is a voltage-gated H+ channel
(A) Whole-cell patch clamp recording from a HEK cell expressing hHV1. Voltage-step
protocol was as indicated in the schematic. (B) Whole-cell patch clamp recording from a
HEK cell expressing HAP5. Voltage-step protocol was as indicated in the schematic.

4.2.4 Structure of the HAP5ΔNΔC chimera
Using the separate constant (FC) and variable regions (FV) of the Fab as search models for
molecular replacement, it was possible to phase the low-resolution anisotropic data set.
The unit cell (which was the asymmetric unit, since the space group was P1) was large
enough to fit eight HAP5ΔNΔC/33H1 complexes; however, clear density was observed
for only five and a half Fabs (6 FVs and 5 FCs), with the remainder of the cell being
disordered. From the initial molecular replacement solution, tubular density was observed
extending from the 33H1 binding sites, which unambiguously corresponded to the four
transmembrane helices of the HAP5ΔNΔC channel (Fig. 4.16).
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Fig. 4.16 Example of helical electron density observed in a 33H1 Fab binding site
Stereo image of 1σ electron density from 2Fo-Fc map calculated from 33H1 Fab
molecular replacement solution prior to any refinement or model building. Strands
corresponding to 33H1 binding site are shown as green ribbons. Map was generated from
data set summarized in Table 4.2 at 4 Å.

It was possible to fit the transmembrane helices into the density without any
refinement of the initial search model (Fig. 4.17). Due to the low resolution and internal
disorder of the data set, it was not possible to unambiguously determine the connectivity
between the different transmembrane helices. However, due to the known interaction
between the KVAP paddle sequence and the 33H1 Fab (Jiang et al. 2003a), it was
possible to identify and register the S3 and S4 helices. Additionally, it was clear from the
density that the channels were arranged as dimers.
Comparing the arrangement of the four transmembrane helices of each
HAP5ΔNΔC subunit it was evident that the observed structure was very different from
that of known VSDs (Jiang et al. 2003a; Long et al. 2005; Long et al. 2007; Payandeh et
al. 2011; Payandeh et al. 2012; Zhang et al. 2012). Additionally, the dimer interface in
the structure was extensive, with the S3 helices wrapping around each other and
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intercalating between the S3 and S4 helices of the opposite subunit in the dimer, causing
a splaying of the paddle motif when compared to the KVAP structure (Fig. 4.18). The
presence of this dimer interface along S3 disagreed with our site directed cross-linking
studies of the wild type hHV1 in membranes, which demonstrated that the dimer interface
was along the S1 helix (see Chapter 2 and Lee et al. 2008).
In spite of these discrepancies seen in the model of HAP5ΔNΔC (Fig. 4.17) and
the cross-linking data presented in Chapter 2, we knew from the electrophysiology and
the flux assay of the reconstituted channel that the chimera was functional. However, the
inconsistency between structural and biochemical data had to be resolved before further
interpretation and refinement of the structure could be carried out.

Fig. 4.17 Helical model of HAP5ΔNΔC
Model of transmembrane helices generated by fitting polyalanine α-helices into the
electron density found at the 33H1 binding site. Left, side view looking from within the
expected membrane plane, right, top view looking down from the hypothetical
extracellular side. The amino acid residues that corresponds to KVAP sequence are
colored green, whereas hHV1 derived residues are magenta.
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Fig. 4.18 Comparison of paddle structures between HAP5 and KVAP isolated VSD
(A) Structural model of the HAP5ΔNΔC paddle colored as in Fig. 4.17. (B) Structural
model of KVAP paddle from (Jiang et al. 2003a). (C) Overlay of paddle structures
demonstrating that the paddle motif in HAP5ΔNΔC is splayed open compared to the
equivalent sequence in KVAP. Also no kink is observed in the S3 helix of HAP5ΔNΔC.

4.2.5 Cross-linking indicates HAP5ΔNΔC chimera structure is not native
To probe the functional dimeric state of the HAP5 chimera, the channel was expressed in
HEK cells in both full-length and C-terminally truncated forms and the pattern of site
specific cross-linking was investigated and compared side-by-side with wild type hHV1
channels. In addition to the positions along S1 that were shown to form robust disulfide
cross-links in hHV1, the amino acid residue positions along S3 that form the dimer
interface in the structure (Fig. 4.17) were also mutated to cysteine one at a time and
probed for cross-linking.
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In both cases, the full-length and C-terminally truncated HAP5 chimera showed
robust spontaneous disulfide bond formation along the top of the S1 helix, exactly
recapitulating the pattern seen for wild-type hHV1 (Fig. 4.19C). Because of the lack of the
C-terminus from the truncated channels, the less specific anti-KVAP antibody 6E1 was
used in the western blots, which resulted in some non-specific signal in spite of which
clear dimer was observed (Fig. 4.19E and G). Addition of oxidizing reagents and cysteine
reactive cross-linkers to the membranes pushed cross-linking at these S1 sites to
completion, just as was seen for the wild type hHV1 channel (Fig. 4.19G; Chapter 2; Lee
et al. 2008).
When the positions along S3 were probed for spontaneous cross-link formation,
no disulfide bond formation was observed (Fig. 4.19B and F). Furthermore, addition of
oxidizing reagents and cysteine-reactive cross-linkers still did not result in the
observation of any cross-linked dimer (Fig. 4.19D and H). These data clearly indicated
that the HAP5 chimera is a dimer in membranes even in the absence of the C-terminus,
and that its dimer interface is along the S1 helix (i.e. similar to wild type hHV1), not along
the S3 helix as seen in the structure.
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Fig. 4.19 Site-specific cross-linking studies of HAP5 and HAP5ΔC in membranes
(A) Cross-linking of the native coiled-coil cysteine (position 249) in both wild type hHV1
and HAP5. Production of a cys-less (CL) construct in which the two native cysteines
have been mutated to serine precludes disulfide-mediated cross-linking. (B) Cysteine
mutants of hHV1 CL along the S3 dimer interface seen in the crystal structure of
HAP5ΔNΔC (C) Cysteine mutants along the S1-S2 loop dimer interface seen in the
cross-linking studies discussed in Chapter 2 for both hHV1 CL and HAP5 CL constructs
(D) Same S3 mutants of hHV1 CL as in (B) but under forcing conditions. (E) Compaing
the effect of C-terminal truncation on the S1-S2 loop cysteine mediated cross-linking of
HAP5 CL and HAP5ΔC CL (F) Cysteine mutants of HAP5ΔC CL along the S3 dimer
interface seen in the crystal structure (G) Same S1-S2 mutants of HAP5 and HAP5ΔC
CL as in (E) but under forcing conditions. (H) Same S3 mutants of HAP5ΔC CL as in (F)
but under forcing conditions. Symbols in blue on the right on gels indicate the
approximate positions for the dimer and monomer of the coiled-coil containing constructs
(circles with tails) and the truncated constructs (circles without tails). (A – D) Use the
αhHV1-coiled-coil antibody 9C1 as the primary antibody (E – H) Use the αKVAP-paddle
antibody 6E1 as the primary antibody.
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4.2.6 Final attempts at chimera strategy
Here, I will briefly describe my efforts to use the non-native HAP5ΔNΔC structure to
design improved chimera with the goal of solving a native structure of the channel. The
main question that needed to be addressed was whether the HAP5ΔNΔC was completely
disordered in detergent or whether Fab binding was forcing the conformational
equilibrium of the chimera into a low occupancy non-native conformation.
Since the Fab was not raised against the HAP5ΔNΔC channel itself but against
the KVAP channel, if the paddle epitope were not properly presented for Fab recognition
in the native chimeric construct, we would expect very little binding of the Fab to the
native chimera. Therefore, four scenarios can be envisioned for binding of a Fab to an
epitope-swapped chimeric channel: 1) the chimera structure is native and highly stable in
detergent but does not present the epitope properly. In this case, Fab would not bind and
we would see no complex on the SEC column. This may be true even if we saw binding
of antibody in ELISAs and Western blots, since under these conditions we expect a
higher proportion of unfolded channels. 2) The chimera is native and stable in detergent
but does not present the epitope properly; however, it is in equilibrium with a low
occupancy non-native (partially unfolded) state in which the Fab is able to bind to the
paddle epitope with high affinity. In this case, we may see some incomplete complex
formation on the SEC column, but high concentrations of Fab would result in the
accumulation of non-native-chimera-Fab complex, which may then crystallize due to the
strength of Fab mediated crystal contacts. 3) Although the native chimera doesn’t present
the paddle epitope properly, the chimera is unstable in detergent and therefore
significantly occupies a non-native conformation that is able to bind Fab with high
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affinity. In this case, we would expect the chimera to be unstable in most non-dispersive
detergents but bind strongly to the Fab resulting in complete complex formation on the
SEC column. 4) The native chimera is highly stable in detergent and properly presents
the paddle epitope in a way that is easily accessible to the Fab. In this case we would
expect a biochemically stable construct and complete complex formation on the SEC
column.
To solve the native structure of a chimeric channel we require chimera that fall
into scenario 4 above. However, based on the evidence presented in this chapter, I
conclude that HAP5ΔNΔC falls into scenario 2: it is biochemically stable in many
detergents and it only forms partial complex with Fab on the SEC column. Therefore, the
33H1 Fab is only binding to a small population of non-native channels on the SEC
column, but the structure is completely non-native when solved in complex with the
33H1 Fab. In addition, I categorize the nHAP3ΔC chimera into scenario 3: it is unstable
in most detergents, but forms complete complex with Fab on the SEC column. The
question then becomes: can we use what we see in the structure to build a chimera that
falls into scenario 4, i.e. one that is stable in detergent and binds to the Fab in the native
conformation?
By examining the structure, it was clear that the S1 and S2 helices were directly
adjacent to the Fab; moreover, the S3-S4 helix-turn-helix paddle motif may be buried
below these two adjacent helices in the native structure (Fig. 4.20A-C). If the paddle
motif were buried, then Fab binding to the native structure would be prevented by steric
clash between the Fab and the S1 and S2 helices.
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Fig. 4.20 Structure based strategy for design of new chimera
(A) Cartoon representation of KVAP VSD in complex with 33H1 Fab structure showing
that the S3-S4 paddle epitope is extended relative to the S1-S2 loop. (B) Cartoon
representation of HAP5ΔNΔC dimer indicating possible source of steric clash between
the S1 and S2 helices and 33H1 Fab. (C) Schematic demonstrating how steric clash could
lead to helix splaying. (D) Sequence of hHV1 paddle; underlined portions indicates
residues that were added to the paddle extension chimera. (E) Sequences of paddle
extension chimera. (F) Schematic demonstrating how Fab binding could lead to
disruption of helical packing (G) Sequences of alternate helical register chimera.
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Looking back over the sequences of all the chimera constructed (Fig. 4.3), it was
determined that, because of the register used to splice in the paddle sequence, the HAP5C
construct actually contained the most extended paddle (the longest combined S3-S4
KVAP/hHV1 sequence) of all the chimeras originally screened. Therefore, four additional
doubly truncated chimeras that shared the same register as HAP5 but with longer S3 and
S4 helices were generated (Fig. 4.20E; nHAP8, nHAP10, nHAP11 and nHAP12 were
constructed). These chimera were expressed, purified and tested for only the two
scenario-4 properties: biochemical stability and complete complex formation with Fab on
the SEC column.
With the exception of nHAP10ΔNΔC (which was approximately one helical turn
longer on S3 and S4 with respect to HAP5), most of the paddle extensions resulted in
decreased stability of the chimeric constructs. Although the nHAP10ΔNΔC chimera was
stable, the alterations did not improve Fab binding. The binding of nHAP10ΔNΔC to
both 6E1 and 33H1 Fabs looked very similar to that of HAP5ΔNΔC, with only a small
proportion of complex formation, likely placing it into scenario 2.
Another possible way in which the paddle epitope may be incorrectly presented
for Fab binding on the chimeric channel is if the register of the S3 and S4 helices is
wrong relative to that of native KVAP. If S3 is longer or shorter than S4 in the chimera
relative to the equivalent positions of the KVAP S3 and S4 helices, then the S3-S4 helix
turn helix motif may be askew, resulting in poor Fab binding and disruption on helical
packing when the Fab does bind (Fig. 4.20F). To address this, eight additional chimeric
constructs were built: four in which successive single amino acid residue deletions were
carried out in S3 and four in which successive single amino acid residue additions were
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carried out in S4 (Fig. 4.20G). These deletions/additions were carried out on the
background of the nHAP10ΔNΔC construct, since it was the most stable chimera with the
most extended paddle motif. Expression and purification of these eight constructs
demonstrated that the nHAP10ΔNΔC S3-1, S3-1 and S4+4 constructs (Fig. 4.20G) were
very stable and monodisperse on the sizing column. However, none of these constructs
improve binding of either 6E1 of 33H1 Fabs.
Although there are a great number of possible combinations of amino acid residue
additions/deletions that could be tested for these paddle chimeras, after failure of this set
of eight constructs it was decided that it would be more productive to pursue other
avenues for improved Fab binding. Therefore, the paddle chimera strategy was
abandoned in favor of raising Fabs against the hHVΔNΔC channel by phage display
(discussed below) and of nuclear magnetic resonance (NMR) characterization of the wild
type channel (discussed in the next chapter).

4.3 RAISING FABS BY PHAGE DISPLAY
4.3.1 Phage display selections overview
For soluble proteins, phage display selections are done via biotinylation and
immobilization of the protein of interest onto streptavidin or neutravidin coated 96-well
plates (Sidhu et al. 2000). In this way, large phage libraries with >1013 sequence diversity
can be applied to the sample for selection of binders by successive washing steps
(Persson et al. 2013). In practice, the phage libraries are applied first to a streptavidincoated well alone to remove any phage clones with non-specific or streptavidin specific
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binding, and then the phage are moved to the wells with the immobilized sample (Sidhu
et al. 2000). After incubation and 4-5 rounds of washing, the bound phage are eluted
from the sample by addition of acid and are then amplified overnight in bacterial culture.
This process is repeated in four or five rounds of selection, using higher concentrations of
phage in each successive round. Increasing the phage concentration as the selection
rounds progress results in greater competition between the remaining phage, selecting for
the higher affinity binders (Sidhu et al. 2000). After the final round of selection, phageinfected bacteria are plated out in order to isolate single clones, which are then expanded
and tested for binding to the antigen by ELISAs. Positive-binding clones are then
sequenced and the Fabs present can be easily cloned, expressed and purified for use in
structural studies (Sidhu et al. 2000).
This process was very much the same for purified membrane proteins, except that
each step required the presence of detergents to keep the proteins in solutions. Due to the
long time course of the selection process (generally 4-5 days), it is necessary that the
membrane protein of interest be highly stable in detergent over long time spans. For most
membrane proteins, including hHV1, this is not the case, complicating the phage-display
selection process. Nonetheless, because of our desire for high-affinity antibodies against
the hHV1 transmembrane domain, we initiated a collaboration with the laboratory of Dr
Sachdev Sidhu at the University of Toronto. Before going to Dr Sidhu’s laboratory, I was
able to show that the hHVΔNΔC construct was efficiently biotinylated using two different
reagents: one that reacts specifically with cysteine residues and one that reacts with
primary amines such as the side chains of lysine residues.
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Working with postdoctoral fellow Dr Yuko Arita, I carried out five rounds of
phage

selections

against

the

hHVΔNΔC

channel

in

diheptanoyl-glycerol-

phosphatidylcholine (DHPC) detergent using two different phage-Fab libraries (Fellouse
et al. 2007; Persson et al. 2013). After several days of selections, it was clear that the
channel was becoming unstable, as small amounts of precipitate were seen in the sample
tubes. Although we were able to prevent the protein from precipitating by diluting our
stock concentration, we were still unsuccessful in isolating any strong binders from our
selections. Instead, we obtained a plethora of phage that bound non-specifically to the
plates and did not express functional Fab domains: PCR and sequencing analysis
indicated either the presence of no Fab, or of frame-shift or nonsense mutations within
the complementarity determining regions (CDRs).
An abundance of non-specific “sticky” binders is common where there are no
strong specific binders present in the phage library, or if there is heterogeneity in the
target sample such that the selection pressure for strong binders is low. Because of the
long time course required for the selections and the inherent instability of hHVΔNΔC
channel in detergent, we concluded that it would be unproductive to continue attempting
selections according to this standard protocol. However, due to my experience with
channel reconstitution and functional analysis (see Chapter 3) it occurred to me that it
would be beneficial to develop a phage-selection protocol using reconstituted channels.
The hHVΔNΔC channels in vesicles are highly stable, and reconstituted vesicles
can be frozen and stored at -80°C until needed. By using the reconstituted channels, the
buffers needed for selections and ELISAs would no longer require detergents, thereby
greatly reducing the cost of the entire protocol. Efficient negative selections could be
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carried out using vesicles that did not contain any hHVΔNΔC channels, thereby removing
any phage that non-specifically bound to lipids. Furthermore, the activity of the
reconstituted hHVΔNΔC channels could be tested by the fluorescence-based concentrative
uptake flux assay described in Chapter 3, thus allowing confirmation that the channels
were in a functional native state. Therefore, we decided to develop this new phagedisplay library selection method for reconstituted membrane proteins.

4.3.2 Vesicle-based selections of reconstituted hHVΔNΔC
Another benefit of using the vesicle-based selections is that it is possible to incorporate
biotin-modified lipids into the membrane, thereby bypassing the need for potentially
structure-altering modifications (biotinylation) of the protein of interest. In the case of the
hHVΔNΔC, vesicles reconstitution was done in 3:1 1-palmitoyl-2-oleoyl-sn-glycero-3phosphoethanolamine
glycerol)

(POPG)

(POPE):
lipids

1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-(1'-rac-

doped

with

0.5%

1,2-dipalmitoyl-sn-glycero-3-

phosphoethanolamine-N-(cap biotinyl) headgroup modified PE (DPPE-biotin). Assuming
an average vesicle radius of 100 nm, this concentration of DPPE-biotin would result in
approximately 30-40 DPPE-biotin molecules per vesicle or 15-20 DPPE-biotin per
membrane leaflet. Vesicles prepared in this way should be efficiently captured by
streptavidin-coated plates.
To test streptavidin binding to the reconstituted DPPE-biotin containing vesicles,
sucrose flotation assays were carried out on a sample of the vesicles to determine whether
the streptavidin would migrate with the vesicles in the sucrose gradient. In the presence
of streptavidin, the DPPE-biotin containing vesicles formed a gel at the interface of the
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10% and 30% sucrose solutions in the step gradient. This gel phase was not observed
with the DPPE-biotin containing vesicles in the absence of streptavidin or with normal
vesicles not containing DPPE-biotin in the presence of streptavidin. Since streptavidin is
a tetramer in solution, the gel phase is likely formed by cross-linking from the binding of
multiple DPPE-biotin-containing vesicles by single streptavidin tetramers. These
observations led me to conclude that the DPPE-biotin was presented on the surface of the
vesicles in a way that allows for efficient streptavidin capture of the biotin-modified
headgroup.
For the selections, the hHVΔNΔC were reconstituted into the DPPE-biotin
containing vesicles at a protein-to-lipid ratio of 1:100 (wt:wt). At this ratio, there should
be approximately 20 channels per vesicle on average. To confirm efficient incorporation
of the channel into the vesicles, a sucrose flotation assay was performed and the
functional state of the channels was tested with the fluorescence-based flux assay. These
data showed that the hHVΔNΔC channels were efficiently incorporated into the vesicles
and that the reconstituted channels were functional (Fig. 4.21).
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Fig. 4.21 H+ uptake into vesicles containing truncated hHV1 channels
Fluorescence-based H+ flux assay for vesicles containing hHVΔNΔC (purple) compared to
empty vesicles (orange) and wild type hHV1 containing vesicles (cyan). Valinomycin and
CCCP were added at the indicated time points and the fluorescence measurements were
repeated 3-4 times (error bars represent the standard error of the mean).

When Dr Arita performed the phage selections with DPPE-biotin-containing
vesicles, the use of empty vesicles for negative selection and of hHVΔNΔC-containing
vesicles for positive selections markedly improved the results compared to those of the
detergent-based selections. As opposed to the detergent-based selections (which did not
produce any potential HV binding Fab clones), the vesicle-based selections generated nine
Fab clones that showed significant selective binding to hHVΔNΔC-containing vesicles
(Table 4.3). Dr Arita subcloned these Fab genes into an expression vector and I expressed
and purified each of the Fabs with the exception of Fab9 (Table 4.3), which did not
express.
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Table 4.3 ELISA Data for the best Fabs isolated from vesicle based selections
Raw ELISA Data ‡
Ratios *
Fab ID
BSA
Empty FLAG hHVΔNΔC FLAG/BSA hHVΔNΔC/Empty
Fab1
0.087
0.332
0.815
1.197
9.4
3.6
Fab2
0.082
0.288
0.839
1.236
10.2
4.3
Fab3
0.086
0.434
0.116
1.664
1.3
3.8
Fab4
0.100
0.164
0.996
1.433
10.0
8.7
Fab5
0.079
0.193
1.065
0.647
13.5
3.4
Fab6
0.075
0.347
0.185
0.856
2.5
2.5
Fab7
0.092
0.148
0.117
0.430
1.3
2.9
Fab8
0.094
0.237
0.644
0.604
6.9
2.5
Fab9
0.086
0.226
0.114
0.695
1.3
3.1
These ELISAs were performed by Dr Yuko Arita
‡ Raw ELISA data corresponds to wells containing BSA control (BSA), Empty Vesicles
(Empty), hHVΔNΔC containing vesicles probed with an αFLAG Ab (FLAG),
hHVΔNΔC containing vesicles. All wells were probed with αM13 phage Ab unless
otherwise stated. The Fab gene on the phage contains a C-terminal FLAG-tag therefore
the αFLAG antibody will only bind to phage that expresses a full-length Fab gene.
* High FLAG/BSA ratio indicates the presence of a bound phage that expresses a fulllength Fab gene. High hHVΔNΔC/Empty ratio indicates specific phage binding to
hHVΔNΔC. The two best hHVΔNΔC/Empty ratios are highlighted in green.

The remaining eight Fabs were tested for binding to the hHVΔNΔC channel in
DHPC. Only Fab2 showed evidence of weak binding to the channel on the SEC column
in detergent (Fig. 4.22). Although there was almost no complex seen on the SEC column,
a shift to lower elution volumes of some Fab2 was observed when the fractions were run
on an SDS-PAGE gel (Fig. 4.22C). This shifting of elution volume was not observed for
the other best candidate, Fab4 (Table 4.3), indicating that Fab2 did bind weakly to the
channel in DHPC. However, the binding observed for Fab2 was very weak and was not
considered significant enough to carry forward into full-scale crystallization trials.
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Fig. 4.22 Evidence for weak complex formation between Fab2 and hHVΔNΔC
(A) SEC chromatogram of hHVΔNΔC with Fab2. (B) SEC chromatogram of hHVΔNΔC
with Fab4. (C) SDS-PAGE reducing gel of SEC fractions showing a shift in the elution
volume for Fab2 indicating weak binding of Fab2 to hHVΔNΔC.

4.3.3 Future directions
Although Fab2 showed some evidence of weak binding, stronger-binding Fabs are
needed to justify full-scale crystallization trials. Therefore, Dr Arita is developing
affinity-matured libraries based on the sequences of the best binders from the vesiclebased selections (Fab2 and Fab4; Table 4.3). These libraries are currently being screened
for Fabs with improved binding to vesicle-reconstituted hHVΔNΔC. If Fabs with a
significant improvement in binding are identified, they will be tested for Fab-channel
complex formation by SEC. All promising candidates will be followed up in
crystallization trials.
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4.4 CONCLUSIONS
In this chapter, I described my efforts to obtain the X-ray crystal structure of a HV
channel. Together with Dr Seok-Yong Lee we attempted crystallization of the wild type
channel, lysozyme and dimer fusion constructs, and chimeric channels. Although I did
obtain a crystal structure with the HAP5ΔNΔC chimera, I concluded that this structure
was non-native. Because of the power of Fab mediated crystallization it is still desirable
to isolate high affinity antibodies against the transmembrane domain of hHV1. My work
in collaboration with Dr Yuko Arita in the Sidhu lab at the University of Toronto on the
isolation of phage display Fabs has the potential to achieve this goal. However, if we are
unable to isolate high affinity antibodies by this method it may still be possible to get
high affinity crystallization chaperones by other means. By injecting hHV1 into llamas it
may be possible to generate hHV1 specific nanobodies. These single-chain camelid
antibody fragments have been used successfully for the crystallization of membrane
proteins that lack well-structured soluble domains (Rasmussen et al. 2010).
As an alternative strategy for structure determination, working with Dr Joel
Butterwick in the laboratory, I decided to pursue NMR characterization of hHV1ΔNΔC.
As described in the next chapter, this methodology allowed us to define the secondary
structure of the channel and we experimentally identified a short N-terminal S0 helix that
precedes the transmembrane domain.
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CHAPTER 5: NMR
During the final stages of the crystallography work discussed in Chapter 4, I set out to
also study the chimeric HAP5ΔC by nuclear magnetic resonance (NMR) with detergentsolubilized channels. Together with postdoctoral fellow Dr Joel Butterwick, I planned to
examine the titratable amino acid residues within the transmembrane domain of the
channel in order to investigate the conduction mechanism. Because of the sensitivity of
NMR to the protonation state of amino acid side chains, this technique complements the
crystallographic studies and can provide additional insight into the mechanism of H+
conduction through HV.
Although our studies began with the chimeric HAP5ΔC channels, after the
crystallography indicated that this channel might not be properly structured in detergent,
we decided to work on the wild type truncated hHVΔNΔC channel. In this chapter, I will
briefly discuss our initial NMR work on the HAP5ΔC channel and will then present our
efforts to solve the hHVΔNΔC channel structure.
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5.1 NMR ON THE HAP5 CHIMERA
5.1.1 Removal of N-terminus allows for detection of transmembrane peaks
The HAP5ΔC construct was chosen as the best candidate for NMR because of its stability
at high concentrations at room temperature (required to maintain its homogeneity during
the multi-day length of the experiments) and because of the progress that its structural
characterization by X-ray crystallography showed at the time.
To collect a 1H-15N heteronuclear single quantum coherence (HSQC) spectrum,
the protein had to be uniformly labeled with the heavy 15N isotope. Since the only source
of nitrogen during the expression of the channel in Pichia pastoris was from the
ammonium sulfate added to the media, we were able to uniformly label the protein by
replacing all of the ammonium sulfate with 15N-ammonium sulfate.
The original spectra collected on the HAP5ΔC in LDAO channel showed many
peaks (Fig. 5.1). Since every peak on the 1H-15N HSQC spectrum corresponds to a
covalently bound 1H-15N pair, the majority of the peaks seen derived from the main chain
amide bond, with a subset originating from the side chains of asparagine, glutamine and
tryptophan residues (Cavanagh et al. 2007). Depending on the local environment of the
amino acid residue, it is sometimes possible to see peaks corresponding to the side chains
of arginine residues, but it is very rare to see peaks corresponding to histidine and lysine
side chains because of their fast rate of H+ exchange with the solvent (Cavanagh et al.
2007).
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Fig. 5.1 1H-15N HSQC spectrum of 15N labeled HAP5ΔC and tHAP5ΔC in LDAO
(A) 1H-15N HSQC spectrum of HAP5ΔC in N,N-Dimethyldodecylamine N-oxide
(LDAO) at 25°C (top) with the glycine resonances highlighted to demonstrate the
eclipsing effect of the N-terminus. Four glycine resonances, which likely correspond to
the four glycines in the N-terminus are much stronger than two other glycine peaks
observed that likely correspond to glycines from the transmembrane segment. (B) 1H-15N
HSQC spectrum of trypsinized HAP5ΔC (tHAP5ΔC) in LDAO at 25°C (bottom)
demonstrating that the majority of the intense peaks derived from the N-terminus.
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The intensity of the peaks observed on the 1H-15N HSQC is positively correlated
to the flexibility of the protein; thus, loops and unstructured regions might eclipse the
more stable parts of the protein (Cavanagh et al. 2007). This can be worse with detergentsolubilized membrane proteins since the interactions with the detergent micelle can
further broaden peaks corresponding to the transmembrane domain (Butterwick &
Mackinnon 2010). Therefore, we suspected that the strong peaks observed in the 1H-15N
HSQC spectrum of the HAP5ΔC channel originated from residues within the
unstructured N-terminus (Fig. 5.1A). For example six peaks corresponding to glycine
resonances can be seen in the 1H-15N HSQC spectrum of the HAP5ΔC (Fig. 5.1A) the
four intense glycine peaks likely correspond to the four glycines found in the N-terminus,
whereas the two weaker glycine peaks likely correspond to glycines from the
transmembrane domain (Fig. 5.1A).
To isolate the peaks originating from the transmembrane domain, we collected a
spectrum from trypsinized HAP5ΔC (tHAP5ΔC) channels in which the digested Nterminus had been purified away (Fig. 5.1B). This spectrum clearly indicated that the
unstructured N-terminus was indeed eclipsing the transmembrane region in the spectrum
of the untrypsinized HAP5ΔC and that, if we wanted to examine the titratable residues in
the transmembrane domain, we would have to work with the doubly truncated
HAP5ΔNΔC construct.
To improve to resolution of the spectrum, it was desirable to perdeuterate the
protein. By using transverse relaxation-optimized spectroscopy (TROSY), it is possible to
sharpen the line-width of the peaks, making it easier to make out individual 1H-15N peaks
(Cavanagh et al. 2007). Although the expression levels were greatly reduced by growing
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the Pichia pastoris in heavy water (2H2O a.k.a. D2O), we were able to purify a sample of
perdeuterated HAP5ΔNΔC. By perdeuteration and by changing detergents from LDAO to
the lipid-like detergent 1-palmitoyl-2-hydroxy-sn-glycero-3-phospho-(1'-rac-glycerol)
(LPPG) the resolution of this spectrum was greatly improved (Fig. 5.2).
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Fig. 5.2 Spectra of HAP5ΔNΔC in LPPG
(A) 1H-15N HSQC spectrum of 15N-labeled HAP5ΔNΔC in LPPG at 25°C. Peaks that are
aliased in the 15N dimension are shown in black. All five expected glycines can be seen,
as well as the side chains of the arginine, asparagine, glutamine and tryptophan (inset)
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residues. (B) 1H-15N HSQC TROSY of 2H-15N labeled HAP5ΔNΔC in LPPG at 25°C.
Peaks that are aliased in the 15N dimension are shown in blue.
5.1.2 Abandonment of the chimeric channel in favor of wild type
With spectra of perdeuterated,

15

N-labeled HAP5ΔNΔC in our hands, we planned to

begin the assignment of the 1H-15N HSQC spectrum peaks. However, at this time, the
results from the crystallography experiments indicated that, although the HAP5 chimera
is a functional H+ channel, its structure might be destabilized by extraction from the
membrane and solubilization by detergent (see Chapter 4). Therefore we decided that it
would be best not to pursue further NMR analysis of the HAP5ΔNΔC chimeric construct.
However, my work with the chimeric proteins, discussed in Chapter 4, required
the redesign of the protein expression construct, which resulted in greatly improved
yields after purification. We reasoned that if we were to apply the same changes to the
wild type hHVΔNΔC construct (i.e. moving the GFP tag and PreScission protease site to
the N-terminus), we should also improve the yield of purified wild type channel. In
addition, if detergent conditions could be found in which this channel was highly stable it
should be possible to examine the wild type hHV transmembrane domain by NMR.
Dr. Butterwick had previously solved the structure of the isolated voltage-sensor
domain (VSD) of KVAP by NMR (Butterwick & Mackinnon 2010). Therefore, although
we were unable thus far to solve the structure of the hHVΔNΔC construct by
crystallography (see Chapter 4), we reasoned that with improved expression and stability
it might be possible to solve the structure by NMR.
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5.2 NMR STUDIES OF HUMAN HV CHANNELS
5.2.1 Truncated hHV1 channels are functional
In addition to the functional analysis of the reconstituted hHVΔNΔC channels by the flux
assay presented in Chapter 4 (Fig. 4.21 on page 133), electrophysiological studies were
carried out on the truncated versions of the hHV1 channel. In order to confirm that the
hHVΔNΔC channel construct used for NMR studies was a functional H+-selective
voltage- and ΔpH-gated channel, whole-cell patch clamp electrophysiology of truncated
channels over-expressed in HEK cells was performed. Due to the importance of the ΔpH
gating in the physiological functions of the channel and its poorly understood molecular
mechanism (see Chapter 1), we wanted to confirm that any construct that we pursued for
structural analysis maintained this important mode of regulation. For completeness, all
three truncated channel constructs (hHVΔN, hHVΔC and hHVΔNΔC) were characterized
and compared to wild type.
The electrophysiological recordings clearly indicated that, although the
truncations altered the gating kinetics, all of the truncated channels were functional
voltage-gated channels (Fig. 5.3). Furthermore, by perfusion of the external solution with
buffers at different pH, it was possible to both measure the ΔpH gating and H+ selectivity
of the channels (Fig. 5.3). These results indicated that, although the truncations did alter
ΔpH-gating behavior, the truncated channels were still ΔpH-gated (Fig. 5.3). By
comparing the reversal potentials of the measured currents to what is expected for the
Nernst equilibrium potential for H+ at the different ΔpHs, it was possible to show that
each of the constructs maintained wild-type-like H+ selectivity (Fig. 5.4).
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Fig. 5.3 Electrophysiological characterization of truncated hHV1 channels
Examples of currents elicited from whole-cell patch clamp recording of HEK cells
expressing (A) hHV1, (B) hHVΔN, (C) hHVΔC and (D) hHVΔNΔC at symmetric pH (pHo
= pHi = 6.5; left) according to the voltage-step protocols shown. Average tail current IV
curves corresponding to the same cell as shown on the right at three different pHo (pHo =
7.0 blue, pHo = 6.5 brown and pHo = 6.0 green). Each recording was performed 2-3 times
per cell per pHo with the error bars on the IV curves corresponding to the standard
deviation are plotted but are smaller than the graph symbols in most cases.
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Fig. 5.4 H+ selectivity of wild type and truncated hHV1 channels
Examples of currents elicited from whole-cell patch clamp recordings of HEK cells
expressing hHVΔNΔC at (A) pHo = 6.0 (B) pHo = 6.5 and (C) pHo = 7.0 according to the
voltage-step protocols shown. In each case pHi = 6.5. (D) IV plot of average current
elicited shortly after variable voltage-step for hHV1 (cyan), hHVΔN (red), hHVΔC (green)
and hHVΔNΔC (purple) according to the same voltage-step protocols show in (A-C) at
the different values of pHo. Each recording was performed 3-4 times per cell per pHo,
error bars corresponding to the standard deviation are plotted but are smaller than the
graph symbols in most cases. (E) Comparison of the reversal potentials for each construct
(colored as in D) to the Nernst equilibrium potential for H+ (black line) at each pHo. Each
point represents the average of 3-4 cells with the error bars corresponding to the standard
deviation.
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It is interesting to note the opposite effect that the N- and C-terminal truncations
have on the gating kinetics and ΔpH-gating. The N-terminal truncation decreased the rate
of both opening and closing of the channel (Fig. 5.3B). Additionally, truncation of the Nterminus also shifted the ΔpH-gating of the channel, resulting in channel opening at leftshifted (more negative) voltages relative to wild type channels at the equivalent ΔpH
(Fig. 5.3B). Unlike the wild type channel, in which ΔpH-gating ensures that the channel
is a perfect outward rectifier (see Chapter 1), this left shift of the delta-N channel allows
small inward H+ currents at high external H+ concentrations (low external pH). In
contrast, the C-terminal truncation increases the rate of both opening and closing of the
channel (Fig. 5.3C) and shifts the ΔpH-gating such that channel opening occurs at more
right-shifted voltages, strengthening the wild-type-like outward rectification (Fig. 5.3A
and C). Although similar to the C-terminal truncation alone in that the rates of channel
opening and closing are sped up in the doubly truncated channel (hHVΔNΔC), the ΔpHgating more resembles that of wild type channels (Fig. 3D).
These data support a potential interaction between the N-terminus and
transmembrane domain in wild type channels. Such an interaction has been previously
proposed by Musset et al., based on modulation of the gating of wild type hHV1 by
phosphorylation of amino acid residue T29 on the N-terminus (Musset et al. 2010a). A
simple explanation for the changes in channel gating observed upon N-terminal
truncation or phosphorylation could be that the unphosphorylated N-terminus binds to the
transmembrane domain and stabilizes the hyperpolarized conformation. If true, this
would mean that disruption of the interaction between the N-terminus and the
transmembrane domain by either removal or phosphorylation of the N-terminus would
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destabilize the hyperpolarized conformation, resulting in the observed left-shift in the
voltage activation of the channel (Fig. 5.3B; Musset et al. 2010a).
More research is required to fully understand the interactions between the termini
and the transmembrane domain and to identify the amino acids residues involved.
However, the data presented in Fig. 5.3 demonstrate that the truncated channels are
functional voltage- and ΔpH-gated H+-selective channels, validating the hHVΔNΔC
construct as a good structural target for generating insight into these interesting
biophysical phenomena.

5.2.2 hHVΔNΔC is biochemically stable in two detergents
Expression of wild type hHVΔNΔC was much improved by the N-terminal decaHis-GFP
tag. In order to get sufficiently enriched channel for the NMR experiments, it was also
necessary to alter the purification protocol. Originally, the purification was carried out
similar to that of the HAP5ΔNΔC construct in DM (discussed in Chapter 4), i.e. via Co2+resin immobilized metal affinity chromatography (IMAC), followed by PreScission
protease digestion, a second round of Co2+-resin IMAC for removal of the cleaved
decaHis-GFP tag and a by final size exclusion chromatography (SEC). However,
dialyzing into low salt during overnight PreScission protease digestion and replacing the
second IMAC step with an anion exchange chromatography step were sufficient to
significantly improve the purity of the hHVΔNΔC channel.
I investigated the detergent stability profile of the truncated channel of this highly
enriched hHVΔNΔC. The hHVΔNΔC channel was unstable in maltoside detergents,
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precipitating after one day at room temperature at high concentrations. However, the
truncated channel was highly stable in the lipid-like detergents DHPC and LPPG. In
either of these detergents, the truncated channel remained in solution and monodisperse
on the SEC column at high concentrations after incubation for several days at room
temperature.
During detergent exchange into LPPG, a slow timescale detergent-exchange
phenomenon was observed, which manifested as a significant shift in the elution volume
of the hHVΔNΔC peak (Fig. 5.5). Specifically, after the ion exchange chromatography
step in DM the channel was concentrated and run over the SEC column equilibrated in
LPPG. During this detergent exchange SEC run the hHVΔNΔC channel eluted as a broad
peak centered at 12.8 mL (Fig. 5.5A). When this peak was pooled, concentrated and rerun over the SEC column in LPPG, the channel eluted as a doublet with peaks centered at
12.4 and 13.4 mL respectively (Fig. 5.5B). If the same sample was re-run over the SEC
column after several hours, the elution profile collapsed into a single sharp peak centered
at 13.3 mL, which then remained stable for up to a week at room temperature (Fig. 5.5C).
Such a detergent-exchange phenomenon was not observed for exchange of hHVΔNΔC
from DM to DHPC.
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Fig. 5.5 DM to LPPG detergent exchange phenomenon of hHVΔNΔC
(A) SEC chromatogram of hHVΔNΔC initial detergent exchange from DM to LPPG. (B)
SEC chromatogram of immediate concentration and rerun of pooled fractions 10-14 mL
from (A) over SEC column equilibrated in LPPG. (C) SEC chromatogram of rerun of
pooled fractions 10-14 mL from (A) over SEC column equilibrated in LPPG after 1 day
incubation at room temperature (RT) at 6 mg/mL.
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Due to the large change observed when hHVΔNΔC was exchanged into LPPG, we
were concerned that we were obtaining either incomplete detergent exchange or a
detergent-dependent refolding of the channel, potentially into a non-native conformation.
We were able to rule out incomplete detergent exchange as a possible cause by looking at
the 1H peaks corresponding to the detergent in the NMR spectrum. Due to the high
concentration of detergent in the concentrated NMR samples, the strongest peaks in the
one-dimensional 1H spectrum come from the detergent molecules. If there were
incomplete detergent exchange between DM and LPPG, we would expect to see 1H peaks
corresponding to DM molecules in the spectrum. However, only peaks corresponding to
LPPG were observed, indicating that complete detergent exchange had occurred. This is
also in agreement with the observation that the exchange phenomenon occurs to the
concentrated hHVΔNΔC samples in the absence of further detergent exchange (i.e. given
time the sample will convert to the 13.3 mL peak without further runs over a SEC column
equilibrated with LPPG).
When we collected a 1H-15N HSQC spectrum of the hHVΔNΔC construct in
LPPG, we observed a highly disperse set of peaks corresponding to the majority of the
hHVΔNΔC main chain amides as well as all of the asparagine, glutamine, arginine and
tryptophan side chains (Fig. 5.6A). Since the quality of the HSQC spectrum is sensitive
to the dynamics of the protein, this high-quality spectrum indicated that the channel was
in a well-folded stable confirmation (Cavanagh et al. 2007). We concluded that the
probability of the channel adopting a well-folded stable non-native conformation was low
and that, therefore, the conformation of the channel after the detergent exchange
phenomenon was likely native.
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Fig. 5.6 Detergent screen 1H-15N HSQC of 15N labeled hHVΔNΔC
(A) 1H-15N HSQC spectrum of

15

N-labeled hHVΔNΔC in LPPG. (B) 1H-15N HSQC

spectrum of 15N-labeled hHVΔNΔC in LDAO. (C) 1H-15N HSQC spectrum of 15N-labeled
hHVΔNΔC in DHPC. All spectra were collected at 25°C. Peaks that are aliased in the 15N
dimension are shown in blue.
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Although the hHVΔNΔC channel was less stable in LDAO than in LPPG or
DHPC, we decided to examine the 1H-15N HSQC spectrum in LDAO because of the high
quality spectrum observed for the chimeric HAP5ΔNΔC in this detergent (Fig. 5.1B).
However, the 1H-15N HSQC spectrum of hHVΔNΔC in LDAO was very weak with only
few distinguishable peaks (Fig. 5.6B).
Detergent exchange of hHVΔNΔC from DM to DHPC did not result in any
equivalent slow exchange phenomenon. During initial detergent exchange into DHPC
hHVΔNΔC elutes as a single peak centered at 14.8 mL and this peak position does not
change significantly with time. However, when we collected a 1H-15N HSQC spectrum in
DHPC the quality of the spectrum was poor (Fig. 5.6C.). The poor quality of the 1H-15N
HSQC spectrum in DHPC prohibited any further structural analysis of hHVΔNΔC by
NMR in this detergent. Therefore, we concluded that structural work by NMR on
hHVΔNΔC would be pursued in LPPG.

5.2.3 Assignment of the hHVΔNΔC spectra in LPPG
Resonance assignments for backbone (1HN, 15N, 13C′, and 13Cα) nuclei at 25°C and neutral
pH were identified using TROSY HNCA, HNCO and HN(CO)CA. Moreover, 15N-edited
1

H–1H nuclear Overhauser effect spectroscopy (NOESY) experiments (Cavanagh et al.

2007) were recorded using 70% deuterated hHVΔNΔC samples. Isotope labeling of the
His-GFP-hHVΔNΔC construct was performed according to the same protocol used for the
HAP5 constructs (see above and Materials and Methods), with the exception that the
concentration of D2O was lowered from 90% to 70%, greatly improving the expression
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with no significant reduction in TROSY spectrum quality. Uniform 13C labeling of the
hHVΔNΔC construct was accomplished by replacing the glycerol in the growth media and
methanol in the expression media with 13C-labeled glycerol and methanol respectively.
In addition to the uniformly labeled samples, we recorded HSQC experiments on
samples with different combinations of labeled amino acids so that specific amino acids
could be distinguished in crowded regions of the spectra: A, G, F, D/N, L, I, K, E/Q, V
and R (for examples see Fig. 5.7A and B). Although bacterial expression had not resulted
in any extractable channel for the original hHV1 constructs (see Chapter 3), we were able
to express and purify the His-GFP-hHVΔNΔC construct from Escherichia coli which, due
to significantly reduced metabolic shuffling of labeled atoms into other amino acids,
facilitated specific amino acid labeling. Resonance assignments were extended along the
side chains using H(C)CH-COSY and

13

C-edited and

15

N-edited NOESY experiments.

Most ambiguities present among the methyl resonances were resolved by repeating the
13

C-edited NOESY using methyl-specific labeling on Ile, Leu, and Val residues

(Cavanagh et al. 2007). Complete backbone resonance assignments (H, N, CA, CO) were
determined for 56% of the 138 residues, whereas 77% of residues have main chain amide
assignments (Fig. 5.7). Importantly, peaks for 84% have at least some (main chain or side
chain) assignments, providing easily accessible probes for nearly every residue within the
hHVΔNΔC construct.
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Fig. 5.7 Amide resonance assignments for hHVΔNΔC in LPPG micelles
1

H-15N HSQC spectra of (A) 15N-Ile/Gly (15N-Ser is also visible because of metabolic

scrambling of 15N-Gly label) and (B) 15N-Arg specific amino acid labeled HVΔNΔC in
LPPG. (C) 1H–15N HSQC TROSY spectrum at 25°C of 2H-15N labeled hHVΔNΔC with
assignments. Main-chain amide peaks for 106 residues (out of 136 residues expected to
be observed; 2 Pro) and N132δ, N133δ, N214δ, Q102ɛ, Q128ɛ, Q191ɛ, Q194ɛ and W207ɛ
side chains have been assigned. Peaks that are unassigned are shown in black. Peaks that
are aliased in the 15N dimension include G90, G199, G215 and the Argɛ resonances.
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5.2.4 Secondary structure shows S1-S4 helices plus a S0 helix
Chemical-shift analysis of the assigned main chain resonances allowed for the
determination of secondary structure of the hHVΔNΔC construct (Fig. 5.8). Patterns of
secondary chemical shifts of main chain resonances (Δδ = observed shift – “random coil”
shift) report on the secondary structure of the protein (Cavanagh et al. 2007; Wishart &
Case 2001). By comparing the Δδs of the different main chain atoms of the same amino
acid residue, it is possible to get a robust determination of the secondary structure for that
residue.
In addition to observing the four transmembrane helices (S1-S4), by examining
the Δδs of the hHVΔNΔC construct in LPPG we experimentally confirmed the existence
of a short N-terminal helix (S0) that precedes the first transmembrane helix S1
(approximately 10 amino acid residue long, R89-S98; Fig. 5.8). Although an analogous
S0 helix has been reported in the NMR structure of the isolated VSD of KVAP
(Butterwick & Mackinnon 2010), this was the first observation of this structural feature
in HV channels.
Based on the Δδ observations, we are able to estimate the amino acid residue span
of each of the transmembrane helices. According to these data, S1 spans residues V103D123, S2 starts at residue N133 and continues at least until residue L163, S3 extends at
least from residue D174 to L188 and S4 spans residues F195-S219 (Fig. 5.8). The
ambiguity in the start position of helix S3 and stop position of helices S2 and S3 derives
from the lack of assignments for main chain atoms from amino acid residues within the
S2-S3 and S3-S4 loops. Nonetheless, it is clear from these data that the secondary
structure of hHVΔNΔC in LPPG matches what would be expected for a VSD.
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Fig. 5.8 Secondary structure of hHVΔNΔC
The VSD helices are identified by the pattern of secondary chemical shifts for 13C′, 13Cα,
[Δδ(13CX); corrected for 2H isotope shifts (Venters et al. 1996) and graphed from − 5 ppm
to + 5 ppm] and 1Hα and 1HN [Δδ(1HX); graphed from − 1 ppm to + 1 ppm] (Wishart &
Case 2001). The helices identified are labeled at the top of the plot and the red arrows to
the right of each plot indicate the direction of Δδ that correspond to helical structure.
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5.2.5 Through-space measurements indicate a poorly defined tertiary structure
In order to solve the three dimensional structure of the channel, we needed to measure
long-range through-space interactions between the different transmembrane helices. The
13

C-edited and

15

N-edited NOESY experiments gave us some distance restraints;

however, due to crowding in the aromatic region of the spectra, we were unable to assign
many of the interactions. Therefore, we performed a series of specific labeling
experiments for paramagnetic relaxation enhancement (PRE), to better constrain the
overall fold and thereby help with the assignments of the observed NOESY peaks.
The electron spin of a stable nitroxide free radical enhances the relaxation of
nearby nuclei in a magnetic field (Hilty et al. 2004). By introducing a cysteine mutation
at a specific site in a cysteine-free background (i.e. C107S) and labeling the cysteine with
a paramagnetic nitroxide-free-radical-containing small molecule, it is possible to measure
a decrease in the peak intensity of nearby nuclei. This decrease in peak intensity is
proportional to the distance between the nucleus and the paramagnetic probe. Through
comparison of the spectrum of the paramagnetic-labeled protein to a control spectrum in
which the cysteine is modified with a diamagnetic version of the small molecule, it is
possible to accurately calculate long-range distances (15-20 Å) between the labeled
position and other parts of the protein. These long-range distances can then be added as
constraints into a structure calculation.
In order to generate long-range distance constraints for the hHVΔNΔC construct,
we labeled the channel at five different positions: R100C at the N-terminus of S1; I127C
and Y134C in the S1-S2 loop; L173C in the S2-S3 loop and F190C in the S3-S4 loop
(Fig. 5.9). The PRE data presented in Fig. 5.9A indicate that the channel was efficiently
160

labeled at each position. However, significant long-range signal suppression was not
apparent. In contrast, when an equivalent position in the S3-S4 loop was labeled on the
homologous KVAP isolated VSD, strong signal suppression was seen for nuclei on the
S1-S2 loop, which is what would be expected for a four-helix bundle (Fig. 5.9C). The
lack of strong PRE signal for the hHVΔNΔC construct indicates the tertiary structure of
the channel in LPPG may be poorly defined. In fact, the only suppression observed was
between positions on the S1-S2 loop (I127 and Y134) and the C-terminus of S4 (Fig.
5.9A). In the native fold of a VSD, these two regions of the protein should be on opposite
sides of the membrane and therefore we would not expect to see any PRE signal between
them. The fact that we did see this suppression at both S1-S2 positions, strongly suggests
that the hHVΔNΔC construct in LPPG was in a non-native conformation.
Our inability to measure strong distance constraints in the hHVΔNΔC construct
and our observation of likely non-native interactions between the S1-S2 loop and the Cterminus of S4 led us to conclude that structure determination of the channel by NMR
under these conditions was infeasible. This approach was therefore abandoned.
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Fig. 5.9 PRE experiments on hHVΔNΔC
(A) PRE data for the different specifically labeled positions along the hHVΔNΔC
construct. Data are presented as the ratio of peak intensity for the spin-labeled sample (Isl)
over the peak intensity for the diamagnetic-labeled sample (Idia) versus amino acid residue
number. In each case the red arrow indicates the site of the label. The solid red curves
indicate the expected intensity drop near the label site for an extended random coil
structure, whereas the dashed red line indicates the expected intensity drop near the label
site for a more compact helical structure. (B) Schematic of hHVΔNΔC topology indicating
the positions of the labeling sites. (C) Data for the KVAP isolated VSD with labels at
equivalent positions on S1-S2 loop (Y46 in KVAP equivalent to I127 in HV) and S3-S4
loop (F116 in KVAP equivalent to F190 in HV) demonstrating the expected signal
suppression between the two “extracellular” loops that would be expected for a four-helix
bundle structure. KVAP data provided by Dr Joel Butterwick from Butterwick &
Mackinnon 2010.
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5.3 THE STRUCTURAL NECESSITY OF THE MEMBRANE
The biochemical characterization of the different hHV1 and chimeric constructs presented
in this thesis clearly demonstrates the importance of the lipid bilayer membrane to the
maintenance of the native structure of HV channels. Before pursuing the structure of each
of the constructs, we had ensured that they were functional by electrophysiology and
again after purification by reconstitution and characterization in the flux assay. However,
in all these functional and cross-linking studies, the channels were embedded within a
lipid bilayer (either that of a cell membrane or of reconstituted lipid vesicles). In contrast,
all structural work was performed on detergent-solubilized channels, i.e. in the absence of
lipid membranes. As described throughout the thesis, in every case, these previously
functional channels adopted a non-native conformation in detergent.
It is clear, then, that although the channel protein is stable in some detergents the
channel structure is unstable when removed from the membrane and that future directions
for structural work on HV channels must focus on membrane-like conditions. Additional
crystallography attempts, including future work using the phage-display Fabs discussed
in Chapter 4, must focus on detergent-lipid mixtures, bicelle and lipidic cubic phase
conditions. Any future work by solution state NMR should only be performed on HV
channels incorporated into lipid nano-disks. It may also be possible to try solid-state
NMR on pellets of membranes containing reconstituted HV channels.
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MATERIALS AND METHODS
Preparation of cDNA and mutations for HEK cell transfections
Human HV1 cDNA (GI: 34783431, a gift from David Clapham, Havard Universtiy) was
subcloned into pcDNA4 vector (Invitrogen). Mutations were generated using
QuikChange kit (Stratagene). Three additional amino acids (ARG) were introduced into
the C-terminus as a byproduct of cloning into the expression vector. These amino acids
were later removed for all constructs used for electrophysiological recordings.

Electrophysiological recordings from HEK and CHO cells
Full-length hHV1 (Fig. 1.6, 4.15 and 5.3), the HAP5 chimera (Fig. 4.15) and the truncated
constructs (Fig. 5.3) used for crystallization and NMR were cloned into a pcDNA4 vector
(Invitrogen) for mammalian cell expression. All constructs used for recordings shown in
Fig. 1.6 and 5.3 contained N-terminal GFP fusions. The hHV1 and HAP5 constructs used
for recordings in Fig. 4.15 had no GFP fusion but were co-transfected with a GFP
containing vector in order to facilitate detection of transfected cells. HEK tsA201 cells
(ATCC) were maintained in DMEM (Gibco) containing 10% FBS. Cells were transfected
using FuGene (Promega) following the manufacturers protocol then, after ~6 hours, were
split onto poly-D-lysine-coated glass coverslips (BD BioCoat) and allowed to recover for
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~12-24 hrs. After 12-48 hrs, coverslips were transferred to the recording chamber.
Immediately before recording, medium was replaced by bath solution. All recordings
were performed at room temperature. Recordings were obtained with an Axopatch 200B
amplifier (Molecular Devices) using standard whole-cell patch-clamp techniques.
Recordings were filtered at 1 kHz with sampling at 10 kHz. Pipettes of 2-5 MΩ
resistance were pulled from borosilicate glass and fire polished. Currents were recorded
according to the voltage step protocols represented schematically in each figure.
Pipette solution for recordings shown in Fig. 1.6 and 5.3 was: 100 mM
Tetramethylammonium chloride (TMACl), 2 mM MgCl2, 100 mM MES (pH 6.5) and 5
mM Glucose (353 mOsm). Bath solutions for recordings shown in Fig. 1.x and 5.x were:
100 mM TMACl, 2 mM MgCl2, 100 mM MES (pH 6.0) and 25 mM Glucose (352
mOsm); 100 mM TMACl, 2 mM MgCl2, 100 mM MES (pH 6.5) and 5 mM Glucose (353
mOsm); 100 mM TMACl, 2 mM MgCl2, 100 mM HEPES (pH 7.0) and 50 mM Glucose
(356 mOsm). All solutions had pH adjusted using N-methyl-D-glucamine (NMDG).
Pipette solutions for recordings in Fig. 4.15 was: 64 mM NMDG, 3 mM MgCl2, 1
mM EGTA and 150 mM MES (pH 6.5). The bath solution was: 75 mM NMDG, 1 mM
MgCl2, 1 mM CaCl2 and 100 mM HEPES (pH 7.5). These solutions had their pH
adjusted with methanesulfonic acid and osmotic concentration matched by addition of
glucose.
The recordings shown in Fig. 1.2 were provided by Josefina del Mármol and were
produced by the whole-cell patch clamp technique described above with slight
modifications. The Rattus norvegicus KV1.1 (GI: 24520) subcloned into a pcDNA3.1
vector containing an IRES mCherry was used to transiently transfect CHO cells (ATCC)
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by means of lipofectamine 2000 (Life Technologies) according to the manufacturers
protocol. Pipette solution was: 150 mM KCl, 10 mM HEPES (pH 7.4), 2 mM MgCl2 and
5 mM EDTA, pH’ed with KOH. Bath solution was: 135 mM NaCl, 15 mM KCl, 10 mM
HEPES (pH 7.4), 2 mM MgCl2, and 1 mM CaCl2, pH’ed with NaOH.

Membrane preparation
cDNAs encoding hHV1 were transfected into tsA201 (HEK293 derivatives) cells using
Lipofectamine 2000 (Invitrogen) for 36-48 h. Membranes were prepared as described
with modifications (Asano et al. 1996). Briefly, cells were washed with phosphate
buffered saline with 1 mM EDTA and lysed with a tissue grinder (wheaton) in the
presence of protease inhibitors (1 mM PMSF, 1 mg/ml leupeptin, 1 mg/ml aprotinin, 1
mg/ml pepstatin). Lysed cells were briefly sonicated for 10 s in a bath sonicator and then
centrifuged at 900 g for 15 min. Supernatants were collected and diluted 4-fold with icecold buffer (20 mM HEPES, pH 7.5, 5 mM KCl, 150 mM NaCl, 5 % glycerol, and 1 mM
EDTA) and ultra-centrifuged for 90 – 120 min at 130,000 g. After ultra-centrifugation,
supernatants were discarded and pellets were resuspended in the same buffer and then
homogenized with a tissue grinder (wheaton). Samples were maintained at 4°C at all
times.

Cross-linking and Western blotting
For non-specific cross-linking experiments, the amino-group reactive bifunctional crosslinker DSS (Pierce) was used. For each reaction, 20-fold concentrated DSS stocks,
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dissolved in dimethylsulfoxide (DMSO), were added to prepared membranes and
incubated at room temperature for 20 min; reactions were quenched by the addition of
Tris-HCl (pH 8.5) to a final concentration of 100 mM. For copper mediated cross-linking,
6 mM CuSO4 and 1.8 mM o-phenanthroline in water were added to prepared membranes
to a final concentration of 300 µM and 900 µM, respectively and incubated at room
temperature for 20 min; reactions were quenched by addition of 20 mM Nethylmaleimide (NEM) and 50 mM EDTA. For cysteine-directed cross-linking, 1 mM
stock of 1,3-propanediyl bismethanethiosulfonate (M3M, Toronto Research Chemicals
Inc) in DMSO was added to the prepared membranes to a final concentration of 50 µM
and incubated on ice for 1 hr; reactions were quenched with 20 mM NEM. Air-oxidized
samples, used immediately after membrane preparation, were treated with 10-20 mM
NEM to prevent cross-linking during electrophoresis. All the samples were mixed with
equal volume of loading buffers containing 4 % (w/v) SDS and 10 % (v/v) bmercaptoethanol (only for reducing condition), then subjected to SDS-PAGE on 12 %
gels, transferred onto polyvinylidene difluoride (PVDF) membrane, and probed with a
mixture of two monoclonal antibodies 25H11 and 9C1. Monoclonal antibodies were
raised in mice injected with purified hHV1 protein by standard protocols (Harlow & Lane
1988).

Expresion of hHV1 in Pichia Pastoris
The gene for the full-length human HV channels (GenBank accession no: 91992153) with
a C-terminal 1D4 tag (ARAAGGTETSQVAPA) was ligated into the PICZ-c vector
(Invitrogen Life Technologies). This vector was transformed into a His+ strain of
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SMD1163 Pichia pastoris and selected as described (Long S. B., et al., 2005).
Transformed cells were grown in 1 L cultures of BMG media (Yeast Nirtogen Base, 100
mM sodium phosphate pH 6.3 and 1% glycerol) at 30°C until an optical density of ~20
was reached. BMG media was exchanged for BMM media (BMG with 0.75-1% MeOH
instead of glycerol) and grown at 24-27°C for 12-24 hours. Cell pellets were frozen in
liquid nitrogen and stored at -80°C until needed. This same expression protocol was used
for the chimeric-1D4 and N-terminal-GFP full-length and truncated chimeric and wild
type channels.
For expression of

15

N labeled protein all ammonium sulfate in the media was

replaced with 15N ammonium sulfate. For 13C labeled samples glycerol in the BMG media
and methanol in the BMM media were replaced by

13

C-glycerol and

13

C-methanol

respectively. In order to promote maximal expression the cells grown in 70-90% D2O
BMG were only allowed to reach an optical density (measured at 600 nm) of ~5. They
were then spun down and resuspended into a half volume of 70-90% D2O BMM
(concentrating the cells twofold) and incubated at 27°C for 16-24 h before harvesting.

Expression of GFP-hHVΔNΔC in E. coli for specific amino acid labeling
To produce amino-acid-specific and methyl-specific labeling patterns samples, we grew
XL-1 Blue cells (Stratagene), which were transformed with an expression vector, in LB
broth at 37°C until the optical density (measured at 600 nm) had reached ∼ 0.8 The cells
were then centrifuged for 10 min at 3000 x g and resuspended in a half volume of M9
minimal medium (concentrating the cells twofold) supplemented with and 10 mg/L
thiamine and the isotopically enriched amino acid (sodium salt) at 50–100 mg/L, and all
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nonlabeled amino acids were included at 100–200 mg/L. Similarly, to specifically label
the Ileδ1 and/or Leuδ/Valγ groups (denoted 13Cmethyl), we added 50 mg/L sodium 2-keto-413C-butyrate (for Ile) and 100 mg/L sodium 2-keto-3-methyl-d3-4-13C-butyrate (for
Leu/Val) in lieu of their respective amino acids (Tugarinov et al. 2006). It should be
noted that for Leuδ and Valγ methyl groups labeled in this manner, one group within the
pair is 13CH3, while the other is 12CD3. After 1 h, protein expression was induced by the
addition of 0.5 mM isopropyl-β-D-thiogalactopyranoside, and the cells were harvested
12–16 h later.

1D4-purification
Frozen pellets were lysed with a mixer mill (Retsch, Inc. Model MM301) and
resuspended in buffer (500 mM NaCl, 50 mM TRIS-HCl, pH 8.5, 2 mM βmercaptoethanol, 0.1 mg/ml deoxyribonuclease I, 1 µg/ml pepstatin, 1 μg/ml leupeptin, 1
μg/ml

aprotinin,

1.0

mM

phenylmethysulfonyl

fluoride

and

2.0

mM

Ethylenediaminetetraacetic acid (EDTA). The pH was adjusted to 8.5 with NaOH, and
0.15 g DDM (n-dodecyl-β-D-maltopyranoside, Anatrace) per g of cells was added prior
to a 2-3 hour extraction at room temperature followed by centrifugation at 31000 x g for
25 min. Supernatant was added to 1D4 antibody-linked sepharose affinity resin
previously equilibrated with buffer A (500 mM NaCl, 50 mM TRIS-HCl (pH 7.5), 1 mM
EDTA and 1 mM DDM) and rotated at room temperature for 2 hours. The resin was
collected on a column, washed with buffer A (4 x 5 column volumes) and eluted with
buffer A containing 0.4 mg/ml 1D4 peptide. Protein was loaded on a Superdex-200 gel
filtration column in 20 mM TRIS-HCl (pH 7.5), 150 mM KCl, 50 mM NaCl and 4 mM
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DM (n-decyl-β-D-maltopyranoside, Anatrace, anagrade; Buffer B). The fractions
corresponding to Hv channels were pooled.

Reconstitution of hHV1 channels
A mixture of 6:6:3:3:1 of POPC:POPE:POPS:SM:PI (1-Palmitoyl-2-Oleoyl-sn-Glycero3-Phosphocholine,

1-Palmitoyl-2-Oleoyl-sn-Glycero-3-Phosphoethanolamine,

Palmitoyl-2-Oleoyl-sn-Glycero-3-Phospho-L-Serine,

Sphingomyelin,

and

1L-a-

Phosphatidylinositol, obtained from Avanti) was prepared based on the composition of
human neutrophil plasma membrane (Tamura et al. 1988). A mixture of 3:1 POPE:POPG
can also be used. The lipid mixture was dried under an Argon stream and then
resuspended to 10 mg/ml in dialysis buffer (20 mM HEPES (pH 7.0), 150 mM KCl, 10%
glycerol, 0.2 mM EGTA and 2 mM 2-mercaptoethanol). The lipid mixture was then
sonicated in a bath sonicator three times for 2 minutes. Decylmaltoside (DM) was added
to the lipid mixture to 10 mM and rotated at room temperature for 1hr. Protein was added
to the lipid mixture in a 1:100 (wt:wt) protein to lipid ratio and an additional 10 mM DM
was added. As a control empty vesicles were made in which only dialysis buffer was
added to the lipids. The protein-lipid mixture was rotated at room temperature for ~3
hours then placed into dialysis membrane (molecular weight cut off of 50 KDa) and
dialyzed in 4 L of dialysis buffer for 5 days at RT exchanging buffer daily. Vesicles were
then harvested and flash frozen in liquid nitrogen and stored at -80°C until needed.
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Fluorescence based flux assay
The fluorescence data for vesicles containing HV channels was obtained using a published
procedure with the following modification (Zhang & Forgac 1994). Vesicles were thawed
in room temperature water and then sonicated once in a bath sonicator for 5 seconds and
then diluted 20 fold into flux buffer (20 mM HEPES (pH 7.0), 150 mM NaCl, 7.5 mM
KCl, 10% glycerol, 0.2 mM EGTA, 0.5 mg/ml BSA, 2 mM 2-mercaptoethanol and 2 mM
ACMA) in a quartz cuvette. Data were collected on a Spex Fluorolog 3-11
spectrofluorometer in time acquisition mode at 30-second intervals with excitation at 410
nm, emission 490 nm, with bandwidth 5 nm and an integration time 2 s. A baseline was
collected for 150 s before the addition of 20 nM valinomycin. After the fluorescence
stabilized carbonyl cyanide m-chloro phenyl hydrazone (CCCP) was added to 2 mM
rendering all vesicles H+ permeable and a minimum baseline was collected for 150
seconds. Data are scaled by (Fi – Fmin)/(Fmax-Fmin), where Fmax is the average value of the
starting baseline and Fmin is the average value of the minimum baseline. Fmax-Fmin (the
total reduction in fluorescence after CCCP addition) was ~ 25 % for all vesicles.

Sucrose Gradient Flotation Assay
Lipid vesicles containing hHV1, with protein to lipid ratio 1: 100 (wt:wt), were layered on
a sucrose gradient (From top to bottom, 140 µl sample plus 60 µl dialysis buffer, 600 µl
7% sucrose, and 1 ml 27% sucrose in dialysis buffer). The gradients were then
centrifuged at 135,000 x g in a Sorvall RP55-S swinging bucket rotor for 2 hours and
then fractionated into 8 x ~225 µl fractions. A 15 ml sample of each fraction was then
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mixed with 15 ml 2x running buffer and run on a 12% gel (SDS-PAGE) and stained with
Coomassie blue.

Mass Spectrometry
Mas spectrometry was performed by the ultra-thin layer method accordind to published
protocols (Cadene & Chait 2000). In short protein samples were concentrated to 1
mg/mL then diluted with FWI (3 parts formic acid, 1 part water, 2 parts isopropanol) into
10X final concentration aliquots which were further diluted (1 to 10) with saturated acyano-4-hydroxycinnamic acid (4-HCCA) in FWI to final ratios of 1:10, 1:20, 1:50,
1:100 and/or 1:200. 0.5 µL of each sample was spotted onto a stainless steal MALDI
sample plate coated with an ultrathinlayer of 4-HCCA. After a visible precipitate had
fromed on the bottom of the spots the excess liquid was aspirated away and the spots
were washed with 2 µL of 0.1% trifluoro acetic acid (TFA) solution. The samples were
then taken for analysis. All spectra were aquired using MALDI time-of-flight mass
spectrometer Voyager-DE STR (PE Biosystem, Foster City, CA) operating in linear,
delayed extraction mode. This instrument is equipped with a nitrogen laser delivering
pulses of ultraviolet light (wavelength 337 nm) at 3 Hz to the matrix spot. Spectra from
200-500 individual laser shots were averaged (using 2-ns data channel width) with
software provided by the manufacturer. The spectra were smoothed, calibrated, and
analyzed

using

the

program

M-over-Z

(http://www.proteometrics.com

http://prowl.rockefeller.edu). For more details see:
http://prowl.rockefeller.edu/protocols/ultra-thin-layer.html
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and

decaHis-GFP- construct purification
Frozen pellets were lysed with a mixer mill (Retsch, Inc. Model MM301) and
resuspended in buffer (500 mM NaCl, 50 mM TRIS-HCl, pH 8.5, 2 mM βmercaptoethanol, 0.1 mg/ml deoxyribonuclease I, 0.1 mg/ml pepstatin, 1 μg/ml leupeptin,
1 μg/ml aprotinin and 1.0 mM phenylmethysulfonyl fluoride). The pH was adjusted to
8.5 with NaOH, and DM (n-dodecyl-β-D-maltopyranoside, Anatrace) was added to a
final concentration of 80 mM prior to a 1.5 hour extraction at room temperature followed
by centrifugation at 31000 x g for 30 min. Supernatant was added to Co2+ Talon
(CloneTech) IMAC resin equilibrated with buffer A (500 mM NaCl, 50 mM TRIS-HCl,
(pH 7.5) 5 mM imidazole and 4 mM DM) and rotated at room temperature for 2 hours.
The resin was collected on a column, washed with buffer A (4 x 5 column volumes),
further washed with buffer A containing 25 mM imidazole and eluted with buffer A
containing 250 mM imidazole.
For the decaHis-GFP-HAP5ΔNΔC construct 2 mM DTT and PreScission protease
were added the elution and the sample was incubated at 4°C overnight followed by a
second round of Talon resin purification in buffer A from which the flow through was
collected and concentrated. This sample was loaded on a Superdex-200 gel filtration
column in 20 mM TRIS-HCl (pH 7.5), 200 mM NaCl and 4 mM DM (Buffer B). The
fractions corresponding to HAPΔNΔC channels were pooled and concentrated.
For the decaHis-GFP-hHVΔNΔC construct 2 mM DTT and PreScission protease
was added the elution and the sample was incubated on ice for 1 h before being added to
15 kDa MWCO dialysis membrane (Spectrum Labs) and dialyzed overnight at 4°C into
low salt buffer (depending on the volume of the decaHis-GFP-hHVΔNΔC sample, 400
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mL of 12.5-30 mM NaCl, 10 mM BisTris (pH 7.0), 2 mM DTT and 4 mM DM) for a
final concentration of 50 mM NaCl. The sample was then applied to a Q-sepharose
column equilibrated in 50 mM NaCl, 10 mM BisTris (pH 7.0), 2 mM DTT and 4 mM
DM buffer. The flow through from the Q-column was collected, concentrated and loaded
on a Superdex-200 gel filtration column in 10 mM HEPES, pH 7.0, 50 mM NaCl and 2
mM LPPG or DHPC. The fractions corresponding to HAPΔNΔC channels were pooled
and concentrated.

33H1 and 6E1 Fab purification
Antibodies were prepared as described in Brohawn et al. with slight modifications
(Brohawn et al. 2013). Briefly, media supernatant from hybridomas was dialyzed against
two changes of 4 L of 10 mM Tris (pH 8.0), 10 mM NaCl in 8-kDa-MWCO dialysis
tubing (Spectrum Labs) overnight. Dialyzed samples were spun at 6,000 × g, and the
supernatant was applied to a 5-mL Q-Sepharose column (GE Healthcare) equilibrated in
10 mM Tris (pH 8.0), 10 mM NaCl. Antibodies were eluted during a gradient to 10 mM
Tris (pH 8.0), 1.0 M NaCl. Eluted antibodies were diluted to 3 mg/mL in PBS. Fab
fragments were generated by reaction with papain (1:100 wt:wt) in PBS with 10 mM βmercaptoethanol, 10 mM L-cysteine HCl, and 10 mM EDTA (pH 7.0) at 37°C for 4 h.
Cleaved antibodies were dialyzed against two changes of 4 L of 10 mM Tris (pH 8.0), 10
mM NaCl in 8-kDa-MMCO dialysis tubing overnight. Dialyzed samples were spun at
6,000 × g, and the supernatant was applied to a 5-mL Q-Sepharose column equilibrated
in 10 mM Tris (pH 8.0), 10 mM NaCl. Fab fragments were collected in the flow-through.
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Crystallization and structure determination of HAP5ΔNΔC/33H1
Pure HAP5ΔNΔC was mixed with pure 33H1 Fab and concentrated (10kDa MWCO,
Millipore) to ~15 mg/mL total protein for crystallization. 0.4 µL protein was added to 0.4
µL reservoir (30% PEG400) in hanging drops. The largest crystals appeared within 1
week and grew to full size in 2-3 weeks at 20° C. Crystals were harvested and frozen in
liquid nitrogen.
Data were collected at NSLS beamline X29 and processed with HKL2000 (Minor
et al. 2006). Data were anisotropic and were elliptically truncated and scaled (Strong et
al. 2006) to 3.9 x 5.1 x 3.8 Å. Molecular replacement solution was found using the
program Phaser (McCoy et al. 2007) and the 33H1 Fv and Fc as search models.
Crystallographic programs from the Phenix and CCP4 suites were used throughout
structure determination (Adams et al. 2010; Winn et al. 2011). Structure figures were
generated with Pymol (Schrödinger LLC).

Phage Display Selections
Were performed as described in sections 4.3.1 and 4.3.2 and Sidhu et al. 2000. In brief,
biotinylation of purified hHVΔNΔC was performed at 1 mg/mL protein in 200 mM NaCl,
20 mM HEPES (pH 7.0), 5 mM DHPC (Buffer PD). For cysteine specific biotinylation
final

concentration

of

2

mM

Biotinylcaproylaminocaproyl-aminoethyl

Methanethiosulfonate (BCAC; Toronto Research Chemicals, Inc.) was added to the
protein and incubated for 3-4 h at room temperature in the dark, excess BCAC was
removed by SEC. For amine specific biotinylation N-hydroxylsuccinimidyl d-biotin-15-
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amido-4,7,10,13-tetraoxapentadecylate (NHS-PEO4-Biotin; Thermo Scientific) was
added in a molar ratio of 1:3 hHVΔNΔC: NHS-PEO4-Biotin and incubated at 4°C,
samples were used directly without removal of excess reagent.
Detergent based selections: Pre-absorption (negative selection) and selection
wells on the 96-well plate (for each selection [positive and negative] the number of wells
was: round 1, 8 wells; round 2, 6 wells; round 3, 4 wells; round 4, 2 wells; round 5, 2
wells) were coated overnight at 4°C with 100 µL of 5-25 µg/mL streptavidin or
neutravidin in 200 mM NaCl, 20 mM HEPES (pH 7.0) then blocked with 200 µL of 0.5%
BSA for 1 h at room temperature. For selections 100 µL of biotinylated hHVΔNΔC was
added to the positive selection wells at 10 µg/mL in buffer PD and incubated at 4°C for
1h at the same time 100 µL phage library at 1012-1013 cfu/mL buffer PD was added to the
negative selection wells and incubated at 4°C for 1h. hHVΔNΔC solution was removed
from positive selection wells and unbound phage were transferred from negative to
positive selection wells and incubated at 4°C for 2h. Phage solution was removed from
the positive selection wells and the wells were washed with 6X for round 1, 8X for round
2, 10X for round 3 and 15X for rounds 4 and 5 with buffer PD. Bound phage were eluted
by adding 100 µL/well of 100 mM HCl and incubating for 5 min at room temperature
with shaking. The HCl solution was then added to an eppendorf tube containing 25 µL 1
M Tris-HCl (pH 8) per well (8 wells = 200 µL Tris + 800 µL phage) then 500 µL of this
phage solution was added to 7.5 mL of actively growing OPTIMAX cells (OD = 0.5-0.8)
in 2YT. Infected OPTIMAX cells were incubated for 30 min at 37°C with shaking then
M13K07 helper phage were added to get 1010 cfu/ml final and then further incubation for
45 min at 37°C with shaking. The culture was transferred to 35 mL final volume
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2YT/carb100/kan25 medium and incubated overnight at 37°C with shaking. Overnight
phage cultures were precipitated: spun cultures in 50 ml Falcon tubes 8000 rpm, 15
minutes, added 8.75 ml (1/5 final volume) PEG/NaCl (20% PEG 8000 w/v, 2.5 M NaCl)
to supernatant, incubated on ice for 20 minutes, spun 20 min at 24000 g, re-suspended
pellets in 1.2 mL volume of buffer PD and transfer to eppendorf tubes, spun again (5 min,
13000 rpm) to remove bacterial debris then transferred supernatant to new tubes (this is
input phage for next round of selections). After each round input and output phage were
titered: 10 µL of 10-fold serial dilutions of precipitated phage (10 µL phage+ 90 µL
2YT), were added to 90 µL OPTIMAX (OD600 0.5-0.8), incubated for 30 min at 37°C,
and then 5 µL of each dilution were spotted plates (carb, kan, tet), final dilutions of 10-2
to 10-7 and the 10-6 to 10-11 were used for output and input phage respectively. Plates were
incubated overnight at 37°C and colonies were counted the next day.
Vesicle based selections: Performed as for the detergent based selections with the
following modifications. Antigen buffer (AB) used was 150 mM KCl, 20 mM HEPES
(pH7.0), 5% glycerol. DPPE-biotin-containing empty vesicles were added to the negative
selection wells prior to the addition of input phage (see section 4.3.2). The unbound
phage from the negative selections were mixed with DPPE-biotin-containing hHVΔNΔC
vesicles for 1 h at 4°C with shaking prior to quick capture of vesicles and bound phage on
streptavidin or neutravidin coated wells (15 min at 4°C) followed by washing and elution.
Isolation of positive binders: The output phage from the final round of selections
were mixed with 7.5 mL of actively growing OPTIMAX cells (OD = 0.5-0.8) in 2YT for
30 min at 37°C then diluted and plated onto LB plates/carb100 in order to grow single
colonies and incubated overnight at 37°C. Single colonies were picked (96-192 per
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library), used to inoculated individual 2 mL cultures of 2YT/carb100 and incubated at
37°C with shaking until OD600 0.5-0.8, then M13K07 helper phage were added and the
cultures were incubated overnight at 37°C with shaking. These cultures were spun down
to pellet bacterial cell debris and the supernatant was used in ELISAs (like the one shown
in Table 4.3). In brief, ELISA plates were coated with streptavidin and blocked with BSA
in the same way as the selection plates, four wells were used per the isolated phage clone:
BSA alone, empty vesicles and two wells containing hHVΔNΔC vesicles. Supernatant
from isolated phage cultures were diluted 2-fold with 2 X AB and incubated with antigen
(either in detergent or in vesicles) for 1 hr at 4°C with shaking prior to quick capture of
biotin on the plates (15 min 4°C with shaking), followed by washes and incubation with
primary antibody (either αFLAG or αM13 see Table 4.3). ELISAs were then developed
by standard protocols. Isolated phage clones that were positive for binding were
sequenced then subcloned into an expression vector for Fab expression and purification.

Phage display Fab expression and purification
Single colonies from E. coli BL21 DE3 transformed with the phagemid DNA containing
the Fab sequence was grown at 37°C in 25 mL 2YT/amp medium for ~3 hours then used
to inoculate 1 L of 2YT/amp media and grown at 37°C until an optical density (measured
at 600 nm) of 0.6 was reached. Expression was induced by the addition of 1 mM IPTG
and the cells were left overnight at 37°C. Cells were pelleted by centrifugation for 10
minutes at 3,000 x g then fozen in liquid nitrogen and stored at -80°C.
Cell pellets were resuspended in lysis buffer (100 mM NaCl, 20 mM Tris (pH
8.0), 0.1 mg/ml deoxyribonuclease I, 0.1 mg/ml pepstatin, 1 μg/ml leupeptin, 1 μg/ml
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aprotinin, 1.0 mM phenylmethysulfonyl fluoride) and lysed by sonication. Cell debris
was removed by centrifugation for 40 min at 12,000 rpm. Supernatants were mixed with
2-3 mL of Talon Co2+ resin (CloneTech) equilibrated in wash buffer (100 mM NaCl, 20
mM Tris (pH8.0) and 5 mM imidazole) and tumbled for 1-2 h at room temperature. The
resin was collected on a column, washed with wash buffer (4 x 5 column volumes), and
eluted with wash buffer containing 250 mM imidazole. Sample was then dialyzed into
low salt buffer A (10 mM NaCl, 10 mM Tris (pH 8.0)) overnight and then run over a Qsepharose column. The Q-spharose flow through was collected and concentrated for use
in binding experiments.

NMR data collection and analysis
NMR experiments were performed at the New York Structural Biology Center using
Bruker Avance or Avance II instruments operating at static magnetic field strengths of
14.1, 18.8 and 21.1 T, equipped with z-shielded gradient triple-resonance TCI or TXI
cryogenic probes. The sample temperature was maintained at 25°C during the initial
screening of detergent and buffer conditions and for all other experiments. NMR spectra
were processed using the NMRPipe software package (Delaglio et al. 1995) and analyzed
using the program SPARKY (Goddard & Kneller).

Chemical Shift Assignments
Resonance assignments for backbone 1HN,

15

N,

13

C′, and

13

Cα, and

13

Cβ nuclei were

identified using three-dimensional (3D) TROSY HNCA (at 21.1 T), HNCO, HN
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(CO)CA, and HNCACB (at 18.8 T) experiments (Cavanagh et al. 2007; Neri et al. 1989)
performed on 0.15-0.3 mM 2H, 13C, 15N samples. Also, two-dimensional (2D) TROSY
HSQC and 3D 15N-edited NOESY (mixing times τmix = 80) experiments (at 21.1 T) were
recorded on a 0.3 mM 2H,

15

N sample. In addition to uniformly labeled samples, 2D

HSQC, HNCA, and HNCO experiments (at 18.8 T) were recorded on 0.3 mM samples
with varied amino-acid-specific labeling patterns designed to eliminate ambiguities as
discussed in section 5.2.3.
Side-chain resonance assignments were based on 3D HC(C)H-COSY 13C-edited
(aromatic and aliphatic) and 15N-edited (τmix = 80 ms) NOESY experiments (at 21.1 T)
recorded on 0.5 mM 13C, 15N samples in 99.9% (vol/vol) D2O and on a 3D 15N-edited 1H–
1

H NOESY (τmix = 80 ms) experiment (at 21.1 T) recorded using a 0.4 mM 15N sample.

To improve resolution within the Val and Leu methyl regions, we recorded a 3D 13Cedited NOESY (τmix = 100 ms) experiment on a 13Cmethyl-LV sample.
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APPENDIX I
This Appendix contains the MATLAB code for my model of H+ flux into vesicles
reconstituted with hHV1 channels based on the equivalent circuit model found in Moffat
et al. 2008 (see Chapter 3). Green text that follows a ‘%’ indicate comments which I have
used to annotate the code. If you are looking at a PDF file it should be possible to copy
and paste the code along with the other functions below into separate text files and save
them

as

simple_flux_V_Na_Cl.m,

pt_ffluxbias.m,

total_proportional_flux_V.m,

channel_dist_theta.m and unscaled_plot.m then use MATLAB to execute the code by
typing the command simple_flux_V_Na_Cl(30) in the command window. Currently the
conductances for Na+ and Cl- are set to zero but this can be adjusted by altering the
highlighted variables GNa and GCl.

function simple_flux_V_Na_Cl(m)
%calculates the basis set of fluxes for a series of 1 to m
%channels per vesicle
%the basis set is to be use in the programs pt_ffluxbias or
total_proportional_flux_V
%through their global assignment
global time1
global sflux
global fflux

%assigns the time vector as a global variable
%assigns the sflux matrix as a global variable
%assigns the fflux matrix as a global variable

Ki1 = 0.150;
Ko1 = 0.015;
Hi1 = 1e-7;
Ho1 = 1e-7;
Nai1 = 1e-4;
Nao1 = 0.150;
Cli1 = 0.150;
Clo1 = 0.165;
Vo = 0.0008;
Vi = 2.3562e-18;
F = 96485;
R = 8.3145;
T = 298;
BKd = 0.000000028183829;
Bi = 0.02;
Bo = 0.02;
GK = 1e-6;

%initial internal concentration of K+ in M
%initial outer concentration of K+ in M
%initial internal concentration of H+ in M
%initial outer concentration of H+ in M
%initial internal concentration of Na+ in M
%initial outer concentration of Na+ in M
%initial internal concentration of Cl- in M
%initial outer concentration of Cl- in M
%bath volume
%volume inside average vesicles (r = 100 nm)
%Faraday constant 9.6485e4 C/mol
%gas constant 8.3145 V*C/mol*K
%absolute temp 298 K
%dissociation constant for HEPES buffer pKa 7.55
%internal concentration of HEPES buffer
%outer concentration of HEPES buffer
%K+ conductance through the membrane
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Vmid = 0.04;
z = 3;

%V1/2 of voltage sensor Boltzmann
%assigns valence for hHv1 voltage sensor Boltzmann

n = 2000000;
dt = 0.001;

%number of interations of loop
%time step per interation in seconds

%duration of time = n*dt
%builds fflux and sflux matrices
fflux = zeros(m,n+1);
sflux = zeros(m,n+1);
for k = 1:m;
channels
GH = k*1e-16;

%runs this master loop for each of the different number of
%the proton conductance is equal to the unitary conductance
%times the number of channels

GNa = k*0;

%the Na conductance is equal to the unitary conductance
%times the number of channels

GCl = k*0;

%the Cl conductance is equal to the unitary conductance
%times the number of channels

for j = 1:2;

%run this inner loop twice for each number of channels

%builds vectors and assigns initial values
EH = zeros(1,n);
EK = zeros(1,n);
ENa = zeros(1,n);
ECl = zeros(1,n);
VM = zeros(1,n);
JH = zeros(1,n);
JK = zeros(1,n);
JNa = zeros(1,n);
JCl = zeros(1,n);
totHi = zeros(1,n+1);
totHo = zeros(1,n+1);
Ki = zeros(1,n+1);
Ko = zeros(1,n+1);
Hi = zeros(1,n+1);
Ho = zeros(1,n+1);
Nai = zeros(1,n+1);
Nao = zeros(1,n+1);
Cli = zeros(1,n+1);
Clo = zeros(1,n+1);
Ki(1) = Ki1;
Ko(1) = Ko1;
Hi(1) = Hi1;
Ho(1) = Ho1;
Nai(1) = Nai1;
Nao(1) = Nao1;
Cli(1) = Cli1;
Clo(1) = Clo1;
totHi(1) = (BKd + Hi1 + Bi)/(1+(BKd/Hi1));
totHo(1) = (BKd + Ho1 + Bo)/(1+(BKd/Ho1));
if j == 1
x = 1;
else
x = -1;

%changes the value of x for each of the two times
%through the loop
%x is used a a multiplier of the membrane voltage Vm
%depending on the orientation of the channel the
%membrane voltage is
%either positive or negative, this has a large impact
%on open probability

end
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for i = 1:n;

%this loop runs the solver for equivalent circuit
%differential equation

EH(i) = ((R.*T)./F).*log(Ho(i)./Hi(i));
%calculates the equilibrium potential for H+
EK(i) = ((R.*T)./F).*log(Ko(i)./Ki(i));
%calculates the equilibrium potential for K+
ENa(i) = ((R.*T)./F).*log(Nao(i)./Nai(i));
%calculates the equilibrium potential for Na+
ECl(i) = -((R.*T)./F).*log(Clo(i)./Cli(i));
%calculates the equilibrium potential for Na+
VM(i) = (GH.*EH(i) + GK.*EK(i) + GNa.*ENa(i) +
GCl.*ECl(i))./(GH+GK+GNa+GCl);
%calculates the membrane potential
JH(i) = (GH./F).*(VM(i)-EH(i))./(1+exp(-(z*F*(x*VM(i) Vmid)/(R*T))));
%determines flux for H+ mol/s
JK(i) = (GK./F).*(VM(i)-EK(i));

%determines flux for K+ mol/s

JCl(i) = -(GCl./F).*(VM(i)-ECl(i));

%determines flux for Cl- mol/s

JNa(i) = (GNa./F).*(VM(i)-ENa(i));

%determines flux for Na+ mol/s

totHi(i+1) = totHi(i)-(JH(i).*dt)./Vi; %determines concentration
%change inside for H+
totHo(i+1) = totHo(i)+(JH(i).*dt)./Vo; %determines concentration
%change outside for H+
Ki(i+1) = Ki(i)-(JK(i).*dt)./Vi;

%determines concentration
%change inside for K+

Ko(i+1) = Ko(i)+(JK(i).*dt)./Vo;

%determines concentration
%change outside for K+

Nai(i+1) = Nai(i)-(JNa(i).*dt)./Vi; %determines concentration
%change inside for Na+
Nao(i+1) = Nao(i)+(JNa(i).*dt)./Vo; %determines concentration
%change ouside for Na+
Cli(i+1) = Cli(i)-(JCl(i).*dt)./Vi; %determines concentration
%change inside for Cl+
Clo(i+1) = Clo(i)+(JCl(i).*dt)./Vo; %determines concentration
%change ouside for Cl+
Hi(i+1) = (-(Bi-totHi(i+1)+BKd)+sqrt((Bi-totHi(i+1)+BKd).^2 +
4.*BKd.*totHi(i+1)))./2; %determines the free H+ concentration
%inside after buffering
Ho(i+1) = (-(Bo-totHo(i+1)+BKd)+sqrt((Bo-totHo(i+1)+BKd).^2 +
4.*BKd.*totHo(i+1)))./2; %determines the free H+ concentration
%outside after buffering
end
sig = (1e-6 - Hi)/(1e-6 - 1e-7);

%calculates the internal pH change

if j == 1

%if the channel is in the slow
%conducting configuration
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sflux(k,:) = sig;

%assign pHi to sflux of k channels
%else
%assign pHi to fflux of k channels

else
fflux(k,:) = sig;
end
end
end
time1 = 0:1:n;
time1 = time1.*dt;

%time vector
%standardizes the time to seconds

fflux2 = zeros(m,floor((n+1)/100));
sflux2 = zeros(m,floor((n+1)/100));
time2 = zeros(1,floor((n+1)/100));
for r = 1:floor((n+1)/100); %data reduction loop
sflux2(:,r) = sflux(:,r*100);
fflux2(:,r) = fflux(:,r*100);
time2(r) = time1(:,r*100);
end
sflux = sflux2;
fflux = fflux2;
time1 = time2;
figure
plot(time1,fflux,time1,sflux) %plots all 60 flux time courses
pt_ffluxbias
%calls and executes the script pt_ffluxbias (see below)
total_proportional_flux_V
%calls and executes the script total_proportional_flux_V (see below)
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function pt_ffluxbias
%builds pascals triangle *(1/2)^(number of elements in row)
%then if there are any channels in the fast fluxing orientation it takes
%the flux vector from fflux for however many channels there are in that
%orientation, if there are only slow fluxing channels it takes the flux vector
%form sflux for that number of slow fluxing vesicles
%in each case it multiplies the flux by the ratio given by the probability
%of that configuration and then sums all of the fluxes for a given total
%number of channels per vesicle
global
global
global
global

time1
fflux
sflux
pflux

%retrieves the value of the time vector from simple_flux_V
%retrieves the value of the fflux matrix from simple_flux_V
%retrieves the value of the sflux matrix from simple_flux_V
%assigns the pflux matrix as a global variable

[m n] = size(fflux);

%uses the dimensions of fflux to assign value to script
%components

pflux = zeros(m,n);

%builds pflux matrix

for k = 1:m

%run for each number of channels per vesicle
%k defines the total number of channels in this run

cflux = zeros(1,n); %builds cflux vector
for j = 0:k;

%j defines the number of fast flux oriented channesl

f = (factorial(k)/(factorial(j)*factorial(k-j)))*(1/2)^k;
%f calculates the fraction of vesicles with k channels, j of them
%in the fast fluxing orientation and (k-j) in the slow fluxing
%orientation
if j == 0
%if there are no channels in the fast fluxing orientation
cflux = cflux + sflux(k,:)*f;
%assign the flux as slow flux of k channels
else
cflux = cflux + fflux(j,:)*f;
%assign the flux as fast flux for j channels
%this assumes that the contribution to flux from fast fluxing
%channels is >> than that from slow fluxing channels
end
end
pflux(k,:) = cflux; %assigns total flux for k number of channels to pflux
end
figure
plot(time1,pflux)
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function y = total_proportional_flux_V
global
global
global
global

time1
pflux
totalflux
rho

%retrieves the value of the time vector from simple_flux_V
%retrieves the value of the pflux matrix from pt_ffluxbias
%assigns the totalflux matrix as a global variable

[m,n] = size(pflux);
%uses the dimensions of fflux to assign value to script components
cp = 0.1;
%cp = [0.1 0.02 0.01 0.002 0.001 0.0005 0.00025 0.000167];
%vector of protein concentration in vescle mixtures
%currently set for 1:100 ratio of protein-to-lipid (see channel_dist_theta
%input) but can be set to any/many protein-to-lipid ratios for example see
%the first comment line directly above.
rho = channel_dist_theta(7.57,100,cp);
%determines the Poisson distribution of number of channels per vesicle by
%running the channel_dist function for lipid concentration of 10 mg/ml and
%average vesicle radius of 50 nm
p = length(cp);
%uses the length of cp to assign value to script components
rho2 = rho(:,2:m+1);
%removes empty vesicle component of rho
totalflux = zeros(p,n); %builds totalflux matrix
for j = 1:p; %for each protein concentration
fluxp = zeros(m,n); %builds fluxp vector
rho2(j,:) = rho2(j,:)./sum(rho2(j,:));
%scales each column of rho2 to its total value
for i=1:n; %for each column of pflux
fluxp(:,i) = pflux(:,i).*rho2(j,:)';
%multiplies dot-wise each column of pflux by the scaled probability
%for that number of of channels per vesicle given the protein to
%lipid ratio
end
totalflux(j,:) = sum(fluxp);
%assigns the total flux for each protein to lipid ratio
end
figure
plot(time1,totalflux)
axis([0 max(time1) -0.05 1.05])
xlabel('Time /s')
ylabel('Scaled Vesicle Flux')
title('Scaled Flux by Vesicles Containing Protein for each Protein:Lipid
Ratio')
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function y=channel_dist_theta(cl,r,cp)
%cl final concentration lipids
%r radius of vesicles in nm
%cp final concentration of protein
global

pflux

[m,n] = size(pflux);
p = length(cp);
massl = cl*(10^-3); %mass in grams per 10 mililiter
%mass = mg/ml*(10^-3 g/mg) = g/ml
numlipid = (massl/753.84)*(6.022e23); %number of lipids in sample
%numlipid = (mass lipids in g/ average MW lipid)*Avogadros number
SAlipid = (numlipid*63e-20)/2;
%total surface area of lipid head group in m^2
%factor of 2 remove for bilayer
Nv = SAlipid/(4*pi*(r*1e-9)^2); %calculates the number of vesicles
Np = ((cp*(10^-3))./(2*35000))*6.022e23; %number of channels per ml
f = zeros(p,m);
for i = 0:m;
f(:,i+1) = ((((Np./Nv).^i).*exp(Np./(Nv*0.85)))./(((0.85)^i)*factorial(i)));
end
f = f*0.85;
f(:,1) = f(:,1)+0.15;
y = f;

function unscaled_plot(tf,rho0)
global time1
global slow
p = length(rho0);
for i = 1:p
tf(i,:) = tf(i,:)*(1-rho0(i));
tf(i,:) = tf(i,:)+rho0(i);
end
slow = tf(p,:);
figure
plot(time1,tf)
axis([0 max(time1) -0.05 1.05])
xlabel('Time /s')
ylabel('Scaled Total Flux')
title('Scaled total Flux for each Protein:Lipid Ratio')
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APPENDIX II
Sequences of all putative HV channel genes that were synthesized for expression and
biochemical stability experiments. Each sequence is named according to its GI number
followed by its species. A multiple sequence alignment done using ClustalW of all
putative HV channel genes is also shown compared to the sequence of the Rat KV1.2
voltage-sensor domain (with its transmembrane helices highlighted in cyan). Conserved
residues of possible functional importance are highlighted in yellow (with outliers
highlighted in alternate colors).

Sequences of Putative HV channel Genes
>91992153_Homo_sapiens_(Human)
MATWDEKAVTRRAKVAPAERMSKFLRHFTVVGDDYHAWNINYKKWENEEEEEEEEQPPP
TPVSGEEGRAAAPDVAPAPGPAPRAPLDFRGMLRKLFSSHRFQVIIICLVVLDALLVLA
ELILDLKIIQPDKNNYAAMVFHYMSITILVFFMMEIIFKLFVFRLEFFHHKFEILDAVV
VVVSFILDIVLLFQEHQFEALGLLILLRLWRVARIINGIIISVKTRSERQLLRLKQMNV
QLAAKIQHLEFSCSEKEQEIERLNKLLRQHGLLGEVN
>118344228_Ciona_intestinalis
MEGDNCNKSRHKSHNMINPNYASVRCTQPLPSVIQLRSRNKMIGITEDPSSDSEPVSSN
QPLLLTNLSYEVHTFNDNNNHERPAPQEQSTQNTMISMQSEQKSDRFTASNLGMFQYMK
FEIGEDGDDHEEEAILTNREKLRHILHSKPIHVAIIVLVVLDSFLVVGELLIDLKVIIV
PHGNPAPEILHGFSLSILSIFMVEIALKIIADHRHFIHHKVEVLDAVVVVISFGVDIAL
IFVGESEALAAIGLLVILRLWRVFRIINGIIVTVKTKADDRVHEIKKKNSELELQIHNL
EEKLSQKEQDMSRLHEILRCNNIDIPPTVPLTTSVQIHSTTTASADV
>71897219_Gallus_Gallus_(Chicken)
MSRYLKHFTVVGDDPIQWSNDYQKWENEEEDNGEKDSEIKLEPSRGHVTFQDVMKKLFS
SRRFQIVIVFLVIVDALLVLGELLMDLKIIHPDKYHIAPKVFHYLSLSILTIFLVEVGF
KIFVYGREFFHHKFEVLDSIVVVVSFILDLVLLFREHEFEAVGLLILLRLWRVARIING
IILSVKTRSEQQVSKLKQVNLKLATKVEQLQHSCVEKEQEIERLTRMLKQHGLLSEQT
>6573743_Arabidopsis_thaliana
MNIINTGTVDNVEFSIQNLIKSWCRRRKWRQLCNFSPKQQQEELISINQQWRITLSNFL
ESYQVHLFTIFLLSLDIILTSLELSSSLLSCTSVKKTETENEWFRWGGTVILSILAVKS
MALVVAMGKSFFKQPGCVMDGTLAIVALILQVLLEKKGTGFIVVVSLWRVLRVVETAFE
LSDEAIEVQIDGIISQFQALSKENRTLLETLAEKDEVIKMLEEELNRFKENGDIPFVKP
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>116505721_Coprinopsis_cinerea
MPLQIFIDVVFVLVELGYTLFNPNCSELEPRETPVWMEALSITSLALSALLVTEIPITV
WCMGIQYFNPFGAVHWAALHLFDALINLATFILDLVLRGRERELASLLIILRLWRIAKL
VSSVAVATDSLEEEVEARLEATKQELHRTKEELGKVEEEVFNLRQRLATFETKVVSNSA
V
>329664616_Bos_taurus_(Cow)
MATWNEKAVTRRARVAPAERMSKFLKHFTVVGDDYHAWNINYKKWENEEEEEEEQPPPT
EASASAEEGRATDPTPAPAPVPRPRLDFRTTLRKLFSAHRFQVIIICLVVLDALLVLAE
LVLDLKIIEPDKNNYAPKVFHYMSLAILTFFMMEIFFKIFVFRLEFFHHKFEILDTIVV
VISFILDLVLLFREHQFEALGLLILLRLWRVARIINGIIISVKTRSERQLLRLKQINIQ
LATKIQHLEFSCSEKEQEIERLNKLLRQHGLLGEVN
>345790859_Canis_lupis_familiaris_(Dog)
MATWDEKASSRRARVAPAERMSKFLKHFTVVGDDYHAWNVNYKKWENEEDDEEEEQPPP
TAASGEEGRADPTAAPTPRPPLDFRATLRKLFSSHRFQVIIICLVILDALLVLAELILD
LKIIQGDKNNYATKVFHYSSFAILTLFMMEVFLKLFVFRLEFFHHKFEILDTFVVVVSF
ILDLVLLFQKHEFEALGLLILLRLWRVARIINGIIISVKTRSERQLLRLKQMNIQLAAK
IQHLEFSCSEKEQEIERLNKLLRQHGLLGEVN
>148235789_Xenopus_laevis_(Frog)
MAGCLRHFTSVGDDTKKREWKQEDVEVAYEEPLKNTPHPFIASYSFRGALKWLLSSHKF
QIVIICLVILDALFVLVEVLLDLELLAEKVDHIIPEIFHYLSISVLTFFILEIAGKLYA
FRLEFFHHKFEVFDAAIVVISFIIDIVYISREDIFNAVGLLILLRLWRVARIVNGVIVS
VKTRAEEKMHKLKEQKGSLLEKVAQLEQQCAQQEQEIGRLHKLLQEHNVFPAS
>83774308_Aspergillus_oryzae
MASPSDPLLHEHTGPRSLRQRPIYLPEEQGQRIIAQWRRAARDFLSSRRGHYLVLLLVS
VDVACTFADFLIELHVCELTKHGSHVAIGWGVTQKVLAIVGLVFSCLFMLELMVTVFSF
GKGYFSSKFHVFDALVIIVAFGVDVALHGIEEELGSLIVVLRLWRVFKIIEELQSANED
TLEEYEHEIERLRQENTYLRQRLNVSLSNADPMD
>124360845_Medicago_truncatula
MIRVLSILLLTIDLIITILELSSSLVSCKQKINIVEELYFHWIGIGILSIISMKIIALL
VGLGFSFFKHPGYVVDGIVAIGALIMEVFLEKRGGGLLVVVSLWRVIRVVESVFELSDE
AIEAQIEGIVCQFEALKDENIRLLGIINEKDKLIEKLKEELDKCR
>109098724_Macaca_mulatta_(Indian_Monkey)
MATWDEKAVTRRAKVAPAERMSKFLKHFTVVGDDYHAWNINYKKWENEEDEEEEEQPPP
TPASGEEGRVAGPDAAPAPGPAPRAPLDFRGTLRKLFSSHRFQVIIICLVVLDTLLVLA
ELILDLRIIQPDKKNYAAMIFHYMSIAILALFMMEITFKLFVFRLEFFHHKFEILDAVV
VVVSFVLDVVLLFQEHEFEALGLLILLRLWRVARIINGIIISVKTRSERQLLRLKQMNV
QLAAKIQHLEFSCSEKEQEIERLNKLLRQHGLLGEVN
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>334327101_Monodelphis_domesticus_(opossum)
MGPKQWNNNSGSHTGSGQEELSEQHRQWVPLKDGSPRAMSRFLRHFTVVGDDHYKWNTR
YKKWDNEDEDDEQPQVPTGPAPGADVPGTESNAVQVPGETVTPPKAPPDFRTVMRKLFG
SHRFQVIIICLVIMDALLVLAELMLDLKIIQPDKDNYAARVFHYLSIAILTFFMIEVAL
KLYVFRLEFFYHKFEILDAVIVIISFVLDIVLLFQEHAFEALGLLILLRLWRVARIING
IIISVKTRSERQLSRLKLINHQLATKIQHLEFSCTEKEQEIERLNKLLRDHGLLE
>109809754_Mus_musculus_(Mouse)
MTSHDPKAVTRRTKVAPTKRMSRFLKHFTVVGDDYHTWNVNYKKWENEEEEEEPAPTSA
EGEGNAEGPDAEAGSASTPRQSLDFRSRLRKLFSSHRFQVIIICLVVLDALLVLAELLL
DLKIIEPDEQDYAVTAFHYMSFAILVFFMLEIFFKIFVFRLEFFHHKFEILDAFVVVVS
FVLDLVLLFKSHHFEALGLLILLRLWRVARIINGIIISVKTRSERQILRLKQINIQLAT
KIQHLEFSCSEKEQEIERLNKLLKQNGLLGDVN
>109497399_Rattus_norvegicus_(Rat)
MRGDTIHARGNRLGKGLEAWNAGRMAKQGEAVTRRTKVAPTKRMSRFLKHFTVVGDDYH
TWNVNYKKWENEEDEEEPAPTSAEGEGSAVGPDAEAGSASTPRPSLDFRSRLRKLFSSH
RFQVIIICLVVLDALLVLAELLLDLRIIEPDLSKYSTKVFHYLSLAILAFFVLEISLKV
FVFRLEFFHHKFEILDAIVVVVSFVLDLILLFKNHHFEALGLLILLRLWRVARIINGII
ISVKTRSERQILRLKQINLQLATKIQHLEFSCSEKEQEIERLSKLLRQNGLLEDVNVN
>187282419_Strongylocentrotus_purpuratus_(sea_urchin)
MFGFRRLSDTTKPSEGNDQQRVIVKDDSSDSVVSDSHDGHPARTEPLSLREKLHEIMET
QKFHIAILVLVVIDCILVIVELVIDFEVLSQEEGQCNATETDKEEKEVTAANVLHYISI
GILSIFMIELLIKIPVFRMEFFRSKLEVFDGIIIVISFVLDVVSLIYEEQFAVLQLLVL
LRLWRIVRVVNGVILSVETQAKKKIEQQKHLRAEVEHEMEKFRRYCAAQEKEIEVLRNT
LNQHGIQIDDDYVAKKPQFSLNQLNVVVEMNSADKHDTGEDEGEGEEGGGDGNTRRHEK
EREALGEHTITLTTDDNVNTIQADYHPQDTTFT
>50539752_Danio_rerio_(zebra_fish)
MSRYLKHFTAVGDNKSAVPTWHEEDTSHHVTTLHDAPDGLEVSTGQHLGQLSFRDSLRK
LYSTERFQIVVVCLVVLDAIFVLCELLIDLSIIEADHHRIAPQVFHYLSLALLTFFMVE
LAGKIFAYRLEFLHHKFEVFDGIVVVVSFILDIIYISKEDAFDAMGLLILLRLWRVARI
INGILVSVQNRANHRVEKLKEINESLVHQVNELKEQNTKMDQENVRLRALLKDHSIDF
>156364735_Nematostella_vectensis_(sea_anemone)
MESDNQQLVGQLVFDTQSLGERAMDKEIEVEVGDGGGDAQVVSSTPCWHILKDRPRLCE
IIHGQKAQYTIIALVIIDCIIVIAELLVDLEILKVHHDNPAPHILHDVSIAILSLFIIE
LIVKIYAMGMEFFHHKLEVFDGIVVIVSFALDIAFSGGNAAEGASLLIILRLWRVTRIV
NGIILSVKMQDEKKIHHLHKVIEELQEELDRLKTRNAELENELKTLKGTKEEPVAEEAT
T
>156374277_Nematostella_vectensis_(sea_anemone_baby)
MAEKVESVEQTAEDGKRQTFQNLNRRRSTKEWMQGGCGILRTSLGKMLTGITWQFTIIL
LVLVEVAINLVLMCISLNAINDSEQHFASRLLHFVGISILAIFALEVFLKLFALGIEYF
KIEKLEIFDAVIVITALIVEILLSATHTSKAWKSLGFVIGLRLWRVCRVITNIIEFREE
LYELIDESDGRSKRPTSSATETLHTERESLHETK
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>338727680_Equus_caballus_(Horse)
MRGASGTEDTKLSAVLGCNYKDTETVTRRPKVAPAERMSKFLRHFTVVGDDYHTWNINY
KKWENEEEEEEEEQAPPAPASGEEGRAAEPTAARVPAPRPPLDFRTMLRKLFSCHRFQV
IIICLVILDALLVLAELILDLKIIEADKNNYVPRVFHYMSLAILTFFMTEVSLKIFVFR
LEFFHHKFEILDAVVVVVSFVLDIVLIFREHEFEALGLLILLRLWRVARIINGIIISVK
TRSERQLLRLKQMNIQLAAKVQHLEFSCSEKEQEIERLNKLLQQHGLLGEVI
>345305006_Ornithorhynchus_anatinus_(Platypus)
MSTPHLGSARFYHLLRFEVSSRASGLRGLRLVIGDLQNFRVTIVCLVIVDALLVLAELL
LDLRIIHPDEKQVAPKVFHYLSICILTFFVVEVVLKMFVYRLEFFHHKFEVLDAVVVII
SFILDLVLLFREHEFEALGLLILLRLWRVARIINGIIISVKTRSEQQLSRLRQANLQLV
AKVQHLEFSCNEKEQEIERLNALLKQHGLIN
>156059386_Sclerotinia_sclerotiorum_(Fungal_pathogen)
MSRRNSDISEHAPLIRASSQPISITSELPYHHTPRLSFSRRLSNGYRKSRSYVRSFLST
RGQHYTVLLLVACDLIGIFADIIINLYQCDNDKEGKTDPIWNEVRVGLGIAGLVFSCLF
MLELIASVWAFGWSKFHCFDATVIVAGFVVDVLLHGIVEEVASLVIVLRLWRFFKIIEE
FSVGAQEQMDVLEERIEQLEMENKRLKKELRKRNDNDNDEDLENGERTR
>145234953_Aspergillus_niger
MRSPSDPLLASESQPLPPGQIYLPDEDDENTQSTEPLIARCRRSARNYLSSRFGHYLVL
FLVSVDVACVFADFLIEIYVCELEKKYKHVPSGWEDAQEALSITGLVFSCLFMLELVVA
VGSFGMSYFSSKFHIFDSAVIIVAFAIDVAMRGLVEELGSLVVVLRLWRVFKIIEELES
ANADSLEEYEREIDRLKEENYLLRRRAEFGSDGVN
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ClustalW Alignment
91992153_Human
118344228_Ciona
71897219_Chicken
6573743_Arabidopsis
116505721_Coprinopsis
329664616_Cow
345790859_Dog
148235789_Frog
83774308_Aspergillus
124360845_Medicago
109098724_Indian_Monkey
334327101_opossum
109809754_Mouse
109497399_Rat
187282419_sea_urchin
50539752_zebra_fish
156364735_sea_anemone
156374277_sea_anemone_baby
338727680_Horse
345305006_Platypus
156059386_Fungal_pathogen
145234953_Aspergillus

---------------------------------------------MATWD
MEGDNCNKSRHKSHNMINPNYASVRCTQPLPSVIQLRSRNKMIGITEDPS
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------MATWN
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EKAVTRRAKVAPAERMSKFLRHFTVVGDDYHAWNINYKKWENEEEEEEEE
SDSEPVSSNQPLLLTNLSYEVHTFNDNNNHERPAPQEQSTQNTMISMQSE
---------------MSRYLKHFTVVGDDPIQWSNDYQKWENEEEDNG------------MNIINTGTVDNVEFSIQNLIKSWCRRRKWRQLCNFSPKQ
-------------------------------------------------EKAVTRRARVAPAERMSKFLKHFTVVGDDYHAWNINYKKWENEE-EEEEE
EKASSRRARVAPAERMSKFLKHFTVVGDDYHAWNVNYKKWENEEDDEEEE
---------------MAGCLRHFTSVGDDTKKREWKQEDVEVAYEEPLKN
---------------MASPSDPLLHEHTGPRSLRQRPIYLPEEQGQ----------------------------------------------------EKAVTRRAKVAPAERMSKFLKHFTVVGDDYHAWNINYKKWENEEDEEEEE
QHRQWVPLKDGSPRAMSRFLRHFTVVGDDHYKWNTRYKKWDNEDEDDEQP
PKAVTRRTKVAPTKRMSRFLKHFTVVGDDYHTWNVNYKKWENEEEEEE-GEAVTRRTKVAPTKRMSRFLKHFTVVGDDYHTWNVNYKKWENEEDEEE----------------MFGFRRLSDTTKPSEGNDQQRVIVKDDSSDSVVSD
---------------MSRYLKHFTAVGDNKSAVPTWHEEDTSHHVTTLHD
-------MESDNQQLVGQLVFDTQSLGERAMDKEIEVEVGDGGGDAQVVS
---------------MAEKVESVEQTAEDGKRQTFQNLNRRRSTKEWMQG
TETVTRRPKVAPAERMSKFLRHFTVVGDDYHTWNINYKKWENEEEEEEEE
--MSTPHLGSARFYHLLRFEVSSRASG-------------------------------MSRRNSDISEHAPLIRASSQPISITSELPYHHTPRLSFSRR
---------------MRSPSDPLLASESQP--LPPGQIYLPDEDDENTQS
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ARIIA
QPPPTPVSGEEGRAAAPDVAPAP---GPAPRAPLDFRGMLRKLFSSHRFQ
QKSDRFTASNLGMFQYMKFEIGEDGDDHEEEAILTNREKLRHILHSKPIH
-------------------EKDSEIKLEPSRGHVTFQDVMKKLFSSRRFQ
QQEELISIN------------------------QQWRITLSNFLESYQVH
-----------------------------------------------MPL
QPPPTEASASAEEGRATDPTPAP---APVPRPRLDFRTTLRKLFSAHRFQ
QPPPTAASGEEG-----RADPTA---APTPRPPLDFRATLRKLFSSHRFQ
TPHPFIAS-------------------------YSFRGALKWLLSSHKFQ
--R----------------------------IIAQWRRAARDFLSSRRGH
-----------------------------------------------MIR
QPPPTPASGEEGRVAGPDAAPAP---GPAPRAPLDFRGTLRKLFSSHRFQ
QVPTGPAPGADVPGTESNAVQVPGETVTPPKAPPDFRTVMRKLFGSHRFQ
--PAPTSAEGEGNAEGPDAEAGS---ASTPRQSLDFRSRLRKLFSSHRFQ
--PAPTSAEGEGSAVGPDAEAGS---ASTPRPSLDFRSRLRKLFSSHRFQ
SHDGHPA----------------------RTEPLSLREKLHEIMETQKFH
APDGLEVSTGQH------------------LGQLSFRDSLRKLYSTERFQ
STP--------------------------CWHILKDRPRLCEIIHGQKAQ
GCG-------------------------------ILRTSLGKMLTGITWQ
QAPPAPASGEE--GRAAEPTAAR---VPAPRPPLDFRTMLRKLFSCHRFQ
-----------------------------------LRGLRLVIGDLQNFR
LSN----------------------------GYRKSRSYVRSFLSTRGQH
TEP----------------------------LIARCRRSARNYLSSRFGH
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IVSVMVILISIVSFCLETLPIFRDENEDMHGGGVT-/-GYQQSTSFTDPF
VIIICLVVLDALLVLAELILDLKIIQPDKNN-------------YAAMVF
VAIIVLVVLDSFLVVGELLIDLKVIIVPHGN-------------PAPEIL
IVIVFLVIVDALLVLGELLMDLKIIHPDKYH-------------IAPKVF
LFTIFLLSLDIILTSLELSSSLLSCTSVKKT------------ETENEWF
QIFIDVVFVLVELGYTLFNPNCSELEPRETP-------------VWMEAL
VIIICLVVLDALLVLAELVLDLKIIEPDKNN-------------YAPKVF
VIIICLVILDALLVLAELILDLKIIQGDKNN-------------YATKVF
IVIICLVILDALFVLVEVLLDLELLAEKVDH-------------IIPEIF
YLVLLLVSVDVACTFADFLIELHVCELTKHGS-----HVAIGWGVTQKVL
VLSILLLTIDLIITILELSSSLVSCKQKIN-------------IVEELYF
VIIICLVVLDTLLVLAELILDLRIIQPDKKN-------------YAAMIF
VIIICLVIMDALLVLAELMLDLKIIQPDKDN-------------YAARVF
VIIICLVVLDALLVLAELLLDLKIIEPDEQD-------------YAVTAF
VIIICLVVLDALLVLAELLLDLRIIEPDLSK-------------YSTKVF
IAILVLVVIDCILVIVELVIDFEVLSQEEGQCNATETDKEEKEVTAANVL
IVVVCLVVLDAIFVLCELLIDLSIIEADHHR-------------IAPQVF
YTIIALVIIDCIIVIAELLVDLEILKVHHDNP-------------APHIL
FTIILLVLVEVAINLVLMCISLNAINDSEQH-------------FASRLL
VIIICLVILDALLVLAELILDLKIIEADKNN-------------YVPRVF
VTIVCLVIVDALLVLAELLLDLRIIHPDEKQ-------------VAPKVF
YTVLLLVACDLIGIFADIIINLYQCDNDKEGK-----TDPI-WNEVRVGL
YLVLFLVSVDVACVFADFLIEIYVCELEKKYK-----HVPSGWEDAQEAL
: ::
. .
:
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FIVETLCIIWFSFEFLVRFFACPSKAGFFT-----NIMNIIDIVAIIPYF
HYMSITILVFFMMEIIFKLFVFRLEFFHHK-------FEILDAVVVVVSF
HGFSLSILSIFMVEIALKIIADHRHFIHHK-------VEVLDAVVVVISF
HYLSLSILTIFLVEVGFKIFVYGREFFHHK-------FEVLDSIVVVVSF
RWGGTVILSILAVKSMALVVAMGKSFFKQP-------GCVMDGTLAIVAL
SITSLALSALLVTEIPITVWCMGIQYFNPFGAVHWAALHLFDALINLATF
HYMSLAILTFFMMEIFFKIFVFRLEFFHHK-------FEILDTIVVVISF
HYSSFAILTLFMMEVFLKLFVFRLEFFHHK-------FEILDTFVVVVSF
HYLSISVLTFFILEIAGKLYAFRLEFFHHK-------FEVFDAAIVVISF
AIVGLVFSCLFMLELMVTVFSFGKGYFSSK-------FHVFDALVIIVAF
HWIGIGILSIISMKIIALLVGLGFSFFKHP-------GYVVDGIVAIGAL
HYMSIAILALFMMEITFKLFVFRLEFFHHK-------FEILDAVVVVVSF
HYLSIAILTFFMIEVALKLYVFRLEFFYHK-------FEILDAVIVIISF
HYMSFAILVFFMLEIFFKIFVFRLEFFHHK-------FEILDAFVVVVSF
HYLSLAILAFFVLEISLKVFVFRLEFFHHK-------FEILDAIVVVVSF
HYISIGILSIFMIELLIKIPVFRMEFFRSK-------LEVFDGIIIVISF
HYLSLALLTFFMVELAGKIFAYRLEFLHHK-------FEVFDGIVVVVSF
HDVSIAILSLFIIELIVKIYAMGMEFFHHK-------LEVFDGIVVIVSF
HFVGISILAIFALEVFLKLFALGIEYFKIEK------LEIFDAVIVITAL
HYMSLAILTFFMTEVSLKIFVFRLEFFHHK-------FEILDAVVVVVSF
HYLSICILTFFVVEVVLKMFVYRLEFFHHK-------FEVLDAVVVIISF
GIAGLVFSCLFMLELIASVWAFG----WSK-------FHCFDATVIVAGF
SITGLVFSCLFMLELVVAVGSFGMSYFSSK-------FHIFDSAVIIVAF
. . :: :
:
.* : : :
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ITLGTELAE-/-MSLAILRVIRLVRVFRIFKLSRHSKGLQILGQTLKAS
ILDIVLLFQ--EHQFEALGLLILLRLWRVARIINGIIISVKTRSERQLLR
GVDIALIFVGESEALAAIGLLVILRLWRVFRIINGIIVTVKTKADDRVHE
ILDLVLLFR--EHEFEAVGLLILLRLWRVARIINGIILSVKTRSEQQVSK
ILQVLLEKK-------GTGFIVVVSLWRVLRVVETAFELSDEAIEVQIDG
ILDLVLRGR----ERELASLLIILRLWRIAKLVSSVAVATDSLEEEVEAR
ILDLVLLFR--EHQFEALGLLILLRLWRVARIINGIIISVKTRSERQLLR
ILDLVLLFQ--KHEFEALGLLILLRLWRVARIINGIIISVKTRSERQLLR
IIDIVYISR--EDIFNAVGLLILLRLWRVARIVNGVIVSVKTRAEEKMHK
GVDVALHGI----EEELGSLIVVLRLWRVFKIIEELQSANEDTLEEYEHE
IMEVFLEKR-------GGGLLVVVSLWRVIRVVESVFELSDEAIEAQIEG
VLDVVLLFQ--EHEFEALGLLILLRLWRVARIINGIIISVKTRSERQLLR
VLDIVLLFQ--EHAFEALGLLILLRLWRVARIINGIIISVKTRSERQLSR
VLDLVLLFK--SHHFEALGLLILLRLWRVARIINGIIISVKTRSERQILR
VLDLILLFK--NHHFEALGLLILLRLWRVARIINGIIISVKTRSERQILR
VLDVVSLIY--EEQFAVLQLLVLLRLWRIVRVVNGVILSVETQAKKKIEQ
ILDIIYISK--EDAFDAMGLLILLRLWRVARIINGILVSVQNRANHRVEK
ALDIA-FSG--GNAAEGASLLIILRLWRVTRIVNGIILSVKMQDEKKIHH
IVEILLSATHTSKAWKSLGFVIGLRLWRVCRVITNIIEFREELYELIDES
VLDIVLIFR--EHEFEALGLLILLRLWRVARIINGIIISVKTRSERQLLR
ILDLVLLFR--EHEFEALGLLILLRLWRVARIINGIIISVKTRSEQQLSR
VVDVLLHGI----VEEVASLVIVLRLWRFFKIIEEFSVGAQEQMDVLEER
AIDVAMRGL----VEELGSLVVVLRLWRVFKIIEELESANADSLEEYERE
:::
::: : ***. :::
.
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LKQMNVQLAAKIQHLEFSCSEKEQEIERLNKLLRQHGLLGEVN------IKKKNSELELQIHNLEEKLSQKEQDMSRLHEILRCNNIDIPPTVPLTTSV
LKQVNLKLATKVEQLQHSCVEKEQEIERLTRMLKQHGLLSEQT------IISQFQALSKENRTLLETLAEKDEVIKMLEEELNRFKENGDIPFVKP--LEATKQELHRTKEELGKVEEEVFNLRQRLATFETKVVSNSAV-------LKQINIQLATKIQHLEFSCSEKEQEIERLNKLLRQHGLLGEVN------LKQMNIQLAAKIQHLEFSCSEKEQEIERLNKLLRQHGLLGEVN------LKEQKGSLLEKVAQLEQQCAQQEQEIGRLHKLLQEHNVFPAS-------IERLRQENTYLRQRLNVSLSNADPMD-----------------------IVCQFEALKDENIRLLGIINEKDKLIEKLKEELDKCR------------LKQMNVQLAAKIQHLEFSCSEKEQEIERLNKLLRQHGLLGEVN------LKLINHQLATKIQHLEFSCTEKEQEIERLNKLLRDHGLLE---------LKQINIQLATKIQHLEFSCSEKEQEIERLNKLLKQNGLLGDVN------LKQINLQLATKIQHLEFSCSEKEQEIERLSKLLRQNGLLEDVNVN----QKHLRAEVEHEMEKFRRYCAAQEKEIEVLRNTLNQHGIQIDDDYVAKKPQ
LKEINESLVHQVNELKEQNTKMDQENVRLRALLKDHSIDF---------LHKVIEELQEELDRLKTRNAELENELKTLKGTK----------------DGRSKRPTSSATETLHTERESLHETK-----------------------LKQMNIQLAAKVQHLEFSCSEKEQEIERLNKLLQQHGLLGEVI------LRQANLQLVAKVQHLEFSCNEKEQEIERLNALLKQHGLIN---------IEQLEMENKRLKKELRKRNDNDNDEDLENGERTR---------------IDRLKEENYLLRRRAEFGSDGVN---------------------------
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